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ABSTRACT 
It is well established that CD4+ T-helper cells are vital in the adaptive immune response 
and mediate the clearance of persistent pathogens.  Specific T-helper cell phenotypes that 
secrete distinct profiles of cytokines are generated in response to infection.  These 
cytokines orchestrate homeostasis and pathogen clearance through autocrine and endocrine 
signalling.  Dysregulation of this process can lead to inflammation and autoimmune 
disease.  Secretion of cytokines is facilitated by highly regulated SNARE proteins.  
SNAREs have been shown to form specific partnerships and facilitate membrane-
membrane fusion required for the exocytosis of cytokines and other proteins from immune 
cells.  Using an optimised in vitro model, isolated CD4+ T-cells were polarised into T-
helper cell subsets in order to profile SNARE expression and regulation.  Syntaxin-11 
(STX11) was identified as a candidate regulatory SNARE in Th1 and Th17 cells.   Further 
investigation in vivo using two mouse models of inflammation suggested that STX11 was 
regulated in Th17/Th1 mediated disease.  Finally, we examined Th1 and Th17 responses in 
STX11 deficient mice and demonstrated that in the absence of STX11, T helper cell 
secreted increased levels of IFN-γ and were unable to differentiate into a Th17 subset. The 
elucidation of SNARE trafficking pathways in CD4+ T-helper cells may represent potential 
therapeutic targets for blocking cytokine secretion from targeted cells and control 
inflammation.  It may also lead to a better understanding of SNARE deficient immune 
disorders such as familial haemophagocytic lymphohistocytosis - 4 (FHL-4), characterised 
by over production of cytokines and high number of activated lymphocytes due to STX11 
deficiency.  
  
 
CHAPTER 1  
 
 
 
GENERAL INTRODUCTION 
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1.1  INTRODUCTION 
The immune system has evolved to compose two arms of defence; the innate and adaptive 
immune system, which together can co-ordinate a response to invading pathogens and 
parasites.  The first line of defence in infection is the innate immune system which is made 
up of physical barriers, phagocytic cells, granule releasing killer cells and importantly, 
antigen presenting cells (APCs) (Janeway & Medzhitov 2002).  Dendtiric cells (DCs) in 
particular are highly specialised APCs that form part of an intricate link between the innate 
and adaptive immune response (Banchereau & Steinman 1998).  Many pathogens can 
overcome the innate system and switch on the adaptive immune system to mount a second 
specialised response to invaders (Janeway & Medzhitov 2002). 
1.1.1 ADAPTIVE IMMUNITY 
The adaptive immune system is capable of mounting a targeted specific type of immune 
response necessary to clear a multitude of different infections. It is a tightly regulated and 
controlled response that is often self limiting and therefore dysregulation can be the cause 
of auto immunity or inflammatory disease.  The adaptive immune system can mount two 
main types of response to infection; the first is a humoral response orchestrated by B-cells.  
B-cells, named for their origin in the bone marrow, present antibodies on their cell surface 
capable of binding a host of chemical structures (Hardy & Hayakawa 2001).  They attempt 
to target antigens on invading pathogen or infected cells.  Successful antibody responses 
convert B-cells into antibody secreting plasma cells producing large amounts of specific 
antibody targeting an invading pathogen and neutralising it or tagging it for killing by the 
innate responder cells (Mauri 2010).  Following completion of this task, the response is 
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suppressed, however some B-cells that recognise specific antigen persist and are converted 
to memory B-cells which become inert and migrate around the body ready to respond 
quickly to a repeat infection (Mauri 2010). 
The second response is the cellular T-cell mediated response.  T-cells develop in the 
thymus where a number of processes take place before deriving T-cells into one of two 
specific lineages identified by their cell surface receptor expression; CD8+ cytotoxic 
lymphocytes (CTLs) and CD4+ T-helper cells (Fink 2013).  In the thymus early T-cell 
progenenitors lack expression of CD4 or CD8 and undergo four cell surface marker stages 
(CD44 and CD25 derived) of development before a final stage of expressing CD4 ,CD8 
and a formed T-cell receptor (TCR) essential for activation and peptide recognition 
(Germain 2002).  The cells are then exposed to self antigens associated with the multiple 
histocompatability complex (MHC) that present antigen in a complex form on the surface 
of cells.  The MHC are subdivided into two main classes involved in antigen processing 
and presentation; MHC I and MHC II, which are associated with CD8 and CD4 
respectively.  If the cells become activated following engagement of MHC they are deleted; 
this is termed negative selection.  If the cells are not engaged they are deleted (Fink 2013).  
However, an intermediate interaction with self peptide results in the positive selection of 
the T-cell.  Interaction with MHC I peptide self antigen complex leads to CD8+ CTL cells, 
and interaction with MHC II-self antigen complex leads to the positive selection of CD4+ 
T-helper cells (Germain 2002). 
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1.1.2 MAJOR HISTOCOMPATIBILITY COMPLEX 
MHC I is expressed by all nucleated cells and its function is to present peptides from within 
the cell which form part of normal protein production mechanisms, CTLs recognise these 
as self peptides following the positive selection process, and do not engage with the cell.  
However, if the cell is cancerous or infected by a virus, it can present antigens on its 
surface in the MHC I complex which are not usually present and activates naïve CTLs.  
These CTLs become activated effector cells and respond to target antigen undergoing rapid 
expansion proliferating up to as many as 15 generations of cells within 7 days to produce 
an armoury of targeting killer cells (Bevan 2004).  CTLs act as directed killers of tumour 
and pathogen infected cells using two main methods; cell-cell contact and cell targeted 
secretion of granules containing factors that include perforin and granzymes.  Perforin and 
Granzyme form a complex that allows the granzyme to enter the cell where it induces 
apoptosis via caspase cleavage and activation.  Cell-cell contact cell death is mediated 
trough the Fas/Fas ligand pathways that also induce cell death via cleavage and activation 
of caspases in the cell (Russell 2002).  Some of these CTLs recognizing specific antigens 
will become CD8+ memory cells and facilitate a rapid killing response when the antigen is 
encountered again (Barber et al. 2003).   
MHC II is expressed by DCs following the phagocytosis of invading extracellular 
pathogens (Banchereau & Steinman 1998).  Internalised proteins are degraded by proteases 
and delivered in an MHC II complex to the cell surface.  They present peptides from the 
invading pathogens to CD4+ T-cells which undergo proliferation and differentiation into 
distinct T-helper subsets of cells when activated (J. Zhu et al. 2010).  Activation of CD4+ 
T-cells requires a number of signals to initiate this differentiation and prevent an 
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unnecessary immune response which can lead to inflammatory disease or autoimmunity 
(Jelley-Gibbs et al. 2000) 
1.1.2 CD4+ T-CELL ACTIVATION 
Dendritic cells are sentinels that reside in the skin and mucosa awaiting activation upon 
contact and recognition of pathogen associated molecular patterns (PAMPs) via toll like 
receptors (TLRs).  The activated DCs migrate through the lymphatic system to secondary 
lymphatic structures, spleen and lymph nodes, were T-cells reside.  Three signals from the 
activated DC are required for the full activation of T cells. The first is MHC II which is up-
regulated on activated DCs and engages with T-cells that recognise the antigen through the 
TCR and CD4 surface molecules (Kenneth Murphy  Mark Walport 2008).  This signal 
alone is not sufficient to activate the T-cells.  DCs may routinely present MHC II in 
complex with self antigens on their surface, recognition and activation to self antigen 
results in autoimmunity.  Therefore a second signal is required to ensure specific activation 
of the CD4+ T-cells.  Upon activation DCs up-regulate CD80, a member of the B7 family 
of receptors on the cell surface.  CD80 forms a complex with the CD28 surface receptor 
that is found on naïve CD4+ T-cells activating a co-stimulatory signalling cascade 
necessary for activation (Lenschow et al. 1996).  This leads to up-regulation of CD86 on 
the surface of DCs, a second member of the B7 family that engages CD28 on the T-cell 
providing co-stimulatory signals. Activation in the absence of co-stimulatory signals leads 
to cell anergy or deletion (Greenwald 2005).  A third signal that is crucial for activation, 
and specifically the differentiation of CD4+ T-helper cells, is cytokine signalling (Yamane 
& Paul 2012).  The cytokine environment in which the cell is activated will influence the 
type of CD4+ T-cell that is generated.  This cytokine milieu is dictated in part by the DC, 
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depending on the nature of its own activation via the TLRs (Banchereau & Steinman 1998).  
Specific CD4+ T-cell phenotypes are generated in order to adapt and provide a specific 
immunological response required to clear infection (Jiang & Dong 2013). 
1.1.3 CD4+ T-CELL SUBSETS 
CD4 T helper cells have a number of different functions. They assist B-cells in the humoral 
immune response facilitating antibody secretion and memory formation (Crotty 2011).  
They also enhance and maintain CD8+ T-cells responses  and regulate phagocyte function 
via secretion of cytokines (Bevan 2004).  CD4+ T-helper cells play an essential role in 
immune regulation and clearance of pathogens.  They carry out these specialised functions 
via polarisation into specific cell phenotypes that are defined by the expression of a unique 
set of transcription factors and secretion of specific key cytokines.  Interaction of CD4+ T-
cells with APC leads to TCR mediated stimulation which, along with the cytokine 
environment secreted by the APCs, dictates the transcriptional activation of naïve T-cells 
directing them towards a distinct Th phenotype (Yamane & Paul 2013). 
1.1.3.1 THE Th1/Th2 PARADIGM 
The first identification of different T-helper subsets of cells was the classification of Th1 
and Th2 cells by Mossmann and Coffman (1986).  They distinguished differences in clones 
in the CD4+ T-cell population; they differentiated the clones by the specific cytokine 
profiles they secreted and also their differences in cell surface marker expression.  Th1 
cells were classified by their production of IFN-γ, IL-2 and GM-CSF.  Th2 cells on the 
other hand produced IL-4, IL-5 and IL-13.   
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Two independent labs demonstrated the generation of IL-4 producing T-cells following 
activation in the presence of IL-4 (Le Gros 1990; Swain et al. 1990).  In the year following 
these studies, work published by Hsieh et al (1993) showed that IL-12, in the absence of 
IL-4, led to Th1 polarisation in vitro.  This study highlighted the fact that IL-4, the cytokine 
that drives Th2/IL-4 producing cells to secrete large amounts of IL-4, inhibited the 
generation of Th1 cells.  Th1 would later be shown to inhibit Th2 cells via IFN-γ mediated 
inhibition of IL-4 production (Gajewski & Fitch 1988).  IFN-γ production also stabilised 
differentiation of Th1 cells in an autocrine fashion and induce phagocytes to produce IL-12 
(Yoshida et al. 1994).  Therefore, in response to APC stimulation, Th1 or Th2 cells were 
polarised via cytokine signals secreted by the APC.  This T-cell subset would then produce 
cytokines to establish extrinsic feedback loops and stabilise differentiation while 
simultaneously inhibiting the other subset.  This provided an explanation for the stable Th1 
or Th2 responses observed in patients in response to different chronic infections 
(Romagnani 1994).  Th1 cells were later shown to be involved in delayed type 
hypersensitivity in which the immune response is cell mediated over a number of days.  
They promoted intracellular killing of pathogens in macrophages via IFN-γ secretion and 
promoted IgG production from B-cells.  Given that opsonising IgG antibodies tag 
pathogens for destruction via macrophage phagocytosis or cell-mediated cytotoxicity by 
CD8+ CTLs (Basu et al. 2013),  Th1 cells were identified as the helper cells involved in 
mobilising the immune system to clear intracellular pathogens. 
Th2 cells induced production of IgE and IgG1 antibodies. These antibodies promote mast 
cell and basopil degranulation, enhance mucus production and promote the development of 
eosinophils and aid in immune responses to parasitic helminths (Basu et al. 2013).  This 
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hypothesis was shown nicely in a study identifying that human CD4+ T-cell clones specific 
for M. tuberculosis were IFN-γ producing Th1 cells and CD4+ T-cell clones specific for the 
helminth Toxocara canis were mainly IL-4 producing Th2 cells (Delprete et al. 1991). 
Cytokine signalling is essential in deciding gene transcription programmes in T-cells via 
Type I/II cytokine receptor family.  Type I/II receptors signal through the Janus kinase-
signal transducer and activator of transcription (STAT) signalling pathway in order to 
initiate signalling pathways differentiating cell populations (Yamane & Paul 2012).  The 
current system of defining T helper subsets attributes specific STAT pathways, activated by 
cytokine signalling, to the transcription and expression of a “master regulator” gene.  Each 
cell lineage has been attributed to the expression of a master regulator and is in most cases 
responsible for the transcription of its key cytokine (Vahedi et al. 2013).  Following the 
establishment of Th1 and Th2 CD4+ T-cell clones, subsequent studies led to the 
identification of the transcriptional pathways that drive the commitment of these cells into a 
specific lineage (Zheng & Flavell 1997; Szabo et al. 2000) 
1.1.3.2 T-HELPER 2 CELLS 
Th2 cells have been generated in vitro via stimulation of the TCR and the addition of IL-4.  
IL-4 was shown to drive Th2 polarisation via the activation of STAT6 and STAT6 
knockouts fail to induce Th2 polarisation upon stimulation with IL-4 or IL-13 (Shimoda et 
al. 1996; Takeda et al. 1996; Kaplan et al. 1996).  Following this discovery, STAT6 was 
later revealed to be an activator of the transcription factor GATA-3 (Zheng & Flavell 
1997).  Ectopic expression of GATA-3 in Th1 cells induced IL-4 production and GATA-3 
expression (Ouyang et al. 1998).  Conditional GATA-3 knockout in cells led to an inability 
to drive Th2 polarisation and cells became Th1 polarised in the absence of IL-12 and IFN-
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γ.  This work also demonstrated the inhibitory role of GATA-3 on Th1 polarisation (Zhu et 
al. 2004).  Deletion of GATA-3 in established Th2 cells resulted in the loss of IL-5 and IL-
13 production but not IL-4, indicating that GATA-3 expression is required for the initial 
polarisation of Th2 cells but late IL-4 is regulated independently of GATA-3.  Indeed, IL-4 
and STAT6 deficient mice are still able to develop Th2 differentiation in response to 
infection, however GATA-3 is indispensible and GATA-3 deficient mice develop a Th1 
mediated IFN-γ response to infection with Nippostrongylus brasilienis (Yamane & Paul 
2012).  IL-2 mediated activation of STAT5 is also a requirement for Th2 development in 
vitro (Cote-Sierra et al. 2004).  Originally recognised as a T-cell growth factor, 
neutralisation of IL-2 in activated naïve CD4+ T-cell cultures inhibited Th2 polarisation in 
the presence of IL-4.  STAT5a deficient T-cells were unable to differentiate into a Th2 
subset following activation in the presence of IL-2.  This was rescued following ectopic 
expression of a constitutively active form of STAT5a demonstrating a requirement in early 
STAT5 activation in Th2 differentiation.  Activated STAT5 binds to the IL-4 genetic 
region and neutralisation of IL-2 leads to a loss in early IL-4 production but does not effect 
GATA-3 expression.  STAT5 is thought to bind and act to maintain the Il4 locus in an open 
configuration allowing access for transcription factors involved in Th2 differentiation.  So 
STAT5 is independent of GATA-3 signalling and over-expression of GATA-3 does not 
rescue the reduction in IL-4 production in the absence of STAT5 signalling (Zhu et al. 
2006).  STAT5 also maintains commitment in Th2 cells and its own expression in an 
autocrine manner.  STAT5 regulates expression of the IL-4Rα and is also important in 
maintaining IL-2R (CD25) expression during T-cell activation.  IL-2 produced by the 
activated cells then interacts with CD25 and activates STAT5.  GATA-3 can also act to 
 10 
maintain a positive feedback loop and acts directly on IL-4 production with STAT5, and 
IL-4 enhances IL-4Rα expression and also activates STAT6 to up-regulate GATA-3 
expression (Zhu 2010). 
It is clear that both GATA-3 and STAT5 are major elements that act synergisticically in the 
differentiation of Th2 cells.  The differentiation of these cells in vivo remains to be 
elucidated as IL-4 dependant and independent pathways can lead to Th2 differentiation, as 
demonstrated by the STAT6 and IL-4 knockout experiments (Yamane & Paul 2012).  It is 
possible that basal expression of GATA-3 is enough to drive Th2 cell responses in certain 
conditions and TCR receptor activation is also revealing mechanisms of Th2 differentiation 
depending on peptide dose stimulation; with low-dose stimulation of T-cells preferentially 
leading to Th2 cell responses.  What is clear from these findings is that GATA-3 is 
necessary for Th2 polarisation, but other cytokines and transcription factors are involved in 
the fine tuning of Th2 cell responses in vivo and their mechanisms are under investigation 
(Zhu et al. 2006).  Despite their important role in defence against extracellular pathogens 
and their regulated interaction with Th1 cells through inhibition and feedback mechanisms 
in the Th1/Th2 paradigm, Th2 cells will not be part of the focus of this thesis and therefore 
will not be discussed further. 
1.1.3.2 T-HELPER 1 CELLS 
Murphy and colleagues demonstrated that IL-12 induced Th1 cell differentiation via 
STAT4 (Jacobson et al. 1995).  This was later shown to be the inducer of the master 
regulator T-bet, a transcription factor that transactivates IFN-γ production, the key cytokine 
produced by Th1 cells.  In this study Szabo et al (2000) showed that T-bet was expressed in 
Th1, but not Th2 cells.  They also showed that T-bet induced IFN-γ production in 
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retrovirally transduced naïve T-cells and Th2 committed T-cells (Szabo et al. 2000).  
Furthermore, subsequent studies in T-bet deficient mice showed that these mice were 
unable to clear infections requiring an IFN-γ driven response and the cells showed 
defective IFN-γ production when stimulated with IL-12 in vitro (Szabo et al. 2002).  In line 
with the findings that Th1 and Th2 cells both inhibit the development of the other, T-bet 
was shown to directly inhibit GATA-3 and subsequent Th2 differentiation (Hwang et al. 
2005).  Conversely GATA-3 inhibits Th1 polarisation via repression of STAT4 and IL-
12Rβ2, the active receptor for IL-12 signalling (Usui et al. 2003).  IL-12 signalling induces 
IFN-γ production in Th1 cells and is a potent inducer of T-bet.  IFN-γ production therefore 
in turn stabilises T-bet expression in a positive feedback.  However, despite the ability of 
IFN-γ to induce T-bet expression, IFN-γ alone is not sufficient to drive Th1 differentiation 
(Macatonia et al. 1993; Seder et al. 1993).  IFN-γ drives early T-bet expression, however, 
this expression is repressed and returns after four days despite no change in IFN-γ 
expression.  This indicted that the second peak in T-bet that commits T-cells to the Th1 
lineage is IFN-γ independent (Schulz et al. 2009).  The IFN-γR is expressed on naïve CD4+ 
T-cells, but the IL-12Rβ2 necessary for IL-12 signalling and induction of IFN-γ and Th1 
differentiation is not expressed on naïve CD4+ T-cells and remains low in the first few days 
following activation (Afkarian et al. 2002).  This was explained in a two-step regulated 
sequential mechanism for Th1 differentiation of T-cells.  The role of early IFN-γ/STAT1 
signalling and late IL-12/STAT4 signalling was shown in an elegant study using Ifngr-/- 
mice and anti-IL-12 antibodies (Schulz et al. 2009).  TCR engagement induced early T-bet 
and IFN-γ expression and simultaneously suppressed IL-12-STAT4 activation via down-
regulation of the IL-12Rβ.  Loss of antigen signalling and increased IFN-γ production 
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increased the expression of IL-12Rβ and initiated the late induction of T-bet and 
commitment to Th1 phenotype via IL-12-STAT4 signalling.  This offered an explanation 
for the strong inhibition of Th1 cell differentiation following IL-12 mediated Th1 
differentiation in  cells from Ifngr-/- mice (Macatonia et al. 1993; Seder et al. 1993).  This 
study shows the synergistic requirement for both early IFN-γ signalling via STAT1 and late 
IL-12 commitment via STAT4 signalling.  Upon stimulation, Th1 derived cells also secrete 
the cytokine IL-2.  IL-2 activates STAT5 and regulates binding of T-bet to the promoter 
region of the gene encoding IFN-γ production (Ifnγ).  IL-2 activation of the STAT5 
pathway is also responsible for the induction of IL-12Rβ2 which leads to up-regulation of 
the IL-12R and imprinting of Th1 commitment.  The necessity of this pathway in the 
induction of T-bet and Th1 cell lineage commitment is still not confirmed (Yamane & Paul 
2012).   
Th1 cells secrete IFN-γ in high amounts in response to intracellular pathogens.  The 
secretion of IFN-γ has a wide range of effects on cell populations in vivo.  As described 
above, IL-12 secretion by APCs leads to Th1/IFN-γ responses and inflammation.  IFN-γ 
has also been shown to up-regulate the IL-12Rβ on the surface of T-cells leading to an 
increased response to IL-12 (Schroder et al. 2004).  It also has the effect of up-regulating 
IL-12 secretion in phagocytes thereby further driving and stabilising a Th1 response 
(Hochrein et al. 2001).  Furthermore, IFN-γ is a potent inducer of T-bet expression, and T-
bet regulates IFN-γ production in a number of other cells in the innate response (Schroder 
et al. 2004).   IFN-γ can act in co-ordinating a number of responses.  It is active in the 
response to microbial infection through its influence on macrophages inducing the 
NADPH-dependant phagocyte oxidase pathway and up –regulation of lysosomal enzymes 
 13 
promoting microbe destruction.  In viral infection responses IFN-γ induces antiviral 
enzymes and increases intracellular killing through activation of phagocytes creating an 
anti-viral environment (Schroder et al. 2004).   
Th1 cells also play a role in inflammatory responses to bacterial and viral infection in the 
gut.  The effects of Th1 cells in intestinal inflammation have been studied in isolation in the 
adoptive transfer model of colitis.  Naïve T-helper cells are transferred to RAG-/- mice that 
are lacking mature T and B-cell effectors due to a mutation in the recombination activating 
gene (Mombaerts et al. 1992).  Naïve T-cells migrate to the intestines and induce colitis in 
acceptor mice.  This model allows users to study the role of specific subsets of cells and 
their role in intestinal inflammation (Ostanin et al. 2009).  Interestingly, anti-IFN-γ 
antibody treatment can prevent intestinal inflammation in these mice.  Furthermore, 
transfer of naïve T-cells deficient in T-bet or STAT4, necessary for Th1 differentiation, fail 
to induce colitis in the adoptive transfer model.  Despite this, other studies suggest that T-
cell derived IFN-γ is not necessary for disease or that only early IFN-γ is necessary to 
initiate colitis in transfer mice (Shale et al. 2013).  So it would seem that IFN-γ is necessary 
to induce inflammation in the intestine but the role of Th1 derived IFN-γ requires further 
investigation.   
1.1.3.2 T-REGULATORY CELLS 
T-effector cells undergo extensive expansion once activated, and induce their own 
autocrine feedback loop in the immune response that stabilises the phenotype while 
simultaneously inhibiting others.  However, this response must be limited in some ways as 
a cascading inflammatory response would lead to auto inflammation or inflammatory 
disease without sufficient regulation.  Sakaguchi et al (1985) showed that the deletion of a 
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specific subset of CD5hi T-cells led to a variety of autoimmune diseases in mice.  In the 
study CD5lo cells were transferred alone into nude mice which developed autoimmune 
disease, the transfer of these cells along with CD5hi cells prevented disease suggesting a 
functional suppressing T-cell subset.  This subset was later identified as a CD4+ T cell 
subset (Powrie & Mason 1990), and subsequent studies characterised these cells as CD4+ 
CD25+ natural Treg cells (Sakaguchi et al. 1995; Takahashi et al. 1998; Thornton & 
Shevach 1998).  These natural Treg cells differ from T-helper effector cells in that they 
were derived in the thymus and not from CD4+ naïve pre-cursors in the periphery like Th1 
and Th2 cells.    Natural Treg cells regulate the immune response via migration to the site 
of infection and suppression of effector cells, particularly CD4+ T-helper cell subsets.  This 
is carried out via the secretion of anti-inflammatory cytokines including IL-10, and cell- 
cell contact inhibition.  Recently Treg cells were shown to also be inducible from naïve 
CD4+ T-cells via activation in the presence of TGF-β and further expansion by IL-2 
(Curotto de Lafaille & Lafaille 2009).  Natural Tregs (nTregs) and inducible Tregs (iTreg) 
are thought to co-operate in suppressing the immune response and the presence of iTregs 
greatly expands the antigenic diversity of the nTreg reponse and aids nTregs in immune 
regulation (Haribhai et al. 2011).  The transcription factor FoxP3 has been identified as the 
master regulating gene in Treg cells (Fontenot et al. 2003).  Fontenot et al (2003) 
demonstrated that mice with mutations in Foxp3 showed impaired development or 
dysregulated function of Treg cells resulting in severe autoimmune disease, inflammatory 
bowel syndrome and allergy.  Furthermore, ectopic expression of Foxp3 conferred a Treg 
like suppressive phenotype in CD4+ T-helper effector cells (Fontenot et al. 2003).   
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1.1.3.2 T-HELPER 17  
The Th1/Th2 paradigm was studied in detail for over 10 years before a more complicated 
picture of CD4+ T-cell phenotypes emerged.  In the early 2000’s, groups working on CD4+ 
T-cells studied the effects of blocking IFN-γ and IL-12 function in mouse models of 
autoimmune disease such as experimental autoimmune encephalitis (EAE) and collagen 
induced arthritis in order to study the suggested role of Th1 cells linked with these disease 
models.  Wild type and Ifng knockout mice developed autoimmune disease and 
demonstrated that the presence of IFN-γ was not crucial for development of EAE (Ferber et 
al. 1996).  The blockade of IL-12 was investigated in detail by Becher et al (2002) as 
previous work involving anti-IL-12 antibodies had shown a crucial role for IL-12 and Th1 
cells in EAE, but had targeted the IL-12p40 subunit of IL-12.  IL-12 is a heterodimeric 
cytokine made up of IL-12p35 and a common IL-12p40 subunit that is shared with other 
cytokines.  Interestingly IL-12p40-/- mice did not develop EAE, while in contrast IL-12p35-
/-
 mice were highly susceptible to EAE.  Neither the p40-/- or p35-/- mice were able to 
generate an IL-12p70 active heterodimer, therefore a cytokine other than IL-12 that used 
the IL-12p40 subunit was responsible for the induction of EAE.  The authors suggested that 
the heterodimer IL-23, made up of IL-12p40 and IL-12p19 may be key (Becher et al. 
2002).  This was confirmed in a later study showing that mice lacking the IL-12p19 subunit 
were resistant to EAE.  The same group went on to demonstrate that the mice lacking IL-23 
were resistant to collagen induced arthritis in mice and notably, that there was a correlation 
with a drop in IL-17 producing CD4+ T-cells suggesting a role for IL-23 in the generation 
of IL-17 producing CD4+ T-cells and subsequent disease in this model (Murphy et al. 
2003).  In 2005 two independent groups then identified IL-17 producing CD4+ T-helper 
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cells as a separate cell lineage from Th1 and Th2 cells (Harrington et al. 2005; H. Park et 
al. 2005).  IL-23 was believed to be responsible for the generation of Th17 cells but was 
later shown to have no effect on naïve CD4+ T-cells and thought to play a role in their 
maintenance (Aggarwal et al. 2003).  Naïve CD4+ T-cells were soon discovered to 
differentiate into Th17 cells when activated in the presence of IL-6 and TGF- β (Bettelli et 
al. 2006; Mangan et al. 2006; Veldhoen et al. 2006).  The transcription factor RORγt was 
identified as the master regulator involved in the differentiation of Th17 cells from naïve 
CD4+ T-helper cells (Ivanov et al. 2006).  In this study, Litmans group demonstrated that 
IL-17 producing T-cells in the intestinal lamina propria were absent in RORγt deficient 
mice.  Furthermore, they were unable to differentiate naïve RORγt deficient T-cells into 
Th17 cells upon activation in TGF-β and IL-6 in vitro (Ivanov et al. 2006).  The same 
group later showed that IL-6 induced the Th17 differentiation pathway via its essential 
requirement for STAT3 activation.  Furthermore, STAT3 led to the up-regulation of the IL-
23R and IL-23 was later confirmed to be an essential signal required in Th17 cell lineage 
commitment and expansion (McGeachy et al. 2009).  STAT3 activation also up-regulated 
the cytokine IL-21.  IL-21 is a member of the IL-2 family of cytokines and although it is 
produced by Th1 and Th2 cells, it is predominantly produced by Th17 cells (Korn et al. 
2009).  IL-21 works synergistically with TGF-β to regulate IL-17 and the IL-23R via 
STAT3 initiating a feedback loop for Th17 development (Korn et al. 2007).  This is of 
particular interest as Th1 and Th2 cells secrete IFN-γ and IL-4 respectively, each of which 
maintains the subset that they are secreted by in an autocrine fashion.  IL-17 does not affect 
Th17 cells and therefore this role seems to be carried out by secretion of IL-21.  The loss of 
IL-21 or its receptor results in a reduced number of Th17 cells in vivo and in vitro (Yamane 
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& Paul 2012).  Although IL-21 has been shown to drive a Th17 response with TGF-β in the 
absence of IL-6 (Yang et al. 2008), IL-6 is the dominant inducer of Th17 cells and IL-21 
may play a role in maintaining memory Th17 cells in vivo rather than being essential for 
differentiation (Korn et al. 2009).  This is supported by the dispensable role that has been 
shown for IL-21 as mice deficient in IL-21 or the IL-21R are still able to drive a Th17 
response in vivo (Sonderegger et al. 2008).    
IL-1 cytokine signalling has also been identified as playing a crucial role in Th17 
development in vivo.  The IL-1receptor IL-1Rβ is up-regulated on the surface of activated 
Th17 cells and was dependant on STAT3 and RORγt signalling.  Furthermore, Il1r1-/- mice 
failed to induce EAE in mice and disease was associated with a selective defect in Th17 
cells (Chung et al. 2009).  This study demonstrated the role of IL-1 in the differentiation of 
Th17 cells; however, IL-1 was shown to only function in the presence of IL-6.  IL-6 was 
previously demonstrated to enhance CD4+ T-cell responses to IL-1 and IL-23 and produce 
IL-21 (Yang et al. 2007; Zhou et al. 2007).  Interestingly, activation in the presence of IL-6, 
IL-1β and IL-23 was sufficient to differentiate Th17 cells in the absence of exogenous 
TGF-β.  However, TGF-β was not thought to be absent as it is produced by the T-cells and 
may be present in the serum.  This work presented a model where low concentration of 
TGF-β in the presence of IL-1 and other cytokines could drive a Th17 response (Chung et 
al. 2009). 
This would suggest that a three step model of differentiation of Th17 cells takes place in 
which TGF-β and IL-6 initiate the differentiation of Th17 cells through repression of Th1 
and Th2 cells subsets, initiation of IL-21 production as well as IL-1R and IL-23R 
expression.  Signalling via IL-21 induces a feedback mechanism that stabilises ROR-γt 
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expression and Th17 cell differentiation.  Finally, IL-23 signalling then commits the Th17 
cells and expands the cell population.  
 
Figure 1.1 - Classical CD4+ T-cell differentiation 
 
1.1.3.2 Th17/Treg AXIS 
TGF-β induces the differentiation of Th17 cells by suppressing T-bet and GATA-3 
expression in cells allowing for IL-6/STAT3 activation and up-regulation of the master 
regulator RORγt.  The balance of positive feedback loops and suppression of other T-cell 
effectors therefore is not reserved to the Th1 and Th2 subsets.  In fact T-bet has been 
shown to inhibit RORγt expression and Th17 cell differentiation via runx1 mediated 
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transactivation (Lazarevic et al. 2011).  The shared requirement of TGF-β for Treg and 
Th17 cells suggests that a balance is maintained between these pathogenic and regulatory 
subsets and that they share some early transcriptional programming before cell lineage 
commitment.  In fact, recent studies tracing IL-17+ cells in the gut revealed that at some 
point in their development some of these cells expressed Foxp3.  Furthermore, non-Treg 
cells have been shown to transiently express Foxp3 (Barbi et al. 2013).   Naïve CD4+ T-
cells stimulated in the presence of TGF-β without IL-6 will up-regulate Foxp3 and repress 
ROR-γt and IL-23R expression resulting in a Treg cell lineage commitment.  However, 
TGF-β in the presence of IL-6 or IL-21 induces activation of STAT3 and expression of 
RORγt overcomes Foxp3 repression (Zhou et al. 2008).  This leads to up-regulation of IL-
23R expression and Th17 cell lineage commitment (Barbi et al. 2013).  The balance of 
Tregs and Th17 cells seems dependant on the presence of IL-6 or other inflammatory 
cytokines in the presence of TGF-β.  This model has been hypothesised to maintain the 
delicate balance in immune homeostasis and anti-pathogenic clearance of the gut, where 
the majority of Treg and Th17 cells reside at the mucosal barrier.  When maintaining 
homeostasis, Treg development is favoured and these cells modulate and suppress the 
immune response.  However, when APCs encounter microbial antigens and begin 
producing pro-inflammatory cytokines such as IL-6, they switch differentiation to favour a 
Th17 phenotype in order to clear the infection (Maynard et al. 2012) 
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Figure 1.2 - Th17/Treg axis 
 
1.1.3.4 Th17 RESPONSES IN INFLAMMATION AND DISEASE 
The Th17 effector response initiates a recruitment and activation of large neutrophil 
populations.  This response is required to clear extracellular pathogens and fungi.  A 
requirement for Th17 cells is demonstrated in patients with Job’s syndrome who have a 
mutation in Stat3 leading to an inability to mount a Th17 response.  Patients are susceptible 
to infections with C. albicans and S. aureus in the skin and lungs (Miossec et al. 2009).  
Prior to the discovery of the Th17 subset of CD4+ T-helper cells, Th1 cells were thought to 
instigate the progression of autoimmune disease.  However studies of mice deficient in 
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IFN-γ and IL-12 did not confer resistance to autoimmnity, in fact the mice were more 
susceptible to disease.  The finding that the cytokine IL-23 is critical in inflammation and 
disease led to the discovery of Th17 cells in models of MS (EAE) and collagen induced 
arthritis clearly identifying crucial roles for Th17 cell in these diseases (H. Park et al. 
2005). Th17 effector cells play an important role in immune regulation at mucosal surfaces.  
They are particularly important in the gut where the majority of Th17 cells develop and is 
evidenced by high levels of IL-23, IL-1β and IL-6 during gut inflammation (Shale et al. 
2013).  Furthermore, patients susceptible to inflammatory bowel disease (IBD) show 
sequence variants in the gene coding for the IL-23R signalling necessary to commit and 
expand Th17 cell responses (Duerr et al. 2006)  The introduction of naïve isolated CD4+ 
RBHI T-cells into Rag-/- mice results in the migration of these cells to the gut and symptoms 
of IBD resulting from a Th17 driven response (Ostanin et al. 2009).  The generation of 
Th17 cells in the gut is of particular importance as noted by the lack of Th17 cells in the 
intestines of germ-free mice.  This is believed to be due to segmented filamentous bacteria 
(SFB) and their role in early development in Th17 cells.  SFB induced DCs to produce IL-6 
and IL-23 resulting in the accumulation of Th17 cells in the lamina propria of mice (Ivanov 
et al. 2009).  This finding further supports the role that Th17 cells play in the homeostasis 
of the gut and balance with commensal bacteria and pathogens.   
Indeed, the role of Th17 cells is further complicated by recent work suggesting a degree of 
plasticity in Th17 cells in vivo.  The discovery that Th17 cells share a common early 
transcriptional programme with Tregs led to a study showing that naïve T-cells activated in 
the absence of TGF-β results in the generation of a pathogenic Th17 cell subset (Ghoreschi 
et al. 2010).  In the case of EAE, an autoimmune mouse model of MS, IL-23 was shown to 
 22 
be critical in the development of disease suggesting a primary role for Th17 cells.  
However, T-bet expression usually associated with Th1 cells is also critical in the 
development of EAE.  Indeed, T-bet deficiency confers protection against a number of 
autoimmune diseases but a lack of IFN-γ infers an increased risk (Lee et al. 2012).  This 
contradictory finding resulted in the authors describing a pathogenic T-cell subset that was 
generated in the absence of TGF-β and resulted in IFN-γ and IL-17 producing Th17 cells 
expressing both T-bet and RORγt (Ghoreschi et al. 2010).  Therefore the disease is Th17 
driven but the cells take on a pathogenic phenotype due to T-bet and IFN-γ expression in 
vivo.  Although it is clear that these pathways are inhibitory of each other in development 
of a cell lineage, Th17 cells are able to undergo some plasticity after late commitment to 
the Th17 programme.    IL-23 has been linked to the expression of T-bet in Th17 cells and 
T-bet is suggested to increase IL-23R expression in a proposed feed-forward loop (Gocke 
et al. 2007).  These pathogenic IL-17/IFN-γ double producers (DP) are also implicated in 
colitis and an underlying reliance on the presence of IL-23.  Further analysis of this 
pathogenic subset by the Kuchroo group has resulted in a mechanism of Th17 switching 
dependant on T-bet expression and increased IL-23 signalling leading to a pathogenic Th17 
cell that does not produce IFN-γ (Lee et al. 2012).  The pathogenicity of these cells is 
linked to an increase in IL-23R expression and increased levels of GM-CSF production.  
GM-CSF as been described as a key cytokine in Th17 mediated disease and GM-CSF 
deficient mice are protected against EAE (Lee et al. 2012).  Furthermore the key cytokine 
inducing this pathogenic switching of Th17 cells was identified as TGF-β3 which the cells 
are induced to produce and drives this cell type.  Cells induced with TGF-β3 were potent 
inducers in EAE and the adoptive transfer model of colitis (Lee et al. 2012).     
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This pathogenic ability of Th17 cells in disease is not only regulated by the Treg cell 
population but may also be balanced by the discovery of IL-10 secreting Th17 populations 
activated in the presence of TGF-β and undergoing constant antigenic stimulation.  The 
gene for IL-10 is programmed in the transition to late phase (t=20hrs) in T-cells when 
stimulated with IL-6 and TGF-β (Yosef et al. 2013).  Secretion of IL-10 by Th17 cells may 
be a mechanism of self inhibition and regulatory control orchestrated by the suppressive 
effects of IL-10.  The suppressive regulatory role played by IL-10 is demonstrated in Il-10-/- 
mice which develop severe colitis (Rennick et al. 1997).  A number of studies have now 
identified IL-17+ IL-10+ Th17 cells as non-pathogenic Th17 cell and IL-23 would seem to 
be the driving factor in pathological Th17 cell development by down-regulating IL-10 
(McGeachy et al. 2007).  It is possible that Th17 cells switch their phenotype in a system 
that allows the Th17 cells another level of adaptive immunity catering for specific 
infections, existing within populations of generated Th17 cells.  Indeed Th17 cells have 
been shown to switch their secretion patterns depending on the nature of an infection.  
Th17 cells generated in mice infected with Candida albicans produce IL-17 and IFN-γ as 
described above.  However CD4+ Th17 cells from mice infected with Staphylococcus 
aureus are IL-17 and IL-10 producing cells (Shale et al. 2013).  It is clear that Th17 cells 
play a vital role in clearance and homeostasis and also contribute to autoimmune disease 
due to their inherent plasticity and regulatory role in the gut.  Interestingly this switch to a 
self limiting IL-10 producing subset is not limited to Th17 cells and Th1 cells have also 
been shown to produce late IL-10 via STAT4 activation and high antigen dose (Saraiva et 
al. 2009).  Clearly these self limiting mechanisms play a crucial role in regulating the 
pathogenic response of T-helper effector cells.  Although the conventional model of T-
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helper subset characterisation of STATs and master regulators clearly defines the early 
transcriptional commitment of these cells to their unique cytokine secretion profiles, more 
research is required to establish the complex networks involved in T-cell differentiation and 
plasticity over the lifetime of the subset (Vahedi et al. 2013).  Th17 cells in particular seem 
to display a unique ability to adapt to the cytokine environment and change phenotype 
necessary to maintain gut homeostasis or clear infection.  The balance of this response is 
clearly critical in the development of inflammatory disease and autoimmunity.    
1.1.3.4 OTHER EMERGING T-HELPER SUBSETS 
The discovery of Th17 cells lead to two more subsets of CD4+ T-cells being proposed 
based on their unique cytokine profiles.  The Th9 subset of cells is driven from naïve CD4+ 
cells activated in the presence of TGF-β and IL-4.  The identification of the transcription 
factor PU-1 as the gene necessary for the development of these cells has established them 
as an independent IL-9 producing subset of T-cells involved in inflammatory responses in 
the lung (Chang et al. 2010).  IL-22 is produced by Th17 cells and has been linked to skin 
homeostasis and inflammation through its interaction with epithelial cells and 
keratinocytes.  A subset of IL-22 producing Th22 cells were described by three 
independent labs when activated with IL-6 and TNFα by plasmacytoid DCs (Eyerich et al. 
2009; Duhen et al. 2009; Trifari et al. 2009)    These cells expressed skin homing receptors 
and were found in the skin of psoriasis patients indicating a role in skin inflammation (Tian 
et al. 2013).  Although no transcription factor has been identified in the generation of this 
subset of cells, a genomic transcriptome analysis revealed an up-regulation of Foxo4 and 
BCN2 in Th22 clones isolated from Th22 patients (Jiang & Dong 2013).  Another T-cell 
subset that is currently seeing a renewed interest is the follicular T-helper subset (Tfh).  
 25 
These cells are involved in B-cell help and aid antibody production.  They are found in the 
B-cell follicles of secondary lymphoid organs and help B-cells induce germinal centre 
formation (MacLennan 1994).  The recent discovery of the transcription repressor B-cell 
lymphoma 6 (Bcl-6) as a master regulator following activation of naïve cells in the 
presence of IL-6 and IL-21 has led to the conclusion that these cells represent an individual 
T-cell subset.  Dysregulated Tfh cell responses lead to autoimmune conditions 
characterised by production of auto-antigenic antibodies, while deficiencies result in an 
impaired humoral response to infection (Ma et al. 2012).      
1.1.4 PROTEIN TRAFFICKING 
Clearly the role of immune mediated cytokine release is essential and tailored to specific 
infections in vivo, creating environments adapted to enhance and regulate clearance.  
Protein trafficking is particularly important in immune cells that release immune mediators 
such as cytokines, chemokines and lysosomal enzymes.  This trafficking is highly regulated 
in order to prevent dysregulation, autoimmunity and inflammation and a number of 
mutations or deficiencies resulting in dysregulated trafficking can have major implications 
in immune syndromes (Stow et al. 2006). 
Depending on the required function of an immune mediator, different pathways exist to 
transport newly synthesised proteins out of the cell.  These pathways are usually shared by 
a number of factors and their release can be constant (constitutive release) or triggered 
(regulated release).  The pathway through which the mediators are released is dependant on 
their function and both of these pathways are mediated by vesicular traffic and regulation 
(Benado et al. 2009).     
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Proteins produced in the endoplasmic reticulum (ER) can be soluble and contained within 
vesicles or membrane bound and associated within the plasma membrane of transported 
vesicles, thus a number of proteins share transport to the plasma membrane to conserve 
energy (Benado et al. 2009).  The release of these proteins can be basal or dependant on 
their transcription at gene level in response to cellular signalling as discussed in detail 
above.  Proteins are transported from the ER through the cisternae of the golgi and trans-
golgi network (TGN) where they may undergo post-translational modifications (Jolly & 
Sattentau 2007).  Finally proteins are sorted and packaged into a vesicle for transport to the 
cell surface for release via a number of pathways, or incorporated into the plasma 
membrane of the cell.  These pathways are varied and include the use of recycling 
endosomes that traffic protein to and from the plasma membrane (Murray, Kay, et al. 2005; 
Hsu & Prekeris 2010). 
Regulated release of proteins from cells is inherently conserved in specialised cells such as 
neurons and secretory cells of the immune system.  Immune cells, particularly granulocytes 
such as mast cells, NK cells, CTLs and endothelial cells are capable of secreting large 
amounts of cytokine and immune mediators to a specific site on a cell in a rapid response to 
a specific signal.  Proteins can be processed and stored in granules called lysosome-related 
organelles (LSO) within the cell and held under the control of secretory mechanisms 
awaiting stimulus coupled rapid release for quick response to injury or indeed cell death 
signals inducing lytic release from CTL or NK cells (Benado et al. 2009).  
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Figure 1.3 - Regulated and constitutive release of cytokines 
 
1.1.5 SNARE PROTEINS  
The transport of vesicles between organelles, endosomes and the cell surface plasma 
membrane is controlled by a complex network of cellular machinery such as membrane 
associated proteins, lipids and cytoplasmic proteins.  The budding and fusion of vesicular 
carriers is carried out by multi-protein complexes and one family of proteins in particular 
facilitates the specific fusion of vesicles at target membranes in order to deliver cargo and 
additional lipids (Malsam et al. 2008).  Soluble-N-ethylmaleimide–sensitive factor 
accessory protein receptor proteins (SNAREs) are a large conserved family identified in the 
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docking/fusion machinery that allow membranes to overcome opposing forces and fuse 
docked lipid bilayers (Jahn & Scheller 2006). 
1.1.5.1 SNARE STRUCTURE 
There are currently 38 known mammalian members of the SNARE family of proteins  and 
they are all identified by a common conserved SNARE motif of 60-70 amino acids 
arranged in heptad repeats typical for coiled coils (Stow & Murray 2013).  Most SNAREs 
are type II integral membrane proteins that possess a single trans-membrane domain at their 
carboxy (C-terminal) end that is connected to the SNARE motif by a flexible linker, with 
the majority of the protein extending into the cytoplasm (Sutton et al. 1998).  Some 
SNAREs lack a trans-membrane domain and attach to membranes by post-translational 
acyl modifications such as palmitoylation. The SNAP-25 family of SNAREs, including the 
immune cell enriched variant SNAP-23, express a C-terminal cysteine rich domain ideal 
for palmitoylation.  This process covalently attaches fatty acid groups increasing 
hydrophobicity and membrane binding potential (Greaves et al. 2010).  Similarly, the 
SNARE STX11 also lacks a transmembrane domain.  However, although STX11 also 
expresses a cysteine rich domain, mutations at this site have shown that it may not be 
necessary for membrane binding and in fact STX11 may associate with the membrane by 
binding cognate SNARE complexes (Prekeris et al. 2000)      
The conserved coiled-coil SNARE motif is necessary for complex formation and 
membrane fusion.  A SNARE complex crystal structure was solved during the process of 
exocytosis and revealed the formation of a coiled-coiled four α-helical structure between 
SNARE proteins on opposing membranes.  All four helices arrange themselves so that their 
C-termini are at the anchor end of the complex leaving the rest of the protein available for 
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two-helix interactions (Sutton et al. 1998).  Vesicle and target membrane contribute helices 
that are embedded in the lipid bilayer in order to facilitate binding and fusion (Poirier et al. 
1998).  The complex that is formed is highly thermostable resisting temperatures up to 
90oC and resisting the denaturing effects of sodium dodecyl sulphite (SDS).  This 
extremely stable structure indicates that SNARE assembly is associated with a major 
release of energy (Fasshauer et al. 1998).  
When SNARES form in a tight helical bundle they form a conserved structure of an 
elongated coiled coil of four intertwined α-helices that correspond to the four interacting 
SNARE motifs occupying specific positions in the complex.  There is a highly conserved 
layer of interacting amino acids in the central hydrophobic core of the helical bundle 
consisting of three glutamines and one arginine.  Each of these contributing motifs 
contributes an amino acid and their structures are divided into sub-families used to classify 
the SNARES as R-SNAREs or Q-SNARES.   
R-SNARES are usually found on the membrane and have arginine (R) as the central 
functional residue in the SNARE motif.  Q-SNARES are mainly found on the target 
membrane and are defined by a central glutamine (Q) residue.  In order to form a complex 
and mediate membrane fusion, one R-SNARE and two or three Q-SNARE motifs are 
required to form a stable RQabc four helical bundle (Bock et al. 2001; Jahn & Scheller 
2006).   
The N-terminal of SNARE family members is less conserved than the SNARE motif and 
led to the Q-SNARE family being further divided into three sub-families Qa, Qb and Qc.  
All the Qa family members but only a portion of Qb and Qc members have an anti-parallel 
three-helix that varies in length and is connected to the SNARE motif at the N-terminus 
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and is called the Habc bundle (Jahn & Scheller 2006).  The Habc bundle interacts with the 
C-terminus and forms a closed conformational state in the SNARE preventing complex 
formation.   The role of this change in conformational state is regulatory and may act as a 
recruitment platform for accessory proteins involved in complex formation (Jahn & 
Scheller 2006).      The R-SNARE family currently consists of seven proteins, all of which 
are vesicle associated membrane proteins (VAMPs).  The N-terminal domains of R-
SNARES contain conserved profilin like folds called longin domains (Krzewski et al. 
2011). 
1.1.5.2 SNARE FUNCTION 
The fusion of membranes requires four SNARE motifs with at least one of these present on 
an opposing membrane.  The SNARE proteins interact to form the α-helix bundle that 
“zippers” together from the N-terminus to the C-terminus forming a trans-SNARE complex 
(or SNAREpin).  SNAREs are thought to act as catalysts in membrane fusion through this 
complex assembly which exerts mechanical forces on the complex that is then transferred 
to the membranes.  The energy provided by the zippering complex formation pulls the 
membranes together displacing the water and hydrostatic pressure keeping them apart, 
thereby facilitating the mixing of hydrophobic lipids (Jahn & Scheller 2006).  Once the 
membranes have fused, the trans-SNARE conformation is converted to a highly stable inert 
cis-SNARE conformation on the resulting fused membrane.  In order to dissociate this 
stable structure metabolic energy is required and this is provided by two chaperone 
proteins; N-ethylmaleimide-sensitive factor (NSF) and Soluble NSF attachment protein 
(SNAP) (Block & Rothman 1992; Clary & Rothman 1992).  It was the studies that 
identified these chaperone proteins as part of a complex necessary for efficient intracellular 
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transport that lead to the discovery of SNARE proteins.  The complex consists of NSF, 
SNAP and the cis-SNARE conformation resulting in a 20s particle structure (Hohl et al. 
1998).  NSF provides the energy required for disassembly, it is a member of the AAA+-
protein family that have been shown to function in unfolding proteins and aggregates (Jahn 
& Scheller 2006).  NSF is unable to bind without SNAP which binds to the surface of the 
SNARE proteins, a number of ATP-hydrolysis events then leads to the dissociation of the 
SNARE complex (Hohl et al. 1998).  This dissociation facilitates the recycling of SNARE 
proteins and prevents accumulation of SNAREs on the membrane.  Blocking NSF in cells 
in vivo has been shown to lead to accumulation of SNARES in membranes and cell death 
(Littleton et al. 2001).   The result of this disassembly is energy rich largely unfolded 
SNAREs that are available for repeated use in subsequent membrane fusion events 
(Malsam et al. 2008).          
The recycling of SNAREs transports them back to a specific location in the cell in which 
the SNARE operates.  They are carried on membranes and returned to their intracellular 
membrane where they function.  Most SNAREs function with specific partners although 
some SNAREs are more promiscuous and function in a number of complexes,  and there is 
also a level of redundancy in SNARE partnerships with other SNAREs substituting in a 
less efficient fusion reaction (Hohenstein & Roche 2001).  Many SNAREs operate 
predominantly in a specific subcellular compartment with their partners and some Qa 
SNAREs such as syntaxin 2 and syntaxin 4 are found on the plasma membrane and 
involved in fusion of vesicles and secretion of their contents from the cell.  Other Qa 
SNAREs including syntaxin 5 and the R-SNARE VAMP4 are localised in the golgi 
apparatus (Hong 2005).  These SNAREs are therefore found in the membranes of the donor 
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compartment, acceptor compartment and the intermediate trafficking vesicles (Jahn & 
Scheller 2006).   
 
Figure 1.4 – Functional SNARE cycle 
 
 
1.1.6 SNARE PROTEINS IN IMMUNE CELLS  
The specific locations and partnerships in which SNAREs operate means that studies 
defining the localisation of SNAREs and the proteins that they transport have led to the 
mapping of intracellular pathways in cells.  As previously discussed, some specialised cells 
of the immune system can store cytokines and immune mediators in pre-formed granules 
within cells primed for release via specific cell receptor signalling These include cells of 
the innate immune system; neutrophils, mast cells, eosinophils, NK cells and the CD8+ 
CTLs  of the adaptive immune response (Abraham & St John 2010; Melo et al. 2008; 
Borregaard et al. 2007; de Saint Basile et al. 2010).   
1.1.6.1 NEUTROPHILS 
Neutrophils make up the majority of circulating leukocytes and can rapidly enter tissue 
from the capillaries via the secretion of extravasating factors during inflammation.  
Trans-SNARE Trans-cis-SNARE Cis-SNARE 
20s complex 
Secretory granule 
Recycling of  
free SNARES 
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Neutrophils secrete four different types of granules and vesicles from the cell containing a 
large number of cytokines as well as surface receptors and adhesion proteins that promote 
extravasation.  These include primary (azurophilic), secondary (specific), and gelitinase 
(tertiary) granules and a pool of small secretory vesicles (Häger et al. 2010).  SNARE 
proteins and complexes have been described in the secretion of each of these populations 
however, specific mechanisms associated with cytokine release have not been reported 
therefore the data so far is implied but not directly demonstrated (Stanley & Lacy 2010).  
To date the SNARE complex of VAMP2-SNAP23-STX4 has been implicated in the release 
of secondary and gelitinase granule contents (Mollinedo et al. 2003; Martín-Martín et al. 
2000).  Another study indicated that VAMP1, VAMP2, and SNAP23 complexes were 
involved in the release of specific and gelitinase granules while VAMP1 and VAMP7 are 
mainly involved in the release of contents from azurophilic granules and most likely 
partners again with SNAP23 and STX4 at the surface (Mollinedo et al. 2006). 
Recently D’Orlando et al (2013) showed impaired degranulation from activated neutrophils 
isolated from STX11 deficient mice, suggesting a critical requirement for STX11 in this 
process.  However the mechanism or binding partners of this regulated release have not 
been established (D’Orlando et al. 2013).       
1.1.6.2 MAST CELLS 
Mast cells are tissue resident granulocytes secreting a large amount of cytokines, 
chemokines and growth factors via large granule and smaller secretory vesicle release that 
regulate wound healing and innate immunity.  The release of secretory granules is triggered 
by stimulation of mast cells by aggregated IgE through the FcεRI receptor and this has 
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served as a model for studying granule release from mast cells and mast cell lines (Lorentz 
et al. 2012). 
To date a number of SNAREs have been reported in mast cells including; SNAP23, the Qa 
SNAREs STX2, 3 and 4, and the VAMP family SNARES 2, 3, 4, 7 and 8 (Lorentz et al. 
2012).  SNAP23 and STX4 complex formation is again important for fusion at the cell 
surface.  Antibody inhibition of SNAP23 inhibited the release of granules from mast cells 
while in a separate study, the over expression of SNAP23 enhanced cell excytosis.  Both 
studies show that upon activation, SNAP23 relocated to the cell surface to facilitate 
degranulation and secretion (Guo et al. 1998; Vaidyanathan et al. 2001).  Similarly, siRNA 
knockdown of STX4 and over expression of STX4 but not STX2 or STX3 led to inhibited 
degranulation response in mast cells.  STX4 was also shown to localise at the membrane 
with SNAP23 following IgE induced activation of mast cells (Paumet et al. 2000; Woska & 
Gillespie 2011).  
A role for VAMP8 was investigated using cells from VAMP8 deficient mice.  This study 
revealed that the granule mediated release of histamine and β-hexosaminidase was reduced 
upon stimulation, but release of TNF, CCL2, IL-6 and IL-4 was not affected suggesting 
that VAMP8 is involved in pre-formed mediator secretion in mast cells.  This was further 
confirmed by the finding that VAMP8 deficient mice had diminished passive systemic 
anaphylaxis responses in vivo (Tiwari et al. 2008) 
Although a large arsenal of cytokines are released via degranulation from mast cells, some 
cytokines are transcribed and secreted via constitutive pathways following activation.  TNF 
has been shown to be up-regulated and expressed 1-2 hrs following degranulation of mast 
cells, and a study by Tiwari et al (2008) suggested that this is trafficked through VAMP3 
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mediated membrane fusion.  Similarly IL-6 is also newly synthesised and is not secreted 
via degranulation pathways, although the specific trafficking pathway has yet to be 
elucidated (Kandere-Grzybowska et al. 2003; Stow & Murray 2013).  Mast cells have been 
shown to make use of a secretion mechanism called piecemeal degranulation to 
constitutively secrete cytokines.  In this process small secretory vesicles bud from the 
larger secretory granules and then transport cytokines to the cell surface for release 
independently from the granules (Lacy & Stow 2011). Similar to neutrophils, there is little 
in the literature describing constitutive release mechanisms from mast cells, more work is 
needed to map the secretory pathways of cytokines and mediators from these cells (Lorentz 
et al. 2012) . 
1.1.6.2 NATURAL KILLER CELLS 
Natural killer (NK) cells perform a similar function to CD8+ CTLs and kill virally infected 
or tumorigenetic target cells through cytotoxic release of lytic granules (Stinchcombe & 
Griffiths 2007).  In a similar fashion to the mast cells, cytokines can be secreted from NK 
cells via degranulation or alternative vesicle secreting pathways.  Lytic granules in NK and 
CTL cells are targeted to the immunological synapse, the point at which the cell interacts 
with a target cell.  The lytic granules are released in a specific direction at the synapse to 
isolate effects to the target cell; however cytokine release from NK cells is multidirectional 
(Reefman et al. 2010) .  NK cells secrete TNF and IFN-γ in this manner and are believed to 
share the pathway of exocytosis as vesicles leaving the golgi have been shown to contain 
both cytokines (Reefman et al. 2010).  Although it is not known if TNF and IFN-γ leave the 
cell via the same mechanism, there is evidence to suggest that both VAMP7 and STX11 
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may be involved.  However, more research is required to elucidate these pathways and the 
specific roles of these SNARE proteins (Krzewski et al. 2011; D’Orlando et al. 2013). 
1.1.6 SNARE PROTEINS IN TNF-α TRAFFICKING FROM 
MACROPHAGES  
The most understood and studied pathway for constitutive cytokine secretion in immune 
cells is the exocytosis of TNF from macrophages.  Upon activation by invading pathogens 
via toll like receptors or cytokine stimulation, cells of the immune system upregulate 
protein trafficking and secrete large amounts of protein under regulated mechanisms.  TNF 
in particular is secreted rapidly upon macrophage activation and can be detected within 
10mins post activation (Shurety et al. 2000).  TNF is somewhat unique in that it is 
synthesised as a pre-formed transmembrane cytokine that requires post translational 
modification via proteolytic cleavage by TNF-α converting enzyme (TACE) thereby 
releasing TNF outside the cell (Moss et al. 1997).  The inhibition of TACE in macrophages 
has allowed for detailed imaging and tracking experiments on the constitutive release of 
TNF-α from macrophages and led to detailed mapping of its secretion pathway.  Initially 
the Qa-SNARE syntaxin 4 (STX4), located on the plasma membrane in eukaryotic cells, 
was shown to increase in expression in response to LPS activation in macrophages, 
indicating that SNARE expression is regulated in response to increased trafficking in these 
cells (Pagan et al. 2003).  Pagan et al (2003) further showed the requirement for STX4 at 
the cell surface by expressing a mutant form of STX4 in the macrophage cells that blocked 
delivery of TNF to the cell surface indicating a rate limiting step and requirement for 
specific SNAREs in exocytosis.  In a similar approach, Stow and colleagues showed that a 
SNARE complex consisting of STX6-STX7-Vti1b (vesicle transport through interaction 
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with t-SNAREs homologue 1b) was up-regulated and facilitates transport of TNF from the 
trans-golgi network (TGN) (Murray, Wylie, et al. 2005).  VAMP3 was later identified as 
the required associated R-SNARE in both of these fusion events, and interestingly was 
localised on the recycling endosomes suggesting a novel two-step pathway for secretion of 
TNF from the macrophage (Murray, Kay, et al. 2005).  TNF is transported from the TGN to 
recycling endosomes via membrane fusion facilitated by a SNARE complex of STX6-
STX7-Vti1b-VAMP3.  This recycling endosome then moves to the surface where the 
VAMP3 on the vesicle interacts with STX4 and SNAP23 at the surface.  SNAP23 
contributes two SNARE motifs to the complex resulting in a full trans SNARE bundle and 
membrane fusion (Murray, Kay, et al. 2005; Stow et al. 2006).  The relevance of the TNF 
being secreted through the recycling endosomes was later shown to be related to the 
contribution of membrane from the recycling endosomes to the plasma membrane to 
facilitate phagocytosis carried out by the cell.  TNF-α secretion is therefore explicitly 
linked to phagocytosis and VAMP3 was shown to be necessary for efficient phagocytosis 
(Stow et al. 2006).  
1.1.6 SNARE PROTEINS IN T-CELLS 
Tools such as TACE inhibitors to block TNF secretion, siRNA inhibition, transfection and 
triggered granule release mechanisms have all proved to be valuable tools in the elucidation 
of mechanisms and SNARE complexes playing a role in innate immune cell exocytosis.  
However, little work is published on T-cells which have proved more difficult to work 
with, for instance naïve T-cells cannot be transfected effectively in vitro by traditional 
methods without changing their phenotype and function. This has resulted in new methods 
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of gene inhibition being developed which may lead to more in depth studies on SNARE 
trafficking in T-cells (Yosef et al. 2013).    
T-cell cell lines are limited in their functionality and studies to date have mainly focused on 
formation and trafficking at the immunological synapse (the point at which the cell 
interacts with an APC or target cell) using human leukemia Jurkat T-cells (Das et al. 2004).  
These studies have identified SNAREs and their location within the cells indicating 
potential roles in secretion.  For example, SNAP23 and STX4 have been identified on the 
surface of Jurkat T-cells clustered at the immunological synapse (Das et al. 2004).  These 
SNAREs have been identified as receptor SNAREs for degranulation and vesicle fusing in 
neutrophils (Mollinedo et al. 2003; Martín-Martín et al. 2000) and mast cells (Paumet et al. 
2000; Woska & Gillespie 2011) and may play a similar role in T-cells.   
CD8+ CTL cells are capable of secreting cytokines via regulated lytic granule or 
constitutive vesicle release in a similar fashion to the innate granulocytes.  VAMP8 has 
been implicated in the secretion of lytic granules at the plasma membrane of CTLs.  Cells 
from VAMP8 deficient mice showed reduced efficiency in the secretion of lytic granules 
although the contents of the granules were unaffected when compared to the wild type 
controls (Loo et al. 2009).  A similar role for VAMP8 was shown in mast cells (Tiwari et 
al. 2008).  However, degranulation was reduced and not lost in these cells suggesting some 
redundancy in this pathway. 
Similarly, Vti1b has been shown to mediate lytic granule docking and release at the 
immunological synapse.  Vti1b was up-regulated at the transcriptional level in CTLs and 
lytic granules release was impaired in CTL cells from Vti1b deficient mice (Dressel et al. 
2010; Qu et al. 2011). 
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Another SNARE shown to be crucial for lytic granule release and cytotoxicity in CTLs is 
STX11.  Cells from STX11 deficient mice showed impaired degranulation when compared 
to cell from wild type mice.  Interestingly, constitutive cytokine secretion of  TNF and IFN-
γ was also affected by the deficiency in STX11 suggesting a possible role for STX11 in 
lytic granule and constitutive cytokine release pathways (D’Orlando et al. 2013). 
Recently a detailed study of SNARE expression and localisation in human CTLs was 
published by Pattu et al (2012).  In this study the authors looked at a panel of SNAREs and 
co localised them with lytic granules in the cell and the immune synapse to try and identify 
SNAREs involved in exocytosis in these cells.  This study showed the co-localisation of 
STX8 and STX16 with lytic granules at the immunological synapse as well as Vti1b which 
has been previously described (Pattu et al. 2012).  
Interestingly STX11 was localised at the immunological synapse, but despite its crucial 
role in lytic granule release, it was not co-localised with these structures suggesting an 
alternative function for STX11 prior to membrane fusion at the cell surface (Pattu et al. 
2012).       
There is limited research on the expression, regulation and function of SNAREs in CD4+ T-
cells.   In a study by Huse et al (2006), CD4+ Th1 like cells were derived from Th blasts 
from transgenic mice recognising a peptide of moth cytochrome c amino acids (MCC).  
Using these cells they identified two distinct directions for cytokine secretion in T-cells; 
synaptic and multi-directional, each co-localising with different pools of trafficking 
proteins during exocytosis (Huse et al. 2006).  The cytokines IL-2, IL-10 and IFN-γ were 
all secreted at the immunological synapse and co-localised with Vti1b, Rab3d and Rab19.   
Rab GTPases are a family of trafficking proteins involved in compartmental identity (Zerial 
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& McBride 2001).  Conversely, TNF, IL-4 and the chemokine MIP-1α was secreted in a 
multi-directional fashion and co-localised with Vti1b and STX6.  Each group of cytokines 
was also shown to co-localise with each other indicating that they share the secretion 
pathways.  A model of synaptic and multi-directional release allows a further level of 
control for T-cells to either influence the APC directly to modulate its response, or to 
secrete cytokines into the environment surrounding the cell and influence the cytokine 
milieu in response to a pathogen and recruit other cells to the site of inflammation.  There is 
evidence that the secretion of cytokines on these pathways is temporal and may be 
dependant on the requirements of the cells depending on the need to secrete at the synapse 
or in a multi-direction (Huse et al. 2006).  The steps to commitment and regulation of these 
pathways are unknown.  Furthermore, despite the identification of two differentially 
regulated pathways for secretion, the specific role of SNARE proteins in these pathways 
remains to be elucidated (Huse et al. 2008).  It is possible that SNAP23 and STX4 play a 
role in cytokine release from CD4+ T-cells evidenced by their identification on the surface 
of jurkat T-cells (Das et al. 2004).  Evidence from other immune cells suggest that these 
SNAREs may play a role in vesicle secretion at the immunological synapse, however the 
lack of SNAP23 in CTLs suggests that there are difference between T-cell phenotypes.  
VAMP3 was also identified as the cognate R-SNARE on the vesicles at the membrane (Das 
et al. 2004).  A two directional pathway of secretion suggests a viable model for trafficking 
groups of cytokines through a limited number of potential pathways to save cell energy.  
However, the temporal nature of the directional secretion, the polarisation of naïve cells 
into specific phenotypes and the plasticity of committed CD4+ T-cells suggest a more 
complicated level of regulation involving trafficking proteins and SNAREs.   
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1.1.7 PROJECT RATIONALE AND HYPOTHESIS 
It is well established that CD4+ T-helper cells are vital in the adaptive immune response 
and clearance of persistent pathogens.  Individual subsets are generated in response to 
signals from APCs that drive highly regulated, targeted T-helper cell subsets. 
Dysregulation of this process can lead to inflammation and autoimmune disease.  
Individual T-helper subsets release a distinct profile of cytokines that play role in 
homeostasis and disease mediated by autocrine and endocrine cytokine signalling (J. Zhu et 
al. 2010).  The profile of cytokines secreted is controlled at the transcriptional level 
depending on early cytokine signals and cell programming; however there is strong 
evidence that T-helper cells show considerable plasticity in late stages of differentiation, 
suggesting a number of complex regulatory pathways are involved (Vahedi et al. 2013; 
Bluestone et al. 2009)  
The release of cytokines from cells is facilitated by highly regulated SNARE proteins.  
SNAREs have been shown to form specific partnerships and facilitate membrane-
membrane fusion required for excytosis of  cytokines and other proteins from immune cells 
(Stow et al. 2006).  These specific SNARE partnerships may have a regulatory function in 
the cell providing another layer of control in the secretion of cytokines which can have 
such a profound effect on immune responses and inflammatory disease.  Therefore defining 
a role for SNAREs in these T-helper cells may uncover new therapeutic targets in such 
diseases.  
At present we have little understanding about the SNARE proteins that regulate the 
secretion of cytokines. Defining which SNAREs regulate release of cytokines such as IFNγ 
and IL-17 may help us better understand these complex trafficking pathways.  T-helper 
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cells are capable of producing a number of cytokines depending on their stimulation and 
subset differentiation.  A number of regulatory steps must therefore control the secretion of 
one cytokine but not another in a specific subset.  Given that T-cells are capable of 
secreting both IFN-γ and IL-17, we investigated the SNARE expression in early regulatory 
steps leading to either IFN-γ production, or IL-17 production in Th1 and Th17 cells 
respectively.  Using a combination of recombinant cytokines and neutralising antibodies, it 
is possible to polarise isolated CD4+ T-cells into T-helper cell subsets in vitro in order to 
study their regulation.  Once candidate SNAREs were identified using this model, they 
were investigated in vivo using mouse models of inflammation in order to confirm a 
regulatory role for SNAREs in T-helper mediated disease.   
The identification of trafficking pathways may present potential therapeutic targets for 
blocking cytokine secretion from targeted cell types and control inflammation.  It may also 
lead to a better understanding of SNARE deficient disorders such as familial 
haemophagocytic lymphohistocytosis - 4 (FHL-4), characterised by over production of 
cytokines and high numbers of activated lymphocytes due to STX11 deficiency.  To our 
knowledge there are currently no published data identifying SNARE proteins that play a 
direct role in the secretion of specific cytokines from CD4+ T-cells.     
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1.1.8 PROJECT AIMS  
• Establish a model of CD4+ T-helper cell isolation and differentiation  
• Characterise the T-cell subsets and their cytokine secretion profiles 
• Identify SNARE candidates involved in secretion of key cytokines from T-helper 
subsets 
• Investigate candidate SNAREs in in vivo models of inflammation 
• Elucidate a role for candidate SNAREs in T helper cell cytokine regulation using a 
specific knockout model deficient in a candidate  SNARE 
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CHAPTER 2  
 
 
 
MATERIALS AND METHODS 
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2.1 – MATERIALS  
 
CELL CULTURE MATERIALS 
Material Source 
Fetal Calf Serum Gibco 
Penicillin Streptomycin/Glutamine  Gibco 
RPMI-1640 Gibco 
DPBS Gibco 
Beta-mercaptoethanol Sigma-Aldrich 
6, 24, 96 well tissue culture plates Sarstedt 
Trypan Blue (0.4% w/v) Sigma-Aldrich 
 
TABLE 2.1 CELL CULTURE MATERIALS: All tissue culture materials/reagents used and 
corresponding sources. 
 
 
 
T-CELL DIFFERENTIATION REAGENTS 
Material Source 
rmIL-1b R&D systems 
rmIL-2 R&D systems 
rmIL-4 R&D systems 
rmIL-6 R&D systems 
rmIL-12 R&D systems 
rmIL-23 R&D systems 
rmIFN-γ R&D systems 
rhTGF-β BioLegend 
Anti-mouse IL-4 neutralising antibody R&D systems 
Anti-mouse IFN-γ neutralising antibody  R&D systems 
Anti-mouse CD3 monoclonal antibody BD 
Anti-mouse CD28 monoclonal antibody BD 
 
TABLE 2.2 DIFFERENTIATING CYTOKINES AND ANTIBODIES: All differentiating reagents 
used and corresponding sources. 
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ELISA REAGENTS 
Material Source 
96-well microtitre plate Nunc 
3,3’,5,5’-tetramethyl-benzidine (TMB) R&D systems 
Tween 20 Sigma-Aldrich 
Bovine serum albumin Sigma-Aldrich 
ELISA DuoSet kits 
Sodium azide (NaN3) 
Ready Set Go IL-21 ELISA kit 
1X PBS 
TMB Reagent 
R&D systems 
Sigma -Aldrich 
eBiosciences 
Gibco 
eBiosciences 
 
TABLE 2.3 ELISA REAGENTS: All ELISA reagents used and corresponding sources. 
 
 
 
FLOW CYTOMETRY AND FACS REAGENTS 
Material Source 
FACS Flow BD 
FACSRinse BD 
FACSClean BD 
37% (v/v) paraformaldehyde Sigma-Aldrich 
Fetal bovine serum Sigma-Aldrich 
Sodium azide Sigma-Aldrich 
EDTA Sigma-Aldrich 
Propidium iodide solution Miltenyi biotech 
CFSE eBiosciences 
Tween 20 Sigma-Aldrich 
Triton X-100 Sigma-Aldrich 
Saponin from quillaja bark Sigma-Aldrich 
Anti-IFN-γ antibody BD 
Anti-IL-17 antibody BD 
Anti-RORγt antibody eBioscience 
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Anti-T-bet antibody BD 
Anti-CD3 antibody BD 
Anti-CD4 antibody BD 
Anti-CD44 antibody BD 
Anti-CD62L antibody BD 
Anti-CCL5 antibody BD 
Anti-CD25 antibody BD 
 
TABLE 2.4 FLOW CYTOMETRY AND FACS REAGENTS: All flow cytometry reagents used and 
corresponding sources. 
 
 
 
RNA ISOLATION AND cDNA SYNTHESIS 
Material Source 
Nucleospin RNA II Columns Fisher Scientific 
DEPC treated water Invitrogen 
High Capacity cDNA Reverse                        
Transcription Kit 
Molecular grade ethanol (EtOH) 
Molecular grade isopropanol 
Applied Biosystems 
 
Sigma-Aldrich 
Sigma-Aldrich 
 
Table 2.5 RNA ISOLATION REAGENTS: All reagents used in the isolation of mRNA and 
corresponding sources. 
 
 
 
qPCR REAGENTS 
Material Source 
TaqMan® Universal Mastermix Applied Biosystems 
MicroAmp® Optical 96-well plate Applied Biosystems 
MicroAmp® Optical Adhesive Film Applied Biosystems 
TaqMan® Gene Expression Assays Integrated DNA technologies 
 
TABLE 2.6 QUANTATIVE PCR REAGENTS: All qPCR reagents used and corresponding sources. 
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LAMINA PROPRIA ISOLATION REAGENTS 
Material Source 
HBSS (calcium, magnesium free) Gibco 
EDTA Sigma-Aldrich 
Collagenase V Sigma-Aldrich 
Collagenase D Gibco 
Dispase  Roche 
DNase Roche 
RPMI Gibco 
TABLE 2.7 LAMINIA PROPRIA ISOLATION REAGENTS: All reagents used and corresponding 
sources. 
 
IMMUNOHISTOCHEMISTRY REAGENTS 
Material Source 
Acetone Sigma-Aldrich 
HCl Sigma-Aldrich 
Sodium bicarbonate Sigma-Aldrich 
EtOH Sigma-Aldrich 
Harris Haematoxylin Sigma-Aldrich 
Eosin Sigma-Aldrich 
Histoclear National diagnostics 
Histobond Microscope slides RA Lamb 
OCT compound Tissue-Tek 
TABLE 2.8 LAMINIA PROPRIA ISOLATION REAGENTS: All reagents used and corresponding 
sources. 
 
 
 49 
2.2 – ISOLATION AND CULTURE OF CD4+ T-CELLS  
All tissue culture was carried out using aseptic technique in a class II laminar airflow unit 
(Holten 2010- ThermoElectron Corporation, OH, and USA). Cells were maintained in a 
37°C incubator with 5% CO2 and 95% humidified air (Model381- ThermoElectron 
Corporation, OH, and USA). Cells were grown in complete RPMI-1640 medium 
(cRPMI) (Krummel et al. 2000). FBS was heated at 57oC for 30 mins and then aliquoted 
for storage at -20°C. Supplemented medium was stored at 4°C for no longer than three 
months. 
2.2.1 – CELL ENUMERATION AND VIABILITY ASSESSMENT  
Cell viability was assessed using the Trypan blue exclusion method. This method is based 
on the principal that dead or dying cells which do not have an intact cell membrane will 
allow the trypan blue to enter the cell, staining the cell blue and allowing it to be 
excluded from the viable cell count.  Trypan blue solution (0.4% (v/v)) was mixed in a 
1:1 solution with the cell suspension (diluted as necessary) and after ~2 min cells were 
applied to a brightline haemocytometer (Sigma) and examined under high-power 
magnification (×40) using an inverted microscope (Olympus CKX31, Olympus 
Corporation, Tokyo, Japan). Cells inside the 1mm square grid at each corner were 
counted and averaged [figure 2.1, circled in red].  The number of cells was then 
calculated using the formula:  Cells/ml = N x D (x 104).  Where N = average number of 
cells counted in each of the squares and D = the dilution of cells in PBS. 
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Figure 2.1: Cell enumeration using the haemocytometer 
 
2.2.2 – ISOLATION OF CD4+ T-CELLS 
Primary T-cells were isolated aseptically from female Balb/c mice aged 6-12 weeks.  All 
mice were sourced from Charles River and housed in a Specific Pathogen Free (SPF) 
unit.   
2.2.2.1 – SPLEENOCYTE ISOLATION 
Spleens were removed aseptically and collected in RPMI/10% (v/v) FBS on ice.  A single 
cell suspension was achieved by pushing each spleen through a cell strainer (40µm, BD 
falcon).  Cells were then washed with RPMI/10% (v/v) FBS and counted.  
2.2.2.2 – CD4+ T-CELL MAGNETIC PARTICLE ISOLATION  
(Stemcell technologies- Easysep© Mouse CD4+ T-cell isolation  kit #19852) 
(Stemcell technologies- Easysep© Mouse naïve CD4+ T-cell isolation  kit #19765) 
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Cells were prepared in recommended medium at a concentration of 1x106 cells/ml.  The 
cell solution was then placed in a 5ml polystyrene falcon tube (BD Biosciences).  The 
Easysep™ mouse CD4+ T-cell enrichment cocktail was then added at 50µl/ml of cells, 
mixed well and left at room termperature for 10 minutes.  The cocktail contains a 
selection of antibodies targeting cell surface markers of all cells excluding T-cells. The 
cocktail for the CD4+ T-cell isolation consisted of antibodies directed against all non-
CD4+ cells: CD8, CD11b, CD11c, CD19, CD24, CD45R, CD49b, TCRγ/δ and TER119.  
The naïve CD4+ T-cell isolation cocktail contained antibodies directed to all non-naïve 
CD4+ T-cells: CD8, CD11b, CD11c, CD19, CD24, CD25, CD44, CD45R, CD49b, 
TCRγ/δ.  The Easysep™ streptavidin rapidspheres™ were vortexed well, added at 
75µl/ml of cells, mixed well and left at room temperature for 2.5 minutes.  The 
suspension was then made up to 2.5mls total volume and mixed gently before placing in 
the Easysep™ magnet at room temperature for 2.5 minutes.  The supernatant that was 
poured off contained the CD4+ T-cells and naïve CD4+ T-cells.  These cells were 
centrifuged at 300g for 5mins, enumerated and resuspended in cRPMI media. 
2.2.2.3 – CD4+ T-CELL COLUMN ISOLATION  
(R&D systems – mouse CD4+ T cell subset column kit MCD4C-1000) 
2X108 spleenocytes in 2ml of column wash were mixed with 1 vial of monoclonal 
antibody cocktail and incubated at room temperature for 15 minutes.  During this 
incubation period the column was washed with 10mls of column buffer.  After 
incubation, cells were washed twice with 10mls of column wash and finally resuspended 
in 1ml of column wash.  The cells were added to the column and any liquid displaced 
from the column collected in a sterile falcon tube.  Once the cells had moved into the 
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column, the bottom cap was replaced and cells left in the column at room temperature for 
10 minutes.  This allowed B cells, non-selected T cells and monocytes to bind to the glass 
beads coated with anti-immunoglobulin via both F(ab) and Fc interations.  The column 
was eluted with 10mls of column buffer.  Eluted CD4+ positive T-cells were centrifuged 
(250g for 5 minutes), resuspended in cRPMI and counted using trypan blue exclusion 
method.  Cells were adjusted to the required concentration with cRPMI. 
2.2.3 – POLARISATION OF CD4+ T-CELLS 
Cells were stimulated using agonist antibodies directed to CD3 (clone: 145-2C11 BD 
bioscience) and CD28 (clone: 37.51 BD).  Cells were stimulated in the presence of 
polarising cytokines.  The cocktails used to drive specific T-cell subsets and their 
concentrations are represented in Table 2.9. 
Phenotype Cocktail Concentration Clone Source 
Naïve rmIL-2 10ng/ml  R&D 
TH1 rmIL-12 
anti-IL-4 
10ng/ml 
10µg/ml 
 
 
 
R&D 
R&D 
TH2 rmIL-2 
rmIL-4 
anti-IFN-γ 
10ng/ml 
10ng/ml 
10ug/ml 
 
 
 
R&D 
R&D 
R&D 
TH17 rmIL-1β 
rmIL-6 
rmIL-23 
rhTGF-β 
anti-IFN-γ 
anti-IL-4 
10µg/ml 
20ng/ml 
10ng/ml 
2ng/ml 
10µg/ml 
10µg/ml 
 
 
 
 
 
 
R&D 
R&D 
R&D 
R&D 
R&D 
R&D 
Table 2.9 List of polarising cocktails and concentrations 
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2.3 – FLOW CYTOMETRY 
2.3.1 – BASIC PRINCIPLES OF FLOW CYTOMETRY  
Flow cytometry uses the principles of hydrodynamic focussing to present cells for 
interrogation to a laser light source, one cell at a time.  Data is collected for each 
individual cell, providing information about the size and granularity.  Expression of 
individual protein markers on the surface, or within a cell, can be measured using 
targeted monoclonal antibodies.  These antibodies are conjugated to fluorochromes 
emitting light at various wavelengths.  Following excitation from the flow cytometer 
LASER light source, scattered light is collected by photomultiplier tubes (PMT) 
measuring fluorescence intensity and side scatter (SSC), an indication of cell granularity 
and complexity.  The size of the cell is determined from the forward scatter (FSC) 
detector usually a photodiode.  A photodiode (as opposed to a PMT) is used as the 
detector for the forward scatter owing to the intensity of the light from the LASER source 
emitted directly at the FSC detector.  
Using these parameters individual cells in a complex mixture can be characterised and 
identified.   
2.3.2 – FLUORESCENCE ACTIVATED CELLS SORTING (FACS) 
As the flow cytometer measures the characteristic features on each cell, some machines 
have the capacity to sort cells into individual tubes resulting in pure yields of a single cell 
type.  This is referred to as Fluorescence Activated Cell Sorting (FACS).  FACS 
machines work using charged droplets and an electrostatic deflection system.  An 
oscillation device is used to vibrate the stream and cause it to break into droplets.  The 
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machine is tuned so that each droplet contains a single cell.  This droplet has a charge 
applied to it and it is directed through the electrostatic deflection system into an 
individual tube.  Target tubes for each cell type are assigned when setting the sort 
parameters.  Cells are then sorted to target tubes based on the analysis of each individual 
cell immediately before breaking into a drop from the stream.  In this way individual 
populations of cells can be obtained from heterogenous mixtures at high speed and with 
accuracy. 
2.3.3 – CELL SURFACE MARKER STAINING 
Cells were removed from tissue culture and placed in a 96-well round bottomed plate for 
staining with each well containing 200,000-400,000 cells.  An equal amount of FBS was 
added to block non-specific binding sites on the cell surface.  Cells were then centrifuged 
at 250g for 5mins.  The supernatant was removed and the cells resuspended in FACS 
buffer [See Appendix A].    The plates were centrifuged again and the cell pellet was 
resuspended in 100µl of antibody or isotype mixture as determined by a titre of each 
antibody used.  The plates were incubated in the dark at 4oC for 30mins.  Following 
incubation cells were washed twice with 200µl FACS buffer, and centrifuged for 5mins 
at 250g between washes.  Cells were analysed immediately.  Alternatively cells were 
fixed using a 4% formaldehyde/PBS solution and stored at 4oC in labelled falcon tubes 
for analysis at a later time.  Data was acquired using a FACS Aria (BD Bioscience).  Data 
was analysed using FlowJo Software (TreeStar).   
 55 
2.3.4 – STAINING ANTIBODY TITRATION  
All antibodies used were titrated to acquire the best possible fluorescent signal using the 
least amount of antibody possible.  This technique leads to more efficient staining and a 
reduction in steric hindrance where bulky fluorophores such as Phycoerythrin (PE) can 
block potential binding sites when using multi-colour flow cytometry analysis.  This is 
especially prevalent in intracellular staining.  Cells were stained with a serial dilution of 
antibody.  The Mean Fluorescence Intensity (MFI) was measured for each sample and the 
log MFI was plotted against the concentration of antibody used.  This curve shows a 
point of saturation and a concentration of antibody was selected after this point. 
2.3.5 – INTRACELLULAR PROTEIN STAINING 
Intracellular protein staining involves permeabilisation of the cell membrane to allow 
staining antibodies to pass into the cell and bind target epitopes.  The method of 
permeabilisation can greatly affect the cell membrane and the epitopes immediately 
inside or on the surface of the cell.  For this reason, when staining both surface markers 
and intracellular proteins, the cells are surface stained as described in 2.3.3 before fixing 
and permeabilising for intracellular staining.   
2.3.5.1 – INTRACELLULAR TRANSCRIPTION FACTOR STAINING 
Following the surface staining, cells were washed with FACS buffer and resuspended in 
1% Triton-X100 detergent in PBS.  Triton X-100 is a detergent that partially dissolves 
the nuclear membrane and is therefore very suitable for nuclear antigen staining.  Cells 
were washed twice in a 0.1% Triton-X100 solution by centrifuging at 300g for 5 mins.  
The cells were resuspended in a 1% Triton-X100 solution containing the antibodies and 
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incubated for 30mins at 4oC.  Following this cells were washed twice in 0.1% Triton-
X100/PBS solution.  The cells were then washed twice with FACS buffer and finally 
resuspended in FACS buffer for analysis. 
2.3.5.2 – INTRACELLULAR CYTOKINE STAINING 
T-cells were cultured in polarising conditions for 4 days.  On the last day monensin was 
added to the culture and the cells were stimulated with Phorbol 12-Myristate 13-Acetate 
(PMA) (50ng/ml) and Ionomycin (1µg/ml).  These chemicals are useful for quickly 
inducing and stimulating T-cell populations.  PMA stimulates cells through the protein 
kinase C activation and ionomycin is a calcium ionophore.  The monensin halts transport 
of synthesized proteins from the cell trapping large amounts of cytokine within the cell 
allowing characterisation of cell cytokine production.  The cells were stimulated for 4 hrs 
with monensin added for the last 2 hrs.  The cells were collected by centrifuging at 690g 
for 5mins.  Cell surface epitopes were stained as described in 2.3.3 before 1x106 cells 
were resuspended in cold 3% para-formaldehyde (PAF) in PBS and incubated for 15mins 
at room temperature to fix the cells.  The cells were then washed twice in cold FACS 
buffer and resuspended in 1% Saponin in FACS buffer and incubated for 15mins at room 
temperature. Cells were then centrifuged and resuspended in 50µl of 1% saponin/FACS 
buffer.  An aliquot of 20µl cytokine antibody cocktail was added to each tube and 
incubated for 30mins at room temperature in the dark.  Cells were washed twice with 1% 
saponin/FACS buffer and resuspended in FACS buffer for analysis. 
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2.3.6 – PROLIFERATION ANALYSIS USING CFSE DYE  
CarboxyFluorescein Sucinimidyl Ester (CFSE) is a fluorescent cell staining dye.  This 
dye is supplied in a non-fluorescent form carboxyfluorescein diacetate succinimidyl ester 
(CFDA-SE).  CFDA-SE contains acetate groups and is highly cell permeable and toxic.  
When it is added to cells at optimum levels it enters the cytoplasm of the cells where the 
acetate groups are removed converting the molecule to the fluorescent molecule CFSE 
which is highly stable within the cell.  When the cell undergoes proliferation the dye is 
halved evenly between daughter cells allowing the tracking of cell proliferation up to 8 
generations.  Isolated cells were centrifuged at 170g for 5 mins and resuspended in PBS + 
5% FBS.  The FBS buffers the cells to the toxic effects of CFSE.  The CFSE was added 
at a final concentration of 5µM and the tube was inverted quickly and vortexed to evenly 
distribute the dye.  The cells were incubated for 5 mins and then washed twice with PBS 
+ 5%FBS before re-suspending in RPMI media.   
2.3.7 – CELL VIABILITY AND DEAD CELL EXCLUSION USING 
PROPIDIUM IODIDE STAINING 
Propidium Iodide (PI) is a fluorescent intercalating dye that binds DNA.  PI is used to 
distinguish live and dead cells.  Cell death leads to a compromised cell membrane.  This 
allows PI to enter the cell and stain DNA.  Once PI intercalates with the DNA the 
fluorescence is enhanced allowing dead cells to be distinguished from live cells.  PI is 
added as the last step before analysis and cannot be used with fixed or permeabilised cells 
as these cells are killed in the process.  Cells were removed from culture and washed with 
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FACS buffer.  PI (Miltenyi Biotech) was added at a working concentration of 1µg/ml and 
left for 10mins before reading on the FACS Aria.  
2.4 – CYTOKINE ELISA 
2.4.1 – BASIC PRINCIPLES OF ELISA 
Enzyme Linked ImmunoSorbent Assay (ELISA) is an accurate method used for the 
detection of proteins in cell supernatant.  The method of ELISA used in all studies was a 
sandwich ELISA.  In this method a capture antibody specific to the target molecule was 
diluted in PBS and coated on a 96-well plate.  The wells were then washed to remove 
unbound antibody and blocked using a PBS/BSA solution to block non-specific binding 
sites.  Samples containing an unknown concentration of the target antigen were then 
added to the wells along with a series of diluted standards of a known concentration of 
recombinant target protein.  The plate was incubated overnight at 4oC and then washed to 
remove unbound antigen and a biotinylated detection antibody specific to the target was 
added and incubated for 2 hours at RT.  This method of using two antibodies to 
effectively “sandwich” the target molecule results in low, accurate detection levels to the 
picogram range.  The plate was then washed and incubated with a streptavidin-
horseradish-peroxidase (HRP) for 20mins.  The streptavidin and biotin bind with a high 
affinity and the amount of HRP is proportional to the amount of target antigen in the 
sample.  Tetramethylbenzidine (TMB) was added to the wells and the HRP enzyme 
catalyses the oxidation of the TMB substrate transforming it to a blue compound.  The 
intensity of the colour is proportional to the concentration of target antigen present.   To 
prevent further oxidation the reaction was stopped by the addition of sulphuric acid to 
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each well and the blue turns to a yellow colour.  The intensity of this yellow colour was 
read at 450nm and was then compared to the standards to accurately calculate the 
concentration of antigen present in the sample. 
2.4.2 – TNF-α, IL-4, IL-10 and IL-17 CYTOKINE ELISA 
The recommended reagents were used for R&D duo ELISA kits and included:  Blocking 
buffer/reagent diluent 1% (w/v) BSA/PBS and R&D TMB solution.  Washing buffer was 
made up of PBS + 0.05% tTween-20.     
2.4.3 – IL-2 AND IFN-γ CYTOKINE ELISA 
The method above was followed with two deviations:  Blocking buffer used was 1% 
(w/v) BSA/PBS + 0.05% (w/v) NaN3 and the reagent diluent was 0.1% (w/v) BSA/TBS 
+ 0.05% (v/v) Tween-20. 
2.4.4 – IL-21 CYTOKINE ELISA 
The IL-21 ELISA kit was obtained from eBioscience.  The protocol was followed 
according to manufacturer’s instructions.  All the buffers including the TMB were 
supplied with this kit.   
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2.5 – RNA ANALYSIS 
2.5.1 – BASIC PRINCIPLES OF REAL-TIME qPCR 
Real-time quantitative polymerase chain reaction (qPCR) is a molecular biology method 
based on the principles of PCR where a region of DNA is amplified using primers to 
surround a specific targeted portion of DNA and amplify it to orders of magnitude using 
a heat stable DNA polymerase.  In qPCR the amount of DNA amplified is quantified in 
real time and allows for absolute (total copies) or relative quantification (normalisation to 
a control gene) of target DNA in a sample. 
When qPCR is combined with reverse transcription it allows for the quantification of 
messenger RNA.  A reverse transcription polymerase is used to make complimentary 
DNA (cDNA) copies of total RNA, including mRNA, isolated from cells of interest.  The 
cDNA is used as the template for qPCR and the amount of mRNA in the sample is 
quantified.  Quantification is accomplished using two methods; the intercalating dye 
SYBR or primer-probes. 
The intercalating dye SYBR green non-specifically binds to double stranded DNA.  
When SYBR forms a dye complex with DNA products of PCR it is excited by light at 
492nm and emits light at 520nm.  The non-specific nature of the cyanine dye SYBR 
green can lead to non-specific double-stranded reaction products resulting in increased 
background or false positives.  The use of probes ensures specificity of the signal and 
quantification reducing non-specific products.  The DNA probe is dual labelled with a 
reporter dye and a quencher.  The assay uses unlabelled primers to amplify the region of 
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interest and exploits the 5’-3’ nuclease activity of DNA polymerase to cleave the probe 
and release the reporter dye from the quenching protein resulting in a signal.  The 
disadvantage of this method is the time and cost required to design individual probe 
assays for each gene target and the cost of running the patent protected technique. 
2.5.2 – RNA EXTRACTION 
T-cells were removed from the 24 well plate and centrifuged at 690g for 10mins to 
remove media.  Cells were then re-suspended in RA1 buffer from the Nucleospin® RNA 
II (Machery-Nagel, Germany).  The RNA extraction was then carried out using the 
Nucleospin® RNA II kit according to the manufacturer’s instructions.  The kit works by 
immediately inactivating RNAses in the lysed cell solution and changing the conditions 
to allow absorption of the RNA to a silica membrane.  Contaminating DNA is then 
removed using an rDNAse solution, before washing the silica membrane with two buffers 
(RA2 and RA3) to remove salts, metabolites and macromolecular cellular components.  
The pure RNA is then eluted from the silica membrane in RNA free H2O.  The 
concentration of the RNA was then measured using the Nanodrop 1000 
spectrophotometer (Thermo-Fisher scientific, USA).  The purity of the RNA was 
determined using the A260nm and A280nm absorption wavelengths.  All the RNA used 
in this study had an A280/260 ratio between 1.8 and 2.1, within the accepted range for 
RNA purity for use in PCR experiments.   
2.5.3 – DNA PRODUCT ANALYSIS BY GEL ELECTROPHORESIS 
Gel electrophoresis was used to check DNA products following qPCR.  Samples were 
run on a 2% agarose gel.  Gels were prepared by dissolving 2g of agarose (Thermo-Fisher 
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scientific, USA) in 100mls of TAE buffer and heating to boiling point.  After cooling, 
10µl of SYBR® safe (10’000X concentration) was added to the gel mix before pouring 
into a gel mould and setting the well comb.  DNA samples were mixed with loading 
buffer (Fermentas) and loaded straight onto the gel.  Gels were run for 1hour in TAE 
buffer at 100v.  Gels were visualised using the G-Box cell imaging system (Syngene, 
UK) 
2.5.4 – cDNA SYNTHESIS 
Complimentary DNA (cDNA) is required as a template in two step quantitative PCR.  
cDNA is generated from RNA in a separate step to the qPCR reaction using reverse 
transcriptase PCR (RT-PCR).  The RT-PCR was carried out using the RNA generated 
from the samples and the High Capacity cDNA Reverse Transcriptase Kit (Applied 
Biosystems, USA).  The kit contains a master mix of dNTP, random primers and the 
enzyme reverse transciptase.  Reverse transcriptase synthesises single strand cDNA using 
the RNA strands as template.  The cDNA that is produced in this reaction is a more stable 
and amplified copy of the RNA.  This is then used as the template for the subsequent 
qPCR experiments.  This method is used as opposed to one-step qPCR where the RT-
PCR and qPCR are carried out sequentially in the one tube in a qPCR method.  This 
method uses more sample and introduces more potential errors in the reaction.   
Using quantitative measurements of the RNA, 1µg of RNA was used in each cDNA 
synthesis reaction.  The settings in [Table 2.10] were used in the PCR reaction on a PTC-
200 MJ research thermocycler.  
  .   
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2.5.5 – qPCR ASSAY OPTIMISATION 
In order to ensure accuracy and robustness of qPCR gene expression measurements each 
assay performance had to be evaluated.  This was carried out by assessing the PCR 
efficiency, the linear dynamic range, the limit of detection and the assay precision (Bustin 
et al. 2009).  Primer pairs were purchased from Sigma-Aldrich or IDT [See Appendix 
C].   
The Amplification efficiency was determined by carrying out a ten fold dilution of the 
PCR product and constructing a standard curve of CT vs log of the dilution of product.  
Each change in CT represents a 2-fold change.  If the co-efficient of determination was R2 
>0.980, the equation of the line was used to determine the amplification efficiency (E) of 
the assay using the following formula: 
 
E = 10^ (-1/slope) – 1 x 100 
 
If the efficiency is 100% (Slope 3.32) then the CT values will be 3.3 cycles apart.  The 
accepted range for the amplification efficiency of each assay was between 90% and 
110% (slope 3.1-3.3). 
The linear dynamic range and limit of detection was determined from the efficiency 
curves generated for each sample, the assay precision was determined by carrying out all 
assays and technical replicates in triplicate.  Non-template controls (NTC) were included 
in all experiments for assay targets. Samples with an NTC within 5 cycles of the sample 
Ct value were disregarded and new primers were ordered.  Ct
 
values >36 cycles were also 
disregarded as they are at the limit of detection in this assay and the accuracy is 
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compromised.  The efficiency curve, linear range and limit of detection for each assay 
used in this study are shown in [Appendix B].  
2.5.6 – RELATIVE QUANTITATION USING qPCR 
This method compares the relative expression of different samples, one of which is a 
calibrator or control such as untreated tissue.  Samples were normalised to a 
housekeeping gene.  The housekeeping gene is an endogenous gene that maintains 
expression levels despite treatment. In order to identify a suitable housekeeping gene for 
this experiment, 8 potential common mouse reference genes were investigated.  From the 
endogenous genes examined, the 2 most suitable were selected.  It was necessary to have 
a minimum of 2 housekeeping genes to ensure accuracy in real time assays (Bustin et al. 
2009).  Samples were normalised to the geometric mean of the two housekeeping genes 
CT values.  Samples were then compared using the comparative CT method or ddCt 
method:   
ddCt= dCt sample – dCT reference 
 
Where dCt sample is the normalised Ct value of the treated sample and dCt reference is 
the normalised Ct value of the control sample. 
Quantitative-Real Time PCR (qPCR) was carried out on the ABI Prism 7500 (Applied 
Biosystems, USA).  cDNA was generated as described above and diluted in order to 
bring the target into the range of detection.  PCR reactions were prepared in triplicate for 
each sample with an appropriate dilution of cDNA.   Primers were added for a final 
concentration of 500mM for each primer.  ROX reported dye was used as an internal 
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reference signal to normalise for non-PCR-related fluorescence occurring from well to 
well.   
Samples were added to a 96-well reaction plate and covered with an adhesive cover 
(Applied Biosystems, USA).  Plates were centrifuged for 2mins at 690g and stored at 4oC 
until run.  Samples were run on the ABI Prism 7500 under the following conditions: 
 
 STEP 1 STEP 2 STEP 3 (a) STEP 3 (b) 
Temperature (OC) 50 95 95 60 
Time 2 min 10 min 15 sec* 1 min* 
 
                                                  * Repeat step 3 for 40 cycles 
Table 2.10 – qPCR programme 
 
The results were analysed using the ABI prism sequence detection software (Applied 
Biosystems, USA) and Excel software (Microsoft, USA). 
 
2.6 – IN VIVO WORK AND MOUSE MODELS OF DISEASE 
2.6.1 – DSS MODEL OF COLITIS 
Dextran sodium sulphate (DSS) model of colitis is one of the most widely used 
chemically induced models of inflammatory bowel disease.  It is directly toxic to the 
colonic epithelial cells in the basal crypts and induces an acute inflammatory response.  
When the end point of the model is extended in C57BL/6 mice, it results in a chronic 
inflammatory response. 
DSS mouse work was carried out in collaboration with Silvia Melgar in the Alimentary 
Pharmabiotic Centre, University College Cork (UCC).  25 C57BL/6 female mice weight 
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18-20g at arrival were housed in the Biological Services Unit (BSU) at UCC.  DSS was 
administered to the mice in drinking water.  A final concentration of 3% DSS was 
prepared fresh every day in normal tap water and administered ad libitum.  Mice were 
split into 4 groups for the study depending on the length of time that mice were left 
following DSS treatment: 
1. Control   
No DSS was administered to the control mice. 
2. Early acute 
Mice were administered DSS for 5 days (Day 0-Day 4) followed by 2 days on water 
and sacrificed for sample and tissue processing on Day 7  
3. Late acute 
Mice were administered DSS for 5 days (Day 0-Day 4) followed by 7 days on water 
and sacrificed for sample and tissue processing on Day 12 
4. Chronic 
Mice were administered DSS for 5 days (Day 0-Day 4) followed by 21 days on water 
and sacrificed for sample and tissue processing on day 26 
 
The clinical symptoms recorded in DSS-treated and the control mouse were body weight 
and fur texture/posture on day 0, and 2 times/week from day 4. These were used to 
generate a daily disease activity index.  At the end point of each group the length & 
weight of each colon was also measured and used as an indication of colitis in the mouse 
model. Sections of distal colon were collected for tissue homogenisation and RNA 
purification. 
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2.6.2 – ISOLATION OF LAMINA PROPRIA  
The large intestines of mice were removed and placed on paper towels soaked in PBS and 
the fat was removed. The intestines were opened longitudinally, washed in Hank’s 
balanced salt solution (HBSS) 2% FCS, and cut into 0.5cm sections.  The tissue was then 
shaken vigorously in 10ml HBSS 2% FCS, and the supernatant was discarded.  To 
remove the epithelial layer, 10ml fresh CMF (calcium, magnesium free) HBSS 
containing 2mM EDTA was then added, the tube placed in a shaking water bath for 
15mins at 37oC, before being shaken vigorously and the supernatant discarded.  10ml 
fresh CMF HBSS was then added, the tube shaken again and the supernatant discarded.   
After a second incubation in 2mM EDTA CMF HBSS, the washes were repeated and the 
remaining tissue was digested with pre-warmed 1.25mg/ml collagenase D, 0.85mg/ml 
collagenase V, 1mg dispase, and 30U/ml DNase in complete RPMI medium for 40 
minutes in a shaking water bath at 37oC until complete digestion of the tissue.  At the 
start of the incubation, and at 10 mins intervals thereafter, the tube was shaken vigorously 
and finally the supernatant (containing lamina propria cells) was removed and passed 
through a 40um filter. 
The cells were collected and resuspended in complete RPMI medium.  Cells were passed 
through a 40um filter, counted and kept on ice until use.  Approximately 10-15 x106  
lamina propria cells are isolated per mouse.  
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2.6.3 – TISSUE SECTIONING AND IMMUNOHISTOCHEMISTRY 
Tissue sections of 0.5cm were removed from washed colons and covered in optimum 
cutting temperature (OCT) compound in plastic moulds.  The sections were then flash 
frozen by submerging in liquid nitrogen for 20 seconds.  The sections were cut in a 
controlled temperature cryostat at -20oC and mounted onto slides and left overnight at 
room temperature.  Sections were then fixed in acetone/alcohol mix for 5 mins at room 
temperature and washed in PBS.  Slides were then stained in Harris haemotoxylin for 10 
minutes and washed again under a running tap for 5 mins.  The slides were differentiated 
in 1% acid/alcohol for 30 secs 3 times and then washed under a tap for 1 min.  After 
washing, slides were placed in 0.1% sodium bicarbonate for 1 min and washed under the 
tap for 5 mins.  The slides were then rinsed in 95% alcohol for 10 dips before 
counterstaining in Eosin for 1 min by dipping up & down.  Finally the slides were 
dehydrated by dipping in 75% ETOH for 3 mins, 95% ETOH for 3 mins (x2), followed 
by 100% ETOH for 3 mins and 3 mins in Histoclear.  Slides were then mounted with 
mounting medium and the cover slides pushed down firmly to remove bubbles.   
2.6.4 – CITROBACTER RODENTIUM INFECTION MODEL  
The C. rodentium model of infection is a widely studied mouse model of colitis.  C. 
rodentium induces a Th17 response in mice leading to a transient inflammatory state in 
the colon that is clinically similar to ulcerative colitis.  Infection is usually cleared after 
21 days.   
C. rodentium work was carried out in collaboration with Silvia Melgar in the Alimentary 
Pharmabiotic Centre, University College Cork.  C57BL/6 mice were housed in the 
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Biological Services Unit at UCC.  Mice were divided into groups of 6-8 and inoculated 
orally by a 200µl gavage of approximately 200x109 CFU C. rodentium.  Mice were 
sacrificed at day 9, 14, 21 and 28 for tissue processing.  The colons were removed and 
washed and the length and weight of each colon was measured individually as an 
indication of inflammation of the gut.  Sections of distal colon were collected for tissue 
homogenisation and RNA purification. 
2.6.5 – MICE USED FOR Stx11-/- IN VITRO STUDY 
Wild type C57BL/6 and Stx11-/- mice on a C57BL/6 background were obtained from the 
Borstel research institute in Hamburg, Germany in collaboration with Silvia Bulfone-
Paus and Udo Zur Stadt.  Mice were used between 10-12 weeks old and housed in a 
specific pathogen free unit in the Borstel Research Centre animal facility.   
2.6.6 – MICE USED FOR IN VITRO STUDIES 
All other mice used in this study were purchased from Charles River and housed in the 
specific pathogen free biological resources unit in Dublin City University.  Mice were 
kept in controlled conditions and used between 8-14 weeks old. 
2.7 – STATISTICAL ANALYSIS 
The student T-test was used to determine if differences measured between samples were 
significantly different from one another.  The level of statistical significance was 
indicated by * (p<0.05), ** (p<0.01) and *** (p<0.001).   
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CHAPTER 3  
 
 
 
ISOLATION AND 
POLARISATION OF CD4+           
T- CELLS IN VITRO 
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3.1– INTRODUCTION 
 
Antigen presenting cells (APCs) phagocytose invading pathogens and present molecules 
to T-helper cells in the lymph nodes via the MHC molecule activating T-helper cells and 
the CD3 associated T-cell receptor complex (TCR).  CD4 is a marker of mature T helper 
cells, binds a non-antigen specific region of the MHC and plays an important role in 
boosting T-cell sensitivity to antigen (Krummel et al. 2000; Bour-Jordan et al. 2011).  
This activation must be accompanied by two other molecular signals; the co-stimulatory 
signal and the cytokine milieu. The co-stimulatory signal is necessary to prevent cells 
from mounting immune responses to “self antigens” (Lenschow et al. 1996).  This signal 
is provided by the B7 family of proteins on APCs and will bind with its natural ligand 
CD28 on the T-helper cell to provide a co-stimulatory signal to the antigen presented on 
the APC cells MHC complex.  This combined signalling leads to cell activation and 
cloning.  Without this signal the T-cells will not become fully activated by the interaction 
with the APC and the cell will become anergic (Bour-Jordan et al. 2011).  The cell 
signalling required for T-cell activation can be replicated in vitro using anti-CD3 
antibody which acts as an agonist by cross-reacting the TCR, and an anti-CD28 antibody 
which cross reacts with the CD28 molecule providing activation and co-stimulatory 
signals respectively to the cell.  The cytokine milieu can have a number of effects on the 
fate of the T-cell depending on the cytokines present during activation of the cell.  
Various cytokines can activate signalling cascades leading to T-cell cloning, cell 
inactivation, up-regulation of secreted cytokines, and importantly in the case of this work, 
activation of signal transducers and activators of transcription (STATs) and transcription 
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factors leading to the commitment of a CD4+ T-helper cells to a specific subtype (Vahedi 
et al. 2013). 
In order to maintain CD4+ T-helper cells in vitro, isolation and culture conditions needed 
to be optimised.  CD4+ labelled cells are found in the lymph nodes of mice and humans 
alike, and are abundant in the spleen.  A number of commercial and lab based methods 
exist for the retrieval of CD4+ cells from a spleenocyte solution.  Cells are sensitive to 
culture conditions and supplementation of media is necessary to keep them viable for the 
long periods of time necessary to complete studies in vitro.  The aim of this chapter was 
to optimise the method to isolate pure, viable CD4+ T-helper cells and identify ideal 
conditions for culturing them in vitro.  In order to identify the conditions required for the 
isolation and activation of CD4+ T-helper cells, surface marker expression and cytokine 
secretion were measured.  Cell viability and proliferation studies were also carried out in 
various conditions.  Following this optimisation, the next step was to further polarise the 
cells into subsets of T-helper cells. 
T-helper cells are capable of polarising into specialised subsets of lymphocytes that deal 
with the many diverse challenges posed to the immune system from day to day.  These 
subsets secrete defined cytokine profiles which are tailored to induce conditions required 
for an effective immune response.  The Th1 subset of cells primarily deals with invading 
intracellular pathogens and viral infections.  It does this partly though the secretion of 
large amounts of IFN-γ, the signature cytokine for this cell type (Szabo et al. 2000).  Th2 
cells direct immune defences against invading parasites and aid the humoral immune 
response (Mosmann et al. 1986).  Th17 cells are a recently described subset that are 
characterised by their signature cytokine IL-17 and express the transcription factor 
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RORγt showing a separate lineage commitment to Th1 and Th2 cells.  Th17 cells defend 
against fungal infections and extracellular pathogens.  Th17 cells have also been 
implicated in inflammatory disease (Ivanov et al. 2006).  
Using combinations of recombinant cytokines and neutralising antibodies in optimised 
culture conditions, it was possible to polarise isolated CD4+ T-cells in vitro into T-helper 
cell subsets in order to study them in detail.  Given that each cell subset produces a 
different key signature cytokine in abundance and each cell subset originates from a 
common source containing identical proteins and pathways, this presents an ideal model 
to determine the SNARE proteins involved in the secretion of specific cytokines from 
CD4+ T-helpers cell subsets. 
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3.2– RESULTS 
3.2.1 – ISOLATION, ACTIVATION AND CONFIRMATION OF CD4+ 
T-HELPER CELL POPULATION FROM BALB/C MICE. 
CD4+ T-cells develop in the thymus and reside in the spleen and lymph nodes.  In order 
to isolate these cells from BALB/c mice, the spleen was removed from the mouse 
aseptically and homogenised through a 50µm filter.  The spleenocytes were then re-
suspended in fully supplemented RPMI and T-helper cells were isolated using the 
easysep™ mouse CD4+ T-cell isolation kit available from Stemcell Technologies as 
described in the materials and methods [Section 2.2.2.2].  The CD4 antigen is present on 
mature T-helper cells but is also expressed by some macrophages and dendritic cells; 
therefore it was important to confirm the purity of the T-helper cell population.  CD3 
makes up the TCR complex and is a marker of all T-cells including CD3+/CD8+ cytotoxic 
T-cells, so double staining for the CD3 antigen population was necessary to confirm the 
CD3+/CD4+ T-helper cell population (Krummel et al. 2000).    Isolated CD4+ cells were 
blocked and stained with primary PE conjugated anti-CD4 and primary FITC conjugated 
anti-CD3 antibodies for 30 mins and washed before analysis on a BD FACS Aria, and 
data analysed using flowjo software.  Figure 3.1(a) shows dead cell removal based on 
FSC and SSC, dead cells and debris have a small FSC and SSC and were gated out from 
the main population.  Plot [Figure 3.1(b)] shows cells single stained with the primary PE 
conjugated anti-CD4 antibody, the dots represent a single cell event and as they shift to 
the right the intensity of the staining increased (a shift up in the case of a vertical axis).  
The isolated population was confirmed to be an 89% CD3+ CD4+ T helper cell population 
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as indicated by a shift to the top right quadrant.  Purified cells were stained with directly 
labelled fluorescent antibodies to the cell antigens and analysed using the BD FACS Aria 
[Figure 3.1(c)]. 
The surface marker CD25 (IL-2 receptor) is up-regulated on T-cells upon activation and 
aids in proliferation of T-helper cells (Smith et al. 1980).  It is stained as a marker for 
activated CD4+ T-cells.  In order to demonstrate that the cells isolated were viable and 
could be activated, cells were treated with anti-CD3 (5µg/ml) and anti-CD28 (2.5µg/ml) 
antibodies and stained for CD25 using a PE primary conjugated anti-CD25 antibody 
(BD) (0.5µg/100µl).  Cells were cultured and stimulated for 3 days were stained and 
analysed on the BD FACS Aria.  Figure 3.2 shows an increase in CD25 expression.  
Median has increased from 2.75 to 20.1 and the mean fluorescence intensity increase 
from 4.93 to 27.2.  These data show an increase in CD25 expression on cells, confirming 
T-cell activation [Figure 3.2].  .   
 
3.2.2 – ANTIBODIES DIRECTED TO CD3 AND CD28 PROVIDE 
SIGNALS FOR IN VITRO ACTIVATION OF CD4+ CELLS. 
Three signals are required for T-cell activation; signalling through the T-cells receptor 
complex (TCR), activation of the CD28 co-stimulation pathways, and cytokine signalling 
(Kenneth Murphy  Mark Walport 2008).  CD3 makes up part of the TCR complex and 
activation depends on signalling through this pathway.  Anti-CD3 antibody (BD 
Clone:145-2C11) that cross-links CD3 and activates the TCR complex  was used to 
simulate the interaction of MHC complex (found on an antigen presenting cells (APC)) 
with the TCR (Nobrega et al. 1986; Lu & Durkin 1997).  This method was compared to 
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activation using the anti-CD3 antibody coupled with an anti-CD28 antibody.  The anti-
CD28 antibody cross-links and activates the CD28 pathway which is required to provide 
a co-stimulation signal to the T-cell and prevent cell anergy.  This signal is usually 
provided by the CD80-CD86 ligands on APCs during T-cell activation (Lenschow et al. 
1996). 
There was significant variation in the literature regarding the dose of anti-CD28 used to 
activate the T-cells.  Therefore anti-CD3 alone and in combination with two 
concentrations of anti-CD28 (2.5µg/ml and 5µg/ml) was assessed on the T-cells.  
Spleenocytes were isolated from BALB/c mice and were pooled and enriched for CD4+ 
cells using EasySep Mouse CD4+ T Cell Enrichment Kit (Stemcell technologies).  
Isolated CD4+ cells were cultured with anti-CD3 alone (5µg/ml) or anti-CD3 with 2 
concentrations of anti-CD28 (2.5µg/ml and 5µg/ml).  Cells were stimulated for 3 days 
under these conditions and supernatants were collected for the measurement of IFN-γ, IL-
2, IL-4 and IL-17. 
Figure3.3 shows that the response of the T-cells to CD3 and CD3/CD28 were similar 
with significant production of IFN-γ, IL-2, IL-4 and IL-17 by stimulated cells.  The two 
doses of anti-CD28 (2.5µg/ml and 5µg/ml), in combination with anti-CD3, induced a 
similar profile of cytokine secretion from activated cells, with both inducing secretion of 
IFN-γ, IL-2, IL-4 and IL-17.  The doses of anti-CD28 were also similar to the control of 
anti-CD3 by itself [Figure 3.3].  While anti-CD3 was able to stimulate the cells to secrete 
cytokines alone, CD3 stimulation alone can lead to cell anergy in T-cells as the co-
stimulation signal is not present (Bour-Jordan et al. 2011). Therefore plate bound anti-
CD3 and anti-CD28 at a 2.5µg/ml dose was selected as the method of stimulation.   
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3.2.3 – A COMPARISON OF MAGENTIC AND COLUMN 
PURIFICATION METHODS FOR CD4+ T-CELL ISOLATION. 
In order to determine the best method of CD4+ T-cell isolation, two methods of cell 
isolation were investigated.  A number of commercial methods are available for the 
isolation of specific cells based on antigen markers.  Two of the main methods available 
are column enrichment and magnetic isolation.  Both of these methods are negative 
isolation methods meaning that cells of interest are not bound by antibodies which may 
interfere with downstream assays. 
Spleenocytes isolated from BALB/c mice were enriched for CD4+ cells using EasySep™ 
Mouse CD4+ T Cell Enrichment Kit (Stemcell technologies) and the Mouse CD4+ T Cell 
Enrichment Column (R&D systems).  In the column kit, spleenocytes were first treated to 
lyse the erythrocytes from the cell suspension; this was carried out using an ammonium 
chloride solution. The cell suspension was then mixed with a monoclonal antibody 
cocktail which binds T-cells and other cells that are not of interest during the 15min 
incubation.  This mixed suspension was then loaded into the enrichment column which 
contains glass beads coated with Ig and anti-Ig.  The mixture flows though the column by 
gravitational flow and cells tagged with the monoclonal antibody are bound to the 
column during an additional 15min incubation period.  The anti-Ig beads and Ig also bind 
to B-cells via F(ab)-surface Ig, and monocytes via Fc interactions respectively removing 
them from the flow-through.  The column is then washed and the sample is collected, 
centrifuged and made up in media before counting the cells. 
Stemcells EasySep™ system uses negative selection to enrich the CD4+ population from 
single cell suspensions of spleenocytes.  Unwanted cells are removed by targeting 
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biotinylated antibody cocktails to non-CD4+ T-cells.  Tetrameric antibody complexes 
recognizing both biotin and dextran-coated magnetic particles then bind to these 
antibodies.  The cell suspension is placed into a magnetic field which holds the labelled 
cells in place and the desired unlabelled CD4+ T-cells are poured off.  No column is 
involved in the isolation and there is no requirement to lyse erythrocytes before carrying 
out the isolation. 
Following enrichment, cells were stained with anti-CD4 PE conjugated antibody (BD) 
and analysed using flow cytometry in order to compare the percentage purity of CD4+ 
cells.  Cells were gated on FSC, SSC in order to exclude cell debris [Figure 3.4(a)].  
Cells were then gated on the PE positive population.  This population represents the 
percentage of CD4+ cells in the sample. 
The percentage of CD4+ cells obtained using the EasySep Magnetic enrichment was 
94.8% [Figure 3.4(b)].  This method consistently yielded purities >90%, in agreement 
with the suppliers information.  The T Cell Enrichment Column yielded lower purity 
68.38% [Figure 3.4(c)].  Supplier’s information indicates a purity of ~85%, however the 
percentage obtained was consistently ~70% when using this method.  It is clear from 
these data that the magnetic separation method resulted in a higher percentage purity of 
CD4+ cells.  The magnetic cell separation method also required less preparation and less 
steps involving centrifuging the cells, which resulted in a higher viability in the 
magnetically separated cells.  Viability was calculated using a haemocytometer and 
trypan blue exclusion [Table 3.1].  When cells become apoptotic, their membranes are 
compromised and allow the flow of material through an otherwise highly regulated 
membrane.  Trypan blue can pass into the cell and stain the DNA in the nucleus a blue 
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colour.  Counting the viable and non-viable blue stained cells using a haemocytometer 
determines the percentage of viable cells in culture.  The magnetically isolated cells had a 
viability of 76.9%, which was higher than the viability observed for the column 
separation method of 73.5% [Table 3.1].  It is possible that this loss of viability when 
using the column separation method is due to mechanical stress on the cells using the 
column method as discussed above.  
3.2.4 - MAGNETIC ISOLATION OF CD4+ LYMPHOCYTES 
RESULTS IN ENHANCED CYTOKINE PRODUCTION FOLLOWING 
STIMULATION. 
The two methods of CD4+ cell enrichment were next compared by assessing the cytokine 
production from T-cells after isolation using the column and magnetic separation 
methods.  CD4+ cells were isolated using the magnetic enrichment or column enrichment 
kit and stimulated with 5µg/ml plate bound anti-CD3 and 2.5µg/ml anti-CD28 agonists.  
Cells were stimulated for 3 days and supernatants were collected and measured for IFN-γ, 
IL-4 and IL-17.  Activation of T-cells induced significant levels of IFN-γ, IL-4 and IL-
17.  Magnetically enriched CD4+ cells show an almost 2-fold higher production of all 
cytokines measured by ELISA [Figure 3.5].  This may be in part due to the increased 
viability observed in the previous comparison of the two methods. This confirmed the 
magnetic isolation as a more suitable method for enriching CD4+ T-helper cells. 
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3.2.5 – VARIATIONS IN FETAL BOVINE SERUM (FBS) BATCHES 
EFFECTS CYTOKINE PRODUCTION IN CD4+ LYMPHOCYTES. 
During the initial optimisation experiments some variability was observed in the levels of 
cytokines produced by the cells in independent experiments, therefore the media and 
culture conditions were examined in order to reduce these variations.  The first 
component of the media examined was the Fetal Bovine Serum (FBS).  Earlier 
experiments used different batches of FBS, furthermore, there was also variation in the 
method used in lab for heat inactivation of the FBS before use.  In order to investigate the 
variability between batches and the effects of heat inactivation, batches of FBS were 
obtained from two companies, Gibco and Fisher, summarised in [Table 3.2].  Isolated 
CD4+ cells were cultured in RPMI containing 1% PenStrep and 10% FBS from the 
various batches.  The FBS tested were assigned letters,  A and B are two different batches 
of the same FBS product sourced from GIBCO (Invitrogen life sciences), C is HyClone 
FetalClone FBS (ThermoFisher) and D is HyClone Research Grade (ThermoFisher).  The 
FBS was heat-inactivated according the Gibco protocol for FBS heat-inactivation.  Cells 
were stimulated in naïve conditions for 3 days.  Supernatants were collected and assessed 
for levels of IFN-γ, IL-2, IL-4 and IL-17.  There was variation in the levels of cytokine 
secreted by the cells when different FBS was used.  The non-heat-inactivated samples 
from Gibco (A and B) resulted in low levels of cytokines following stimulation.  All non 
heat-inactivated FBS (A, B, C, D) resulted in low or no secretion of IFN-γ, IL-2, IL-4 and 
IL-17.  Heat-inactivated A and B from Gibco induced significant levels of IFN-γ, IL-2, 
IL-4 and IL-17.  Heat inactivated C and D did not consistently result in high levels of 
cytokines with no IL-17 or IL-2 for heat-inactivated C [Figure 3.6].   
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Given that the levels of cytokines were high using heat inactivated GIBCO batches A and 
B, and the fact that there was consistency between these batches, the Gibco FBS was 
selected for future use.  A single batch of Gibco FBS was ordered in bulk in order to use 
the same batch in all future experiments.  The heat inactivation method was set as a 
standard protocol and all FBS was heat inactivated on arrival and stored in aliquots at -
20oC.  
3.2.6 - ADDITION OF IL-2 INCREASES THE PROLIFERATION OF 
CD4+ LYMPHOCYTES IN VITRO. 
IL-2 has been identified as a proliferative factor for cloning CD4+ T-cells acting in an 
autocrine fashion (Smith 1988).  Upon activation T-cells produce IL-2, however to 
further optimise the culture conditions the effects of adding additional IL-2 to the media 
was assessed with regards to proliferation of the cells. 
Cells were stained with carboxyfluorescein succinimidyl ester (CFSE) dye before 
culturing.  CFSE is a dye that converts to a fluorescent ester upon removal of acetate 
groups in the cell cytosol where it remains due to covalent bonds formed with 
intracellular molecules.  As cells divide, so too does the dye and the intensity of the 
fluorescence is halved.  Each peak of halved fluorescence intensity represents a 
generation of cells and generation numbers can be calculated using software algorithms 
(Quah et al. 2007).  Dead cells were excluded from analysis using propidium iodide dye 
(PI) which was added 10 minutes before cell analysis.  PI can pass through compromised 
membranes in apoptic/necrotic cells and stains the DNA thereby marking non-viable cells 
(Nicoletti et al. 1991).  Cells were analysed using the BD FACs Aria; cells were gated on 
the viable population (PI negative cells) and fit using the CFSE proliferation algorithm on 
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the Flowjo Software (treestar).  The software fits a Gaussian curve to each peak and the 
sum of the curves equals the distribution of the cells measured.  This data can give the 
number of cell generations and the number of cells in each population.   
Addition of IL-2 led to an increase in the number of generations of viable CD4+ cells in 
culture [Figure 3.7].  The analysis shows there to be cells in the fifth generation of cells 
treated with IL-2 compared to only four generation of cells cultured without.  This data 
confirms that IL-2 has a proliferative effect on T-cells in culture and may assist in 
maintaining T-cells in vitro.  The next step in optimising the culture conditions was to 
assess the effects of supplementing the media with beta mercapto-ethanol (BME) in order 
to improve viability of the cells in culture. 
3.2.7 – MEDIA SUPPLEMENTED WITH BME IMPROVES THE 
VIABILITY OF CD4+ T-CELLS IN VITRO. 
Beta mercapto-ethanol (BME) breaks down cystine provided by the FBS allowing T-cells 
to convert it into the amino acid cysteine which is necessary for cell growth.  It is also a 
reducing agent and has the ability to break down toxic metabolites in the media leading to 
improved culture conditions (Chang et al. 1982).  Therefore, the addition of BME was 
assessed as to whether it would further improve supplemented media for optimal 
conditions to culture primary CD4+ cells.  Enriched CD4+ cells were cultured for 5 days 
in media with and without 50µM BME.  As previous experiments have shown, the 
addition of IL-2 increases the proliferation of CD4+ T-cells in vitro. Therefore the 
viability over 5 days was also assessed after the addition of IL-2 alone and IL-2 in 
combination with BME.  Propidium iodide dye (PI) was used to assess cell death.  As 
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previously described above, cells that are apoptotic have a compromised membrane that 
allows the dye to enter the cell and stain the nucleus.   
Samples were taken on day 1, 2, 3 and 5 and cells were gated on live cells as determined 
by PI staining and analysed on the BD FACs Aria.  The percentage of viable cells in each 
condition over the 5 days is represented in Figure 3.8.  The control cells and all treatment 
conditions have the same viability on day one with the combination of BME and IL-2 
showing the highest viability.  On day 2 there is a further improvement in viability for all 
groups.  By day 3 the control and IL-2 treated cells have a significant decrease in 
viability, this is not the case for the BME and BME+IL-2 treated cells which show further 
improvement with a small decrease for all groups on day 5.  The common factor in the 
groups showing an improved viability over 5 days was the addition of BME, IL-2 alone 
was not sufficient to improve the viability of the cells over the 5 days and BME alone had 
a similar effect to the addition of BME in combination with IL-2.  BME significanlty 
increased the viability of CD4+ T-cells in vitro and was added to the culture media for all 
cell culture work at a final working concentration of 50µM. 
3.2.8 – OPTIMISATION OF Th17 CD4+ T-CELL POLARISATION IN 
VITRO. 
Following the optimisation of the cell isolation, activation and media conditions required 
for CD4+ T-helper cells, the next step was to optimise the polarisation of CD4+ T-cells 
into specific cell subsets.  The first to be optimised was the Th17 cell subset.  IL-17 is the 
characteristic cytokine secreted from the class of CD4+ T helper cells designated Th17 
cells.  In order to obtain this subset it is necessary to activate STAT3 and the transcription 
factor RORγt.  This is the master regulator for the IL-17 gene and defines the Th17 
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subset.  IL-6 is also necessary for the activation of STAT3 and RORγt and is required for 
the Th17 polarisation (Ivanov et al. 2006; Zhou et al. 2007).  TGF-β was later recognised 
as a necessary stimulator of both Th17 cells and Treg cells, however, in the presence of 
IL-6 it drives cells to a Th17 cell subset.  IL-23 is responsible for expanding Th17 cells 
but is not sufficient on its own to drive naïve cells into Th17 cells (Zhou et al. 2007).  IL-
1β, one of the last cytokines that has been linked with Th17 cell subsets, has been shown 
to induce naïve T-cells to produce IL-17 in vitro (Chung et al. 2009).  Combinations of 
these cytokines were tested in order to determine the cytokines necessary for generating 
Th17 cells.  A neutralising anti-IFN-γ antibody was also added to block the generation of 
a Th1 subset which inhibits Th17 cell polarisation. 
CD4+ enriched T-helper cells were cultured in media supplemented with IL-6 (20ng/ml), 
IL-23 (20ng/ml), IL-1β (10ng/ml) and neutralising anti-IFN-γ antibody (10µg/ml) with 
and without the addition of TGF-β (0.2ng/ml).  Cells were stimulated with 5µg/ml coated 
anti-CD3 and 2.5µg/ml anti-CD28 for 3 days.  Cells were then transferred to fresh media 
without recombinant cytokines and further stimulated with 5µg/ml coated anti-CD3 and 
2.5µg/ml anti-CD28 for 24 hours before collecting supernatants for ELISA cytokine 
analysis (R & D duosets).  Both cells cultured with and without TGF-β showed a typical 
Th17 profile with high IL-17 and low IFN-γ and IL-4 [Figure 3.9].  While the cells 
stimulated in the presence of TGF-β resulted in a small increase in IL-17; this data 
indicates that there is no requirement for TGF-β in the polarisation of Th17 cells in vitro. 
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3.2.9 – T-CELLS CULTURED IN Th17 POLARISING CONDITIONS 
EXPRESS THE TRANSCRIPTION FACTOR RORγt 
In order to confirm the Th17 subset it was necessary to stain for the transcription factor 
RORγt.  RORγt is the master regulator and transcription factor necessary to commit naïve 
T-cells to a Th17 lineage.  It is activated by IL-6 and along with activation of the STAT3 
transcription factor, leads to the production of IL-17 in T-cells.  CD4+ enriched cells were 
isolated and stimulated with plate bound anti-CD3 and anti-CD28 in the presence of IL-6, 
IL-1β, IL-23 and a neutralising anti-IFN-γ antibody.  Cells were stimulated over three 
days, permeablised and stained for intracellular RORγt using a primary conjugated APC 
labelled anti RORγt antibody (eBioscience) at a number of timepoints (2, 18, 48 and 
72hrs).  In order to optimise the staining of these cells, the amount of antibody required 
was also titrated and a time course was carried out.  The results show an increase in the 
expression of RORγt over time in the cells [Figure 3.10(a)].  The grey shaded peak is the 
isotype control staining antibody which is an antibody of the same isotype and 
conjugated with APC but not targeted to RORγt, it acts as a control for non-specific 
staining.  The biggest increase is detectable at 18hrs with an increase of mean 
fluorescence intensity (MFI) of 45.9 between the isotype and the sample, although 
significant RORγt staining is still present at 48 and 72hrs. 
At all time points supernatants were collected and measured for levels of IL-17.  The 
secretion of IL-17 is evident at 18hrs and increased steadily over the 72hrs [Figure 
3.10(b)]. 
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3.2.10 – INVESTIGATION OF DIFFERENT Th17 CELL SUBSETS 
GENERATED IN THE ABSENCE/PRESENCE OF TGF-β. 
Up to this point all experiments were carried out by polarising Th17 cells using IL-6, IL-
1β, IL-23 and neutralising IFN-γ antibody in supplemented media.  Although the 
literature suggests a requirement for the presence of TGF-β, a Th17 cell subset was 
confirmed by ELISA and intracellular transcription factor staining without TGF-β.  A 
paper published by Ghoreschi K et al (2010) described a Th17 cells subset generated in 
the presence of IL-6, IL-1β and IL-23 with no TGF-β.  The paper describes the subset 
used in this study generated without TGF-β and also compares them to the subset 
generated in the presence of TGF-β.   
Ghoreschi et al (2010) describe the subset generated in the absence of TGF-β as a more 
pathogenic Th17 cell.  These cells are able to class switch to express T-bet after 
committing to RORγt transcription factor expression and are capable of simultaneous 
IFN-γ and IL-17 production in certain conditions.  Given the aim of this model was to 
define the SNARE components involved in IFN-γ and IL-17 production separately in Th1 
and Th17 cells, this method of Th17 polarisation was not suitable for the study.  It was 
therefore necessary to reassess the effects of TGF-β and investigate these subsets to 
ensure that a single IL-17 producing cell subset is obtained. 
T-cell isolations to this point have been based on the isolation of CD4+ cells from the 
spleenocytes of mice.  This population contains naïve CD4+ effector cells capable of 
polarising into specific subsets, but it also contains a population of effector memory cells 
which have already polarised into a specific cells subtype.  Although this population can 
be effectively polarised into T-helper cell subsets and is suitable for the screening of T-
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cell populations for SNARE associated cytokine secretion, in order to specifically 
investigate the effects of TGF-β on polarisation of naïve CD4+ T-helper cells, T-cells 
enriched using the easysep™ stemcell CD4+ enrichment kit were further sorted for pure 
naïve T-cells based on high CD62L (CD62LHi) and low CD44 (CD44Lo) surface marker 
expression.  Sorting cells using Fluorescent Activated Cell Sorting (FACS) allows pure 
naïve T-cells (CD62LHi/ CD44Lo) to be separated from effector and central memory T-
cells.  This will allow the study of TGF-β to be carried out specifically on the naïve 
polarising cells.  
Sorted naïve T-helper cells were stimulated with 5µg/ml plate bound anti-CD3 and 
2.5µg/ml anti-CD28 antibody in the presence of neutralising IFN-γ (10µg/ml), IL-1β 
(10ng/ml),  IL-6 (20ng/ml), IL-23 (20ng/ml) and with or without TGF-β (0.2ng/ml) for 3 
days.  Cells were put in fresh media and re-stimulated for 24 hours.  Supernatants were 
collected and analysed for cytokines.  Cells cultured with TGF-β have similarly high 
levels of IL-17 to the cells generated without TGF-β.  However, while levels of IL-2 are 
detected in the Th17 cells generated without TGF-β, IL-2 levels are significantly reduced 
in the Th17 cells polarised with TGF-β.  Levels of IL-10 are significantly reduced in 
naïve sorted T-helper cell subsets that have been polarised into Th17 cells [Figure 3.11]. 
The two subsets generated show similar results to the cells described in the paper.  This 
was further confirmation of the Th17 cell subsets which correlated with the study by 
Ghoreschi et al (2010).   
To confirm the Th17 subsets, and to investigate the culture for IFN-γ/IL-17 double 
producing cells, the cells were stained for intracellular cytokines to assess the total 
percentage of IL-17 and IFN-γ producing cells.  Cells were cultured for 3 days and re-
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stimulated with anti-CD28 and plate bound anti-CD3 antibody for 24 hours.  Monensin,  
a carboxylic ionophore that interrupts intracellular transport leading to an accumulation 
of cytokine in the Golgi complex, was added for the final 4 hours.  This allows cytokines 
in the cells to be stained using fluorescent antibodies and cytokine production from 
individual cells to be characterised (Foster et al. 2007).   
Cells cultured in Th17 skewing environment show positive staining for intracellular IL-
17.   Of the cells cultured with TGF-β, more than 10% of these cells were IL-17 
producing cells.  This is compared to the IL-23 polarised cells of which ~4% are IL-17 
producing cells.  Cells cultured in both of these conditions have low levels of IFN-γ and 
IL-4 producing cells [Figure 3.12]. 
Despite the low levels of IFN-γ or IFN-γ/IL-17 double producers, studies have shown 
that cells polarised without TGF-β have the ability to class switch to T-bet/RORγt 
positive, IFN-γ/IL-17 double producing cells in Th1 polarising conditions even after 
commitment to the Th17 cell subset.  Therefore it was necessary to use TGF-β in the 
conditions for polarising Th17 cells; these conditions also have the added benefit of 
producing a higher percentage of IL-17 secreting cells in vitro.  Isolating naïve T-cell 
populations greatly decreases the number of cells obtained from the spleens of mice.  
Therefore, the CD4+ enriched T-cells were used to identify initial SNARE candidates as 
described in the next chapter, and a naïve CD4+ T-cell population will be used in later 
chapters to study specific SNAREs in detail.   
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3.2.11 – OPTIMISATION OF Th1 CD4+ T-CELL POLARISATION IN 
VITRO. 
Th1 cells are characterised by production of the hallmark cytokine IFN-γ.  In order to 
identify a Th1 polarised T-cell subset the levels of IFN-γ relative to other T helper cell 
cytokines produced by the cells are assessed.  To drive cells into Th1 subset it is 
necessary to activate the master regulator T-box transcription factor TBX21 (T-bet).  T-
bet controls transcription of the Th1 hallmark cytokine IFN-γ.  IL-12 has been identified 
as a signalling cytokine responsible for triggering STAT4 and subsequent T-bet 
activation leading to an IFN-γ production.  IFN-γ, a strong inducer of T-bet, then acts in 
an autocrine fashion to further drive Th1 polarisation (Schulz et al. 2009; Szabo et al. 
2000).  T-bet transcription is inhibited by GATA-3 expression as it down-regulates 
STAT4 expression and independently suppresses IFN-γ expression (Usui et al. 2003; 
Yagi et al. 2010).  GATA-3 is activated through IL-4 signalling, a product of Th2 
polarised cells.  Therefore, in order to block IL-4 signalling an anti-IL-4 antibody was 
added with IL-12 to trigger T-bet activation and IFN-γ expression.   
In order to establish a method for the generation of a Th1 subset, CD4+ T helper cells 
were cultured in media supplemented with and without 10ng/ml rmIL-12 and 10µg/ml 
anti-IL-4 antibody (R & D) and stimulated in fully supplemented RPMI using 5µg/ml 
plate bound anti-CD3 and 2.5µg/ml anti-CD28 antibody.  Supernatants were collected on 
day 3 and measured for cytokine secretion using ELISA.  Cytokine analysis showed that 
the secretion of IFN-γ from these cells is significantly greater than their secretion of IL-4 
and IL-17, which were secreted in very low levels in comparison [Figure 3.13(a)].  Next 
the IFN-γ secretion profile of the Th1 cells was compared to the Th17 cell subsets.  As 
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expected, Th1 cells had a significantly higher level of IFN-γ production when compared 
to Th17 generated cells [Figure 3.13(b)].  For further experiments involving the Th1 
subset, Th1 polarisation was carried out using 10ng/ml IL-12 and 10µg/ml anti-IL-4 
antibody. 
3.2.12 – T-CELLS CULTURED IN Th1 POLARISING CONDITIONS 
EXPRESS THE T-BOX TRANSCRIPTION FACTOR T-BET. 
In order to confirm that cells generated in the Th1 conditions used are indeed Th1 cells, it 
was necessary to stain the cells and confirm the expression of the transcription factor and 
master regulator T-bet which has been identified as a master regulator of IFN-γ 
producing Th1 cells (Szabo et al. 2000).  To measure expression of T-bet, CD4+ cells 
were cultured and activated in Th1 and Th17 polarising conditions for 3 days.  Cells were 
permeablised and stained for intracellular transcription factor T-bet using PE conjugated 
anti T-bet antibody (BD).  Given that Th0 stimulated cells secrete an array of cytokines 
and express high levels of transcription factors from all subsets, T-bet expression of the 
Th1 cells was compared to a Th17 polarised subset of cells which expresses T-bet at 
lower levels. 
Figure 3.14 demonstrates that the expression of the T-bet transcription factor in Th1 cells 
is higher than that of Th17 cells with an increase in the MFI from 25.9 to 33.6, and in an 
increase in the PE Median from 12.0 to 15.8, further confirmation for a polarised Th1 
subset in vitro.  
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3.2.13 – T-CELLS CULTURED IN Th1 POLARISING CONDITIONS 
EXPRESS THE SURFACE PROTEIN CCR5. 
To further confirm the Th1 cell subset, cells were stained for the chemokine surface 
protein receptor CCR5.  CCR5 has been shown to be up-regulated on the surface of Th1 
cells following activation with 10ng/ml IL-12 (Qin et al. 1998).  CD4+ enriched cells 
were cultured and activated in Th1 polarising conditions for 3 days.  The cells were then 
transferred to fresh media and re-stimulated for a further 24 hours.  Cells were blocked 
and stained for the surface receptor CCR5 using a PE conjugated anti CCR5 antibody 
(BD).  Cells were acquired on the BD FACS Aria and data was analysed using the 
FlowJo software (treestar).  Stimulation of cells in Th1 polarising conditions resulted in 
an up-regulation of surface chemokine receptor CCR5.  PE median intensity increased 
from 10.4 to 13.8 between the naïve and Th1 cells [Figure 3.15]. 
3.2.14 – OPTIMISATION OF Th2 CD4+ T-CELL POLARISATION IN 
VITRO. 
Although Th2 cells are not the main focus of this thesis, this subset may be necessary for 
comparison to Th1 and Th17 subsets in future experiments.  Therefore the culture 
protocol was optimised to generate a Th2 subset.  IL-4 is the characteristic cytokine 
secreted by Th2 cells.  In order to polarise naïve T-cells into a Th2 cell subset it is 
necessary to culture cells in the presence of IL-4 and a neutralising IFN-γ antibody.  IFN-
γ is responsible for driving a Th1 cell subset, which directly inhibits the generation of 
Th2 cells (Gajewski & Fitch 1988; Ouyang et al. 1998).  IL-4 is a direct inducer of 
STAT6 which leads to GATA-3 activation and Th2 polarisation (Zheng & Flavell 1997).  
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As well as being a T-cell growth factor, as shown previously, IL-2 is a strong inducer of 
STAT5.  STAT5, independent of GATA-3, enhances IL-4 production which acts in a 
autocrine fashion as an inducer of STAT6 and GATA-3 activation and further 
polarisation of Th2 cells (Cote-Sierra et al. 2004). 
Isolated CD4+ enriched T-cells were stimulated in supplemented RPMI in the presence of 
10µg/ml neutralising anti-IFN-γ antibody, 10ng/ml IL-4 and 20ng/ml IL-2 for 3 days.  
Cells were then transferred to fresh medium and re-stimulated with 5µg/ml plate bound 
anti-CD3 and 2.5µg/ml anti-CD28 and for 24 hours without recombinant cytokines and 
antibody.  This was in order to accurately measure the concentration of IL-4 produced by 
the cells. These cells were measured for cytokines using ELISA (R&D).  The profile of 
cytokines observed was as expected with high levels of IL-4 and IL-2 and low levels of 
IL-17 and IFN-γ [Figure 3.16].   
3.2.15 – T-CELLS CULTURED IN Th2 POLARISING CONDITIONS 
EXPRESS THE TRANSCRIPTION FACTOR GATA-3. 
In order to confirm the Th2 subset, cells were stained for the Th2 master regulator 
GATA-3.  Th2 cells are polarised from naïve cells after IL-4 signalling and STAT6 
activation of the transcription factor GATA-3 (Zheng & Flavell 1997).  In order to stain 
Th2 cells for GATA-3, CD4+ T-cells were stimulated with 5µ/ml plate bound anti-CD3 
and 2.5µg/ml anti CD28 antibodies for 3 days in Th2 and Th17 (for comparison) 
polarising conditions.  Cells were then transferred to fresh media containing no 
recombinant cytokines and re-stimulated with plate bound anti-CD3 and anti CD28 for a 
further 24 hours.  Cells were permeabilised and stained for the intracellular transcription 
factor GATA-3 using an APC-Cy7 conjugated anti-GATA-3 antibody (BD).  Cells were 
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acquired on the BD FACS Aria and data was analysed using the FlowJo software 
(treestar).  Stimulation of cells in Th2 polarising conditions resulted in an up-regulation 
of GATA-3 in Th2 polarised cells when compared to Th17 polarised cells with an 
increase to 14.56 MFI for Th2 cells compared to 8.65 MFI for the Th17 cells [Figure 
3.17]. 
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Fig.3.1 – CD3 and CD4 surface staining on CD4+ T-helper subset.  Cells were isolated from the spleens 
of female balb/c mice.  Erythrocytes were lysed using an erythrocyte lysing kit (BD).  CD4+ T cells were 
negatively selected using magnetic separation (Stemcell) according to manufacturer’s instructions.  Cells 
were stained with anti mouse antibodies from BD.  Cells were analysed using the BD FACS Aria flow 
cytometer.  (a) FSC and SSC gating to remove dead cells and debris from analysis.  (b)  The dot plot 
represents magnetically isolated CD4+ cells stained with a primary PE conjugated anti-CD4 antibody.  The 
dot plot indicates that the cells are 94.5% CD4+ cells.  (c)  Cells were stained with primary PE conjugated 
anti-CD4 antibody and primary FITC conjugated anti-CD3 antibody.  The cells were double stained and 
single stained samples were used to compensate for the fluorescent emission overlap of FITC and PE.  The 
dot plot indicates 89.4% of the cells are positive for both CD3 and CD4 (Q2). 
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 Spleenocytes (x106) CD4+ T-cells (x106) % Purity % Viability 
Magnet 200 21.32 94.80 76.9 
Column 200 13.66 63.63 73.5 
 
 
 
Table 3.1 – Comparison of magnetic and column isolation methods 
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Fig.3.2 – Comparison of CD25 expression on unstimulated and stimulated T-cells.  CD4+ T-cells were 
negatively selected using magnetic isolation (Stemcell) according to manufacturer’s instructions.  Cells 
were either stimulated with plate-bound anti-CD3 (5 µg/ml) plus anti-CD28 (2.5 µg/ml) or left in culture 
unstimulated for three days.  Cells were collected and stained for CD25 using PE labelled primary 
conjugated anti-CD25 antibody (BD).  Cells were analysed using a BD FACS Aria and data was analysed 
using FlowJo Software (treestar).  Cells were gated on CD4+ expressing cells and histograms of CD25 
expression are overlayed showing an increase in expression of CD25 on stimulated cells. 
PE-CD25 
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Fig. 3.3 – Comparison of CD3 and different doses of anti CD28 agonist.  Cells were isolated from the 
spleens of female balb/c mice.  Erythrocytes were lysed using an erythrocyte lysing kit (BD).  CD4+ T cells 
were negatively selected using magnetic separation (Stemcell) according to manufacturer’s instructions.  
Plates were coated with anti-CD3 antibody (5µg/ml) for two hour at room temperature.  Cells were then 
plates in either uncoated wells, wells with anti-CD3 only or in wells with two different concentrations of 
anti-CD28 (2.5µg/ml and 5µ/ml).  T-cells were left for 3 days in media and supernatants were collected for 
measurement of cytokines by ELISA. 
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Fig.3.4 - Magnetic isolation of CD4+ cells yields a higher purity when compared to column separation 
methods.  Cells were isolated from the spleens of female balb/c mice.  Erythrocytes were lysed using an 
erythrocyte lysing kit (BD).  CD4+ T cells were negatively selected using column (R&D) or magnetic 
separation (Stemcell) according to manufacturer’s instructions.  Cells were stained with anti mouse CD4 
antibody (BD).  Cells were analysed using the BD FACS Aria flow cytometer.  (a) FSC and SSC plot 
showing gating of the cells to exclude dead cells and debris. (b) Dot plot of magnetically enriched CD4+ 
cells.  Cells are gated on the PE positive population, 94.8% are PE positive cells.  (C) Dot plot of column 
separated enriched CD4+ cells.  Cells are gated on PE positive population, 68.8% are PE positive.  Data was 
generated using Flowjo software (treestar).  Cells were selected after gating out dead cells and debris based 
on FSC and SSC.   
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Fig.3.5 – Comparison of magnetic and column purified cells after stimulation.  CD4+ T cells were 
negatively selected using magnetic (Stemcell) or column (R&D) separation according to manufacturer’s 
instructions. Cells were stimulated with plate-bound anti-CD3 (5 µg/ml; 145-2C11) plus anti-CD28 (2.5 
µg/ml; 37.51); Cells were stimulated and supernatants were collected after three days and analysed using 
ELISA duo kits from R&D. 
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Fig 3.6 - Batch testing of heat inactivated Fetal Bovine Serum.  CD4+ T cells were negatively 
selected using magnetic separation (Stemcell Cat# 19752) according to manufacturer’s instructions. 
Cells were stimulated with plate-bound anti-CD3 (5 ug/ml) plus anti-CD28 (2.5 ug/ml).  Media was 
supplemented with a range of Fetal Bovine Serum batches from Sigma, Gibco and ThermoFisher 
(10%).  Fetal Bovine Serum was heat inactivated for 30mins at 56oC and left to cool at room 
temperature.  Cells were stimulated and supernatants were collected and analysed after three days in 
culture using ELISA duo kits from R&D. 
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Designation Brand Name Cat Number Lot Number 
A GIBCO FBS 10270 41G8102K 
B GIBCO FBS 10270 41F8294K 
C HyClone FetalClone SH30080.02 AVK53532 
D HyClone Research Grade SV30160.02 RVE38189 
 
 
 
Table 1.2 – Description of FBS suppliers and lots analysed and designated labels 
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Fig 3.7 – Effects of IL-2 on cell proliferation in supplemented media.  Cells were isolated from female 
balb/c mice using easysep CD4+ Isolation (Stemcell Cat# 19752).  Cells were stained with CFSE dye 
(5µM; eBioscience) for 10 minutes before washing with PBS and fresh medium and plated at 2x106/ml in a 
24 well plate. Cells were stimulated with plate-bound anti-CD3 (5 µg/ml) plus anti-CD28 (2.5 µg/ml).  
Cells were re-stimulated for 3 days and stained with Propidium Iodide (Miltenyi Biotech) for dead cell 
exclusion and read on a BD FACS Aria.  Data was analysed using Flowjo software (Treestar).  (a) 
Proliferation curves generated for each sample using Flowjo software.  Each generation of cells is indicated 
by a number above the peak.  (b) Graph of the proliferation profile showing the numbers of cells in each 
generation calculated using the proliferation algorithm in flowjo analysis software. 
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Fig 3.8 – Effects of BME on cell viability.  Cells were isolated from female balb/c mice using easysep 
CD4+ Isolation (Stemcell Cat# 19752).  Cells were stained with CFSE dye (5µM; eBioscience) Cells were 
plated at 2x106/ml in a 24 well plate. Cells were stimulated with plate-bound anti-CD3 (5 ug/ml; 145-
2C11) plus anti-CD28 (2.5 ug/ml; 37.51.  Cells were re-stimulated in fresh media on day 3.  50µl of cell 
culture was removed on days 1, 2, 3, 5 and 6 and stained with Propidium Iodide (Miltenyi Biotech) and 
read on a BD FACS Aria I within 30mins. 
 
 
 
 
Day 1 Day 2 Day 3 Day 5 
FSC 
PI
 
BME + IL-2 
BME 
IL-2 
Control 
 104 
 
 
 
Un
sti
m
ula
ted
IFN
-
g
IL-
4
IL-
17
0
1000
2000
3000
4000
5000
pg
/m
l
Un
sti
m
ula
ted
IFN
-
g
IL-
4
IL-
17
0
2000
4000
6000
8000
pg
/m
l
 Fig 3.9  – Cytokine profiles for polarised Th17 T-cells with and without TGF-β.  Cells were isolated 
from female balb/c mice using easysep CD4+ Isolation (Stemcell).  Cells were plated at 2x106/ml in a 24 
well plate. Cells were stimulated with plate-bound anti-CD3 (5 µg/ml) plus anti-CD28 (2.5 µg/ml) in media 
supplemented with anti-IFN-γ, IL-1β, IL-6 and IL-23 with and without TGF-β.  Cells were re-stimulated in 
fresh media on day 3 with anti-CD28 and anti-CD3 for 24hours.  Supernatants were collected and analysed 
using ELISA according to manufacturer’s instructions (R&D duoset).  Profile shows an increase in IL-17 
relative to IFN-γ and IL-4.  The high level of IL-17 in relation to these cytokines is indicative of a Th17 
cell subset.  TGF-β stimulated cells secrete a higher level of IL-17. 
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Fig 3.10 – Transcription factor staining for T-helper subsets.  Cells were isolated from female balb/c mice using 
easysep CD4+ Isolation (Stemcell Cat# 19752).  Cells were plated at 2x106/ml in a 24 well plate. Cells were stimulated 
with plate-bound anti-CD3 (5 µg/ml) plus anti-CD28 (2.5 µg/ml) in the media supplemented with neutralising anti-IFN-
γ, IL-1β, IL-6 and IL-23 cytokines for 3 days.  Samples were taken at 2, 18, 48 and 72hrs. (a) Cells were collected at 
each time point and stained for intracellular IL-17 using APC primary conjugated anti RORγt transcription factor 
antibody (ebioscience).  Cells were analysed on BD FACs Aria I, data was analysed using Flowjo software (treestar).  
Cells were stained with an APC conjugated isotype (grey) and overlayed with the RORγt staining (red).  Cells were 
gated on CD4+ cells and histograms represent the fluorescence intensity measured for each conjugated antibody relative 
to protein expression.  Flow cytometry show an increase in RORγt staining over time, there is also a slight increase in 
non specific staining with the isotype at 24 hours.  (b) Supernatants were collected and analysed by ELISA (R&D) to 
confirm the production of Il-17 over time at each time point.  ELISA results show an increase in IL-17 cytokines over 
time. 
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Fig 3.11 - Cytokine profiles for sorted T-helper subsets Th17(23) and Th17(β) .  Cells were isolated 
from female balb/c mice using easysep CD4+ Isolation (Stemcell).  Cells were stained with anti-mouse 
CD4, CD44 and CD62L antibodies (BD) and sorted on a BD FACS Aria I for CD4+, CD62L LO, CD44+ 
Cells.  Cells were plated at 2x106/ml in a 96 well plate. Cells were stimulated with plate-bound anti-CD3 (5 
µg/ml) plus anti-CD28 (2.5 µg/ml) in media supplemented with anti-IFN-γ, IL-6, IL-1β and either (a) IL-23 
(Th17(23)) or (b) TGF-γ (Th17(β)).  Cells were re-stimulated in fresh media on day 4 with anti-CD28 and 
anti-CD3 for 24hours.  Supernatants were collected and analysed using ELISA according to manufacturer’s 
instructions (R&D duoset).  Cells show a large amount of IL-17 in both cell stimulations.  There is IL-2 
present in the Th17(23) population but no Il-2 in the Th17(β) population. 
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Fig 3.12 - Intracellular cytokine staining profiles for sorted T-helper subsets.  Cells were isolated from 
female balb/c mice using easysep CD4+ Isolation (Stemcell).  Cells were stained with anti-mouse CD4, 
CD44 and CD62L antibodies.  Cells were sorted on a BD FACS Aria I for CD4+, CD62L LO, CD44+ Cells.  
Cells were plated at 2x106/ml in a 96 well plate. Cells were stimulated with plate-bound anti-CD3 (5 µg/ml; 
145-2C11) plus anti-CD28 (2.5 µg/ml; 37.51) in media supplemented with anti-IFN-γ, IL-6, IL-1β and 
either IL-23 (Th17(23) or TGF-β Th17(β).  Cells were re-stimulated in fresh media on day 4 with anti-CD28 
and anti-CD3 for 24hours.  Brefeldin A (BD Golgi stop) was added for the last 4 hours.  Cells were 
collected and stained using mouse CD4+ T-cell phenotyping kit (BD) according to manufacturer’s 
instructions.  Cells were analysed on BD FACs Aria, data was analysed using Flowjo software (treestar).  
Both subsets have Th17 producing cells.  The Th17(23) has around 4% IL-17 producing cells, Th17(β) cells 
have a 10% IL-17 producing population. 
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Fig 3.13 – Cytokine profiles for Th1 polarised T-cells stimulated in media supplemented with IL-12 
and anti-IL-4 antibody.  Cells were isolated using easysep CD4+ magnetic Isolation (Stemcell Cat# 
19752).  Cells were plated at 2x106/ml in a 24 well plate. 1x106 cells were stimulated with plate-bound anti-
CD3 (5 µg/ml) plus anti-CD28 (2.5 µg/ml) with 20ng/ml IL-2, 20ng/ml IL-12 and 10µg/ml anti-IL-4 
antibody for 3 days for Th1 polarising conditions.  Supernatants were collected and measured for cytokines 
by ELISA (R&D Duoset).  (a) Cytokine profile for cells stimulated with IL-12 and anti-IL-4 antibody.  
Levels of IFN-γ are high relative to IL-4 and IL-17 cytokines.  (b) Levels of IFN-γ between polarised 
subsets of cells. Th17 cells were polarised in media supplemented with 10µg/ml anti-IFN-γ antibody, 
20ng/ml IL-6, 20ng/ml IL-23 and 10ng/ml IL-1β for 3 days.  Th1 subset of cells shows a significant 
increase in IFN-γ level relative to the Th17 cell subset. 
 
 
(a) (b) 
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Fig 3.14 – T-Bet transcription factor.  Cells were enriched for CD4+ cells using the CD4+ negative 
Isolation kit (Stemcell Cat# 19752).  Cells were plated at 2x106/ml in a 24 well plate. Cells were stimulated 
with plate-bound anti-CD3 (5 µg/ml) plus anti-CD28 (2.5 µg/ml) in media supplemented with 10ng/ml IL-
12 and 10µg/ml anti-IL-4 anti-body for Th1 cells and 10ng/ml IL-1β, 20ng/ml IL-23, 20ng/ml IL-6, 
0.2ng/ml TGF-β, 10µg/ml anti-IL-4 and 10µg/ml anti-IL-6 for Th17 cells.  The cells were re-stimulated in 
fresh media on day 3 with anti-CD28 and anti-CD3 for 24hours.  Cells were collected and stained for 
intracellular T-bet transcription factor using primary PE conjugated anti T-bet antibody (BD).  Cells were 
analysed on BD FACs Aria and data was analysed using Flowjo software (Treestar).  Cells were gated on 
CD4+ expressing cells and histograms represent T-bet expression on Th1 and Th17 cells.  The Th1 subset 
shows an increased expression of intracellular T-bet. 
PE – T-bet 
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Fig 3.15 – CCR5 expression in Th1 polarised T-cells.  Cells were plated at 2x106/ml in a 24 well plate. 
Cells were stimulated with plate-bound anti-CD3 (5 µg/ml) plus anti-CD28 (2.5 µg/ml).  For Th1 cells 
media was supplemented with 10ng/ml IL-12 and 10µg/ml anti-IL-4 anti-body.  Cells were collected on 
day 3 and stained using primary conjugated anti-mouse CCR5 antibody (BD).  Cells were analysed on BD 
FACs Aria I, data was analysed using Flowjo software (treestar).  Histograms represent the fluorescence 
intensity of the stained cells relative to CCR5 expression on naïve T-cells (blue) and Th1 polarised T-cells 
(red).  There is an increase in the expression of CCR5 expression on the Th1 polarised cells. 
 
 
 
 
 
 
 
 
 
 
 
 
 
PE – CCR5 
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Fig 3.16 – Th2 polarised cells.  Cells were isolated using easysep CD4+ negative isolation kit 
(Stemcell).  Cells were plated at 2x106/ml in a 24 well plate. Cells were stimulated with plate-bound 
anti-CD3 (5 µg/ml) plus anti-CD28 (2.5 µg/ml) in media supplemented with 10µg/ml neutralising anti-
IFN-γ antibody and 10ng/ml IL-4.  After 3 days in culture, cells were put in fresh media and re-
stimulated with (5 µg/ml) plate bound anti-CD3 and (2.5 µg/ml) anti-CD28 for 3 days.  On day 6 
Supernatants were collected and analysed using ELISA according to manufacturer’s instructions (R&D 
duoset).  The analysis shows a large amount of IL-4 and Il-2 relative to the IFN-γ and IL-17 levels, 
indicative of a Th2 polarised subset. 
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Fig 3.17 – CD4+ cells culture in Th2 polarising conditions express the transcription factor GATA-3.  
Cells were isolated from female balb/c mice using easysep CD4+ Isolation (Stemcell).  Cells were plated 
at 2x106/ml in a 24 well plate. Cells were stimulated with plate-bound anti-CD3 (5 µg/ml) plus anti-CD28 
(2.5 µg/ml), for Th2 cells supplemented media was further supplemented with 10ng/ml IL-4, 20ng/ml IL-
2 and 10µg/ml anti-IFN-γ neutralising anti-body.  Th17 cell media was supplemented with 10µg/ml anti-
IFN-γ, 20ng/ml IL-6, 10ng/ml IL-1β and 20ng/ml IL-23.  Cells were re-stimulated in fresh media on day 3 
with anti-CD28 and anti-CD3 for 24hours.  Cells were collected and stained using PE-CY7 primary 
conjugated anti-GATA-3 antibody (BD).  Cells were analysed on BD FACs Aria, data was analysed using 
Flowjo software (treestar).  The shaded grey area represents the naive cell population, the blue line 
represents the expression of GATA-3 in Th17 polarised cells and the red line represents GATA-3 
expression in Th2 cells.  There is an increase in the expression of GATA-3 in Th2 cells.  
 
PE-Cy7 – GATA-3 
 113 
3.3– DISCUSSION 
In this chapter a pure viable CD4+ T-cell population was isolated.  The conditions for 
culturing and polarising the cells into differentiated T-helper cell subsets were optimised.  
Column and magnetic based protocols for obtaining CD4+ pure cells from mouse 
spleenocytes were investigated.  The magnetic method of isolation led to a higher purity 
of cells with better viability and response to stimulation.  This technique works using a 
cocktail of antibodies directed against markers on cells that are not of interest.  Magnetic 
nano-particles are then added and form a nano-particle bound complex the antibodies.  
Unwanted cells are then removed by placing the cells in a magnetic field which holds the 
cells bound to a nano-particle in place while the unbound CD4+ cells are poured off and 
collected.  It is important to note that there is no centrifugation or mechanical stress 
placed on the cells during this purification.  The second separation protocol investigated 
was a column kit that works in a similar fashion using a monoclonal antibody cocktail to 
bind spleenocyes that are not of interest.  The mixed suspension is then loaded into the 
enrichment column which contains glass beads coated with Ig and anti-Ig.  Following an 
incubation step the mixture flows though the column by gravity and cells that are not of 
interest are bound to the column enriching the flow through.  The column is then washed 
with buffer to recover the CD4+ cell population.  It is possible that the interaction with 
the column has an affect on cell viability.  The washing step may also contribute to the 
lower purity observed in the column isolated cells.  There was a lot more variation in the 
yields and purity obtained from the column method, which may also be attributed to the 
column washing and elution steps.  Magnetic and column isolated cells were also 
compared post stimulation, with cells showing higher levels of cytokines secreted from 
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the magnetically isolated cell population.  This is most likely due to the higher purity of 
CD4+ T-cells obtained and the higher viability of the cells, which would then lead to an 
improved response following stimulation.  Magnetic isolation was selected as it was a 
faster, more reliable and effective method of isolation resulting in a CD4+ cell population 
with higher purity, viability and response to activation. 
In order to confirm that the isolated cells were indeed CD4+ T-helper cells, the  cells were 
counter-stained for the T-cell surface protein CD3, which is a part of the TCR complex 
involved in cell antigen recognition (Krummel et al. 2000).  Routinely ~90% of the cells 
isolated were CD3+/CD4+ T-cells.  The remainder is made up of contaminating cells 
owing to the method of isolation used and a very small population of CD4+ cells that may 
be present in the spleen that are not bound by the antibody cocktail.  Once isolation of 
CD4+ T-cells was confirmed, the next step was to investigate the effective activation of 
these cells in vitro. 
Activation of T-cells requires the stimulation of both the TCR receptor and the CD28 co-
stimulatory molecule (J. Zhu et al. 2010).  In order to replicate these signals in vitro, cells 
were stimulated with anti-CD3 and anti-CD28 antibodies which cross-react the receptors 
leading to activation and cytokine secretion.  Another method of activation considered 
was chemical stimulation of the cells using Phorbol 12-myristate 13-acetate (PMA).  
PMA does not interact with the cascade and activates protein kinase C late in the pathway 
leading to cell activation and cytokine secretion (Nobrega et al. 1986).  Although PMA 
stimulation in vitro leads to cell activation and cytokine secretion, CD3 and CD28 
activation represents a more physiological method of stimulation, interacting with surface 
proteins on the cell and activating corresponding signalling pathways.  PMA activation 
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has also been shown to have an effect on the expression of IL-2R (CD25) and may lead 
to problems with T-cell proliferation using this model over a longer time period (Chopra 
et al. 1989).  It also leads to over expression of IL-2 via the protein kinase C pathway 
which may interfere with polarisation of T-cells into a Th17 subset in later experiments 
(Laurence et al. 2007; P. Zhu et al. 2010).  PMA was however used in later experiments 
to stimulate non-specific cytokine secretion in polarised cells in order to facilitate 
intracellular staining.  Two concentrations of anti-CD28 antibody were investigated in 
combination with plate bound anti-CD3 activation of the T-cells.  Soluble anti-CD3 has 
been shown to lead to cell anergy and low proliferation in vitro and was therefore plate 
bound at a single concentration for 2hrs prior to activation (Clement et al. 1985).  The 
two concentrations of antit-CD28 investigated appeared to make no difference to the 
activation of Th0 (non-polarised) cells and the lower dose of anti-CD28 was selected for 
the activation of the cells.  Activation strength can however have an effect on the 
polarisation of cells, with recent studies showing the effects of varying concentrations of 
anti-CD28 on the polarisation of Th17 cells in particular (Bouguermouh et al. 2009; 
Purvis et al. 2010).  The method of isolation and dose of antibodies used in this study 
appear to have been effective in the activation and polarisation of the CD4+ T-cells into 
Th1, Th2 and Th17 cells subsets.       
In initial experiments using these conditions isolated cells did not proliferate well in 
culture, therefore different components of the media were assessed in order to identify the 
optimal conditions for culturing CD4+ T-helper cells in vitro over a number of days.  
Fetal bovine serum (FBS) is an undefined media supplement necessary for in vitro cell 
culture.  Stocks of FBS are created commercially in large batches and even FBS ordered 
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from the same company can vary greatly.  Batch testing was carried out in order to 
investigate if different sources and batches could affect the activation and culture of 
CD4+ T-cells.  The results obtained show evidence of variation as there is a difference in 
cytokine secretion between cells cultured with FBS from different sources.  Heat 
inactivation of FBS is carried out routinely in cell culture labs.  It was initially introduced 
to kill heat labile complement protein, viruses and mycobacteria.  A study by Triglia and 
Linscott (1980) observed that modern FBS contains a negligible amount of complement 
and any inactivation required is be carried out when the media is heated to 37oC before 
use.  Modern triple filter systems that filter down to 0.1µm in size remove mycobacteria 
from serum.  However, heat activation protocols are still in place in many research labs 
and heat inactivated serum is available to purchase commercially despite the fact that 
there is also an inherent possibility of degrading heat sensitive growth factors present in 
the sera.  The results in this chapter show that regardless of these reports of heat 
inactivation becoming a redundant method, there is a marked increase in cytokine 
secretion levels following stimulation in media supplemented with heat inactivated sera, 
this is contrary to findings in other labs (Leshem et al. 1999).  No detailed study has been 
reported on the effects of heat inactivation of FBS in T-cell models and more work is 
required to understand affects on in vitro systems  of T-cell activation (Schulz et al. 2009; 
Szabo et al. 2000).  This is made difficult by the undefined nature of FBS.  In order to 
reduce variability between experiments due to FBS, a large stock batch was ordered and a 
standard heat inactivation protocol was established and used for all experiments.   
Once the variability in FBS between experiments was removed, other additions to the 
media were investigated in order to improve culture conditions for T-cells.  β mercapto-
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ethanol (BME) has been reported to improve the viability of cells in a number of cell 
culture systems (Inui et al. 1997).  The amino acid cysteine is required for T-cell 
proliferation but is in short supply in media supplemented with FBS.  T-cells are unable 
to transport its pre-cursor cystine, which is present in the media, to the cytosol.  BME 
reduces cystine to cysteine making it available to T-cells to utilise for cell growth (Chang 
et al. 1982; Aidoo et al. 1991).   
IL-2 is a proliferation factor and stimulation of T-cells leads to up-regulation of the IL-2 
receptor CD25.  IL-2 has been shown to sustain T-cells and aid in their proliferation as 
shown here and by others (Smith 1988).  The addition of IL-2 leads to an increase in 
proliferation of unpolarised T-cells in culture and improved cell viability.  However, IL-2 
has also been show to play an important role in T-helper cell polarisation, particularly in 
the inhibition of Th17 cell differentiation (Laurence et al. 2007; Cote-Sierra et al. 2004).   
Therefore IL-2 was selectively added to experiments rather than being included in the 
cell culture media with BME.   
Having optimised the conditions for culturing cells the next aim was to optimise a system 
to generate differentiated T-helper subsets in vitro.  This was achieved by stimulating 
CD4+ T-helper cells in media supplemented with the relevant combination of 
recombinant cytokines and neutralising antibodies. 
Th17 cells are a recently characterised lineage shown to be independent of Th1 and Th2 
cells (Harrington et al. 2005; H. Park et al. 2005).  Th17 cell produce large amounts of 
predominantly IL-17A and they have been linked to a number of chronic inflammatory 
diseases which makes the study of IL-17 secretion pathways of particular interest 
(Miossec et al. 2009).  The signalling that leads to the establishment of Th17 cells is still 
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under scrutiny with contradicting studies leading to some contention.  Part of this is due 
to a number of factors that were identified as necessary for the commitment of Th17 cells 
being later identified as dispensable.  IL-23 was initially identified as the factor driving 
cells to produce IL-17 in a number of cells types (McKenzie et al. 2006), at this time it 
was not known if IL-17 producing T-cells were a distinct cell type from Th1 and Th2 
cells.  Th17 cells were later established as a distinct CD4+ T-helper cell lineage 
producing IL-17, IL-21 and IL-22 (H. Park et al. 2005).  Initially IL-23 was attributed to 
the induction of Th17 cells signalling via STAT3, however this was later identified as a 
growth factor and inducer of committed Th17 cells as the IL-23 receptor (IL-23R) is not 
expressed on naïve T-cells and is up-regulated on T-cells in an IL-6 dependant manner.  
IL-6, an activator of the STAT3 pathway and inducer of IL-17 production has been 
identified as a cytokine required for polarisation of a Th17 cell subtype (Zhou et al. 
2007).  However, a study by Chen et al (2007) has shown that stimulation in the presence 
of IL-21 and TGF-β is sufficient to induce RORγt and IL-23 receptor expression (Chen et 
al. 2007).  Furthermore, in the presence of IL-6, CD4+ T-cells produce IL-21 which acts 
through the IL-21 receptor and activates STAT3, committing cells to a Th17 phenotype 
in an autocrine fashion (Korn et al. 2007).  Interestingly, early in this study TGF-β was 
also shown to be dispensible in the differentiation of Th17 cells.  Further investigation 
confirmed these cells as a Th17 cell subset with up-regulation of RORγt, the transcription 
factor and master regulator of the Th17 subset (Ivanov et al. 2006),  These results were 
contradictory to published work at the time showing a requirement for TGF-β (Yang et 
al. 2008; O’Garra et al. 2008).  This was later corroborated in a study by Ghoreschi et al 
(2010) confirming the generation of a Th17 subset in the absence of TGF-β (referred to 
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as Th17(23)).  In this study the authors describe these cells to be a pathogenic Th17 cells 
subset  separate from the conventional Th17 T-cells generated in vivo in the presence of 
TGF-β (referred to as Th17(β)) (Ghoreschi et al. 2010).  However, Ghoreschi et al (2010) 
and others have shown that Th17 cells generated in the absence of TGF-β (Th17(23)) 
demonstrate a degree of cell plasticity and are not entirely committed to a Th17 lineage.  
When Th17 cells were put in media containing IL-23 or IL-12, but no TGF-β they 
switched to IFN-γ/IL-17 double producing cells.  They also expressed T-bet and RORγt 
simultaneously, each identified as the Th1 and Th17 master regulator transcription factor 
respectively.  These cells have been identified mainly in the gut and have been identified 
as an overly pathogenic cell subset that is hypothesised to play a role in inflammatory 
disease (Lee et al. 2009; Lee et al. 2012).  Given that the premise for this study was to 
generate two distinct cell types producing large amounts of the subset signature cytokine 
but derived from the same progenitor cells, the potential plasticity of the Th17 cells and 
their ability to produce both IFN-γ and IL-17 could lead to complications when screening 
potential SNARE candidates.  It was therefore necessary to generate both Th17(23) and 
Th17(β) cells subsets and investigate the cell plasticity in this in vitro model. 
In order to study these cells in detail, a pure naïve CD4+ T-cell population was isolated 
from the CD4+ spleenocytes obtained from the spleen.  Work to this point was optimised 
for the cell culture and polarisation of CD4+ enriched T-cells populations from the spleen.  
This population contains both CD4+ unpolarised naïve T-cells and CD4+ memory T-cells.  
Memory cells are usually associated with an acute immune challenge where by a portion 
of T-cells take on a memory phenotype in order to respond quickly to a second challenge 
of antigen.  The balb/c mice used in this study were unchallenged, however it has been 
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suggested that the memory phenotype present in naïve mice is likely generated to 
exposure from gut flora and environmental antigens.  These cells have the capability of 
producing cytokines upon re-stimulation with TCR ligands.  They are sustained and 
proliferate in the same conditions as CD4+ naïve helper T-cells (Seddon et al. 2003).  
Another source of contamination is the presence of CD4+ regulatory cells (Tregs).  Tregs 
are a suppressive T-cell phenotype that is largely studied for its ability to suppress and 
control immune responses (Littman & Rudensky 2010; Wing & Sakaguchi 2010).    In 
the spleens of mice, 6-10% of CD4+ T-cells are Tregs and these present a potential source 
of contamination.  Although this contamination is present in the CD4+ T-cells isolated 
and optimised for polarisation into subsets of cells, these cell purities were sufficient for 
the screening steps that follow in chapter 4.  They also allow for a larger cell number to 
be obtained and the effective use of resources available for the screening stages of the 
project.  However, it was clear that later in the project it would be necessary to study a 
pure naïve CD4+ population for any SNARE candidates that arise in the screening stages.   
Cells were sorted using Fluorescent Activated Cell Sorting (FACS), a method that 
analyses cells for fluorescently labelled antibodies that are targeted to cellular proteins 
and sorts them into individual populations.  The CD4+ cells were stained for the cell 
surface markers CD44 and CD62L and sorted into CD44 low expressing CD62L high 
expressing cell population (CD44lo, CD62Lhi), which have been identified as a pure naïve 
cell phenotype (Seddon et al. 2003).  CD62L (also known as L-selectin) is a cell adhesion 
module that is a marker of naïve effector T-cells.  Naïve cells by their nature have not 
encountered antigen and in order to do that they must enter secondary lymphoid 
structures, CD62L expression allows cells to enter lymph nodes where it can encounter 
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antigen.  Effector memory T-cells do not express CD62L as they do not reside in the 
lymph node structures, but circulate in the periphery, cells are therefore sorted for high 
expression of CD62L (Bradley et al. 1992).  Central memory T-cells however also 
express CD62L as they reside in lymph nodes in order to respond to previously 
encountered antigens, a second marker is therefore necessary.  CD44 is a marker of 
developed memory T-cells and is involved in cell migration and adhesion (Budd et al. 
1987). Hence cells were also sorted for low CD44 expression.  The populations obtained 
were >98% pure and were cultured in polarising conditions for Th17(23) and Th17(β) 
cell types.  The cytokine profiles measured were similar to those measured previously in 
this study and by Ghoreschi et al (2010).  No IFN-γ/IL-17 double producing cells were 
observed in the intracellular cytokine experiments; however there were some differences 
in the derived subsets.  Th17(β) cell polarisation results in a significant increase in the 
number of IL-17 producing cells, as measured by intracellular cytokine staining.  They 
also show an increase in the amount of IL-17 produced in the supernatants by ELISA, 
possibly as a result of a higher number of Th17 producing cells.  This may be as a result 
of the decrease in the amount of IL-2 measured in the supernatant by ELISA when 
compared to Th17(23) cells.  IL-2 inhibits Th17 polarisation and also directly inhibits IL-
17 production via signalling through STAT5 (Laurence et al. 2007).  Given that the aim 
of this model was to identify a SNARE involved in the secretion of cytokine from a 
specific T-cell subset, conventional Th17(β) presented the best option for Th17 
polarisation.  They have been shown to exhibit less plasticity and when measured show 
an increase in the amount of IL-17 production and IL-17 producing cells, TGF-β was 
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therefore included in the antibody/recombinant protein cocktail used to generate CD4+ 
Th17 cells.   
 
Th1 cells are polarised and cloned in vivo in response to pathogenic invaders in the body.  
Macrophage and dendritic cells engulf pathogens and present molecules in the MHC 
complex on the cell surface.  These antigen presenting cells (APCs) secrete large amounts 
of IL-12 into the environment surrounding the cells.  Activation of T-cells by antigen 
through the TCR induces early IFN-γ production.  IFN-γ produced early by activated T-
cells in vitro leads to STAT1 activation and up-regulation of the IL-12 receptor.  IL-12 
signalling acting through STAT4 commits the T-cells to a Th1 differentiated cells by the 
up-regulation of T-bet and in turn, IFN-γ expression.  IFN-γ can then act in an autocrine 
fashion to further induce T-bet expression in T-cells by signalling through the IFN-γ 
receptor, and establishing a self reinforcing feedback loop.  IL-12 signalling also acts 
through a positive feedback loop by enhancing expression of its own receptor IL-12Rβ2 
(Szabo et al. 2000; Schulz et al. 2009).  IL-12 is necessary for commitment to Th1 cells 
and is secreted by APCs but not T-cells.  It is therefore necessary to add recombinant IL-
12 in vitro in order to provide this signal.   
Th1 cells are directly inhibited by IL-4 producing Th2 cells.  IL-4 drives GATA-3 
expression and Th2 lineage commitment which directly inhibits Th1 development 
through two independent pathways;  the direct inhibition of STAT4 induction which is 
necessary for T-bet activation, and the binding and active repressing of Runx3 leading to 
direct inhibition of IFN-γ production (Ouyang et al. 1998; Usui et al. 2003; Yagi et al. 
2010).   
 123 
In order to obtain a Th1 cell subset, IL-12 and anti-IL4 anti-body were added to the 
culture media.  This resulted in a marked increase in IFN-γ production relative to the 
other cytokines measured by ELISA and establishment of an autocrine feedback loop 
committing cells to the Th1 subset.  T-bet is a master regulator of Th1 cells and leads to 
the secretion of IFN-γ (Szabo et al. 2000).  In order to confirm Th1 lineage commitment, 
cells were measured for the expression of the transcription factor T-bet which was found 
to be significantly increased when compared to Th2 cells.  CCR5 and CXCR3 are 
chemokine receptors expressed on the cell surface that have been reportedly up-regulated 
in Th1 cells (Qin et al. 1998).  CXRCR3 has been associated with Th2 cells but CCR5 is 
unique to the Th1 subset.  Up-regulation of CCR5 was observed in T-cells stimulated 
with IL-12 and anti-IL-4 antibody in this study. 
Differentiation of Th2 cells is inhibited by IFN-γ produced early by Th1 and early 
activated T-helper cells.  The addition of antibody to neutralise IFN-γ and the addition of 
IL-4 activates the transcription factors GATA-3 committing naïve T-helper cells to a Th2 
lineage  and inhibiting Th1 commitment (Zheng & Flavell 1997).  Th2 cells were 
generated in vitro and characterised by cytokine production and the expression of GATA-
3.  The Th2 subset was optimised in the lab but the use of this model is not ideal to link 
SNARE expression to IL-4 production.  Although IL-4 is the predominant cytokine 
produced by Th2 cells, it also secretes a number of others; IL-5, IL-9, IL-13 and IL-25 
(Paul & Zhu 2010).  This does not make Th2 cells a good cell line for this study but the 
development of the model was thought to be necessary for potential use as a comparative 
in later work. 
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This study established a model of T-helper cell polarisation for the generation of 
characterised Th1, Th2 and Th17 subsets producing predominantly IFN-γ, IL-4 and IL-17 
cytokines respectively.  This model will allow for the study of specific SNARE transport 
proteins regulating the secretion of signature cytokine produced in each subset of cells.   
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CHAPTER 4  
 
 
 
SNARE EXPRESSION IN CD4+    
T-CELLS 
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4.1– INTRODUCTION 
SNARE proteins were initially identified in the field of neurobiology as soluble synaptic 
trafficking proteins necessary for efficient transport between cellular organelles (Söllner 
et al. 1993).  They were later identified as critical for intracellular transport in most, if not 
all eukaryotic pathways.  Although well studied in neuronal signalling, the last 10 years 
has seen the emergence of a number of SNARE studies in immunological pathways.  A 
lot of this work has been in granulocytes; mast cells, neutrophils and eosinophils (Stow et 
al. 2006).  These studies focused on SNARE regulation in lytic granule release through 
regulated secretory pathways.  Work in macrophages and cytotoxic T-lymphocytes 
(CTL) has also been carried out on regulated secretory pathways and mass release of pre-
formed cytokine and lytic granules through SNARE regulated mechanisms (Murray, 
Wylie, et al. 2005; Qu et al. 2011). A detailed pathway has also been elucidated for the 
release of TNF-α from macrophages, identifying key SNARE complexes at different 
stages of release and a novel method of cell secretion through recycling endosomes 
(Murray, Kay, et al. 2005) .  However, little work has been carried out to identify 
SNARE proteins involved in constitutive release of cytokines from CD4+ T-helper cells.  
A study by Huse et al (2006) identified two multi-directional pathways for cytokine 
release in T-helper cells.  This work used T-cell blasts in order to identify SNAREs 
involved in constitutive release through synaptic directed or multi-directional cytokine 
release (Huse et al. 2006).  Huse et al (2006) co-localised SNARE proteins with two or 
more cytokines being released in synaptic or multi-direction pathways.  However, 
although two pathways were identified using confocal microscopy to show different 
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SNARES in the same locality, SNARES complexes were not associated with the release 
or regulation of specific cytokines in T-helper cells. 
In this chapter the aim was to use the clearly defined T-helper cell subsets Th1 and Th17 
optimised in chapter 3 to screen SNARE expression and identify candidate SNARES 
involved in trafficking of cytokines in T-helper subsets.  Using the established model of 
polarisation, T-cells were differentiated into Th1 and Th17 cells and kinetic studies of 
cytokine release identified optimal times to identify differences in SNARE mRNA 
expression between cell subsets.   
In order to validate the relevance of any SNARE protein found to be associated with 
either Th1 or Th17, the expression of the SNARE was examined in inflammatory disease 
mediated by Th1 and Th17 cells.  Therefore two murine models of ulcerative colitis were 
used to determine SNARE regulation during inflammatory disease. 
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4.2– RESULTS 
4.2.1 – ANALYSIS OF IFN-γ AND IL-17 CYTOKINE LEVELS FROM 
POLARISED CD4+ T-HELPER CELLS OVER A 72hr TIME 
COURSE. 
In order to identify the earliest time post-stimulation at which the IFN-γ and IL-17 
cytokine levels were secreted in Th1 and Th17 cells respectively, a time course 
experiment was set up and supernatants were analysed at 2hr, 6hr, 12hr, 48hr and 72hrs 
following stimulation.  The time point at which the levels of these cytokines differ from 
each other significantly will identify the point at which the cells have polarised into a TH1 
or Th17 subset and are actively secreting cytokine and would provide a logical point to 
analyse the differences in SNARE expression between Th1 and Th17 cells. 
Cells were isolated from the spleens of BALB/c mice using the EasySep Mouse CD4+ T 
Cell Enrichment Kit (Stemcell technologies #19752).  CD4+ cells were plated in triplicate 
at a concentration 2x106 cells/ml in a 24-well plate, 500µl/well.  The cells were then 
stimulated with anti-CD3 (5µg/ml) and anti-CD28 (2.5µg/ml), samples were removed at 
2hr, 6hr, 12hr, 48hr and 72hrs and centrifuged at 2000RPM for 10mins to pellet the cells 
and collect the supernatant.  The supernatant was assessed for levels of IFN-γ and IL-17 
using ELISA duosets (R&D). 
The IFN-γ cytokine levels in Th1 polarised cells began to increase at 6 hours [Figure 
4.1].  The level of IFN-γ measured from Th17 cells was almost undetectable at 6 hours.  
This trend continued with IFN-γ increasing significantly at 12hrs, 24hrs, 48hrs and 72hrs 
in Th1 samples, but remaining low for Th17 samples.   
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IL-17 levels in Th1 and Th17 polarised cells remained low for the first 12hrs following 
stimulation [Figure 4.1].  At 24hrs there was an increase in IL-17 which continued at 48 
and 72 hours.  In the Th1 polarised cells levels of IL-17 remained low over the time 
course [Figure 4.1(B)]. 
These data indicate a steady increase in IFN-γ from 2hrs onwards in Th1 cells with very 
significant levels at 48 and 72 hours.  In the Th17 cells there is a steady increase from 
24hrs with significant increases at 48 and 72hrs.  The largest increase for both cytokines 
was therefore 48hrs after stimulation.  This was selected as the most likely point to record 
a significant change in SNARE mRNA and protein levels, as all the proteins involved in 
secretion of IFN-γ and IL-17 were expressed and cells were polarised and actively 
secreting cytokine.  The profile of cytokine secretion for the cells at this time point was 
as expected with significant levels of IFN-γ and low levels of IL-4 and IL-17 [Figure 
4.2].  In the Th17 cells at 48hrs the level of IL-17 is significantly higher than IFN-γ and 
IL-4.  The 48hr time point was used as the initial screening point for further experiments 
to analyse SNARE mRNA and protein expression in Th1 and Th17 cells.   
4.2.2 – IFN-γ AND IL-17 mRNA EXPRESSION IN Th1 AND Th17 
POLARISED CD4+ T-CELLS AT 48hrs  
The expression of mRNA for signature cytokines IFNγ and IL-17 was measured at 48hrs 
in Th1 and TH17 cells in order to confirm the high expression of each in their respective 
subsets.   An increase in expression of IFN-γ and IL-17 in Th1 and Th17 cells 
respectively would further confirm the polarisation of these cells after 48hrs and also 
indicate transcriptional activity in the T-cells at this time-point.   
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Cells were isolated from the spleens of BALB/c mice and CD4+ T-cells were isolated 
using the EasySep Mouse CD4+ T Cell Enrichment Kit (Stemcell technologies #19752).  
Cells were plated in 500µl/well at a concentration of 2x106 cells/ml and stimulated with 
anti-CD3 (5µg/ml) and anti-CD28 (2.5µg/ml) for 48hrs in Th1 or Th17 polarising 
conditions for 48hrs in triplicate.  Cells were then collected and centrifuged at 2000RPM 
for 10 mins and the supernatant was removed and stored at -20OC for further analysis.  
The cell pellet was re-suspended in 350µl RA1 lysis buffer and 3.5µl DTT and mixed 
well before storing at -20OC until RNA isolation was carried out using the RNA II 
Nucleospin® kit (Macherey-Nage) according to the manufacturer’s instructions.  The 
cDNA was generated using the High Capacity cDNA Reverse Transcriptase Kit (Applied 
Biosystems, USA) and random primers.  The cDNA was diluted 1/12 in DEPC treated 
water and qPCR was carried out on the ABI Prism 7500 using Roche SYBR green 
mastermix and primers for IFN-γ (sigma) and IL-17 (IDT).   
Samples were measured in triplicate for each assay and a non-template control was 
included in each target assay.  Sample Ct values were normalised against two endogenous 
control genes; GusB and TBP.  After normalisation of the samples, expression was 
calculated using the relative expression method and the Th1 cell subset was used as a 
calibrator giving the expression of the target gene in Th1 cells a value of 1.0 and 
calculating the expression in Th17 cells relative to this value.  This gave an indication of 
the difference in expression of the target gene between the two T-cell subsets in terms of 
fold change. 
As expected, the mRNA levels of expression for IFN-γ were significantly reduced in 
Th17 cells when compared to Th1 cells with a 5-fold decrease in expression to an 
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average of 0.2 [Figure 4.3 (A)].  Conversely, the mRNA expression of IL-17 in Th17 
cells was significantly increased (4.5 fold) compared to Th1 cells [Figure 4.3 (B)].  
These data show clearly an increase in mRNA expression of IFN-γ in Th1 cells and an 
increase in expression of IL-17 in Th17 cells when each subset is compared to each other 
and there is a clear difference in the transcriptional activity at the 48hr time point for 
cytokines of interest.  The supernatants from these samples were assessed for cytokine 
levels in order to confirm the increase in expression of IFN-γ and IL-17 in line with an 
increase of mRNA expression.  
These results confirm a Th1 and Th17 cell subset cytokine profile at 48hrs and the clear 
difference between the Th1 and Th17 subset at 48hrs indicated it to be a suitable point to 
examine differences in expression between polarised subsets.  This mRNA was then used 
to measure the expression of SNARE proteins and assess the differences between Th1 
and Th17 cells. 
4.2.4 – DIFFERENCES IN R-SNARE EXPRESSION IN Th17 CELLS 
COMPARED TO Th1 CELLS USING qPCR ANALYSIS OF 
SAMPLES AT 48hrs. 
Using the mRNA generated from the three experiments carried out in 4.2.2, mRNA 
expression of a number of R-SNARE targets was carried out using qRT-PCR analysis.  
R-SNAREs differ from the Q-SNARE family of proteins in their conserved amino acid 
contribution to the SNARE complex, R-SNAREs contribute an Arginine (R) to the ionic 
layer and Q-SNAREs contribute Glutamines (Q) (Fasshauer et al. 1998).  R-SNAREs are 
pre-dominantly found on the membrane vesicle as opposed to the target membrane, it is 
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made up mainly of the VAMP family of SNAREs.  The VAMP family of SNAREs that 
have been identified in immunological cells were targeted for analysis; VAMP2, 
VAMP3, VAMP4, VAMP7, VAMP8 and Sec22.  Sequences of the primers used are 
detailed in appendix C.  
Analysis was run on a total of 7 samples generated in 3 individual experiments.  Samples 
were run on the ABI Prism 7500 using SYBR green mastermix and each target was run 
with a non-template control and tested in triplicate.  Ct values were normalised to the 
homogenous controls TBP and GusB.  The expression of the target mRNA was 
normalised setting the expression of the gene in the Th1 sample to a value of 1.0.   
There was no significant change in the expression of VAMP3, VAMP4 or VAMP8 
mRNA between Th1 and Th17 cells. However, there was a significant difference in 
expression of the remaining targets; VAMP2, VAMP7 and Sec22 [Figure 4.4]. Th17 
cells had significantly higher expression of VAMP2 (p<0.001) and sec22 (p<0.01) 
compared to Th1 and Th17 cells had decreased expression of VAMP7 (p<0.05) when 
compared to Th1 cells. 
4.2.5 – DIFFERENCES IN Qa-SNARE EXPRESSION IN Th17 
CELLS COMPARED TO Th1 CELLS USING qPCR ANALYSIS OF 
SAMPLES AT 48hrs. 
The next family of SNAREs to be analysed for differences in Th1 and Th17 cell subsets 
were the Q-SNAREs.  These SNARES are broken up into 3 families; Qa, Qb and Qc.  A 
SNARE complex is usually made up from a single R-SNARE and three Q-SNARES, one 
from each a, b and c.  SNAREs contributing Qb and Qc motifs to the complex can be 
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sourced from a single SNARE (Qbc), or a combination of a Qb and Qc.  However a 
single member of the Qa family is always part of the SNARE complex.  This is an 
important contingent of SNAREs that is mainly made up of the Syntaxin (STX) family.  
The Qa SNARE targets measured were those previously identified in immune cells; 
STX2, STX4, STX5a, STX5L, STX6 and STX11.  Primers used for the qRT-PCR 
analysis are listed in Appendix C.  Samples were analysed using the ABI Prism 7500 and 
SYBR green master mix (Roche, USA).  All targets were measured in triplicate with an 
NTC, results are representative of 3 experiments.  Samples were tested for significance 
using the unpaired student t-test. 
Th17 cells had a significant increase in expression of STX2 and STX11 (p<0.001) 
compared to Th1 cells [Figure 4.5].  No significant difference was detected for the 
remaining Qa SNARE targets analysed; STX 3, STX5a, STX5L and STX6.  Although 
STX5a and STX5L did show a small increase of 0.5 fold, they were not statistically 
significant [Figure 4.5]. 
4.2.6 – DIFFERENCES IN Qb AND Qbc-SNARE EXPRESSION IN 
Th17 CELLS COMPARED TO Th1 CELLS USING qPCR 
ANALYSIS OF SAMPLES AT 48hrs. 
Qb and Qbc SNARES were the next families which contribute to the R-Qabc complex to 
be analysed.  The Qb-SNARE Vti1b was examined for changes in mRNA expression in 
Th17 cells as it is a SNARE that has been identified in a number of immune pathways of 
cytokine release (Murray, Wylie, et al. 2005; Qu et al. 2011; Offenhäuser et al. 2011). 
SNAREs classified as Qbc are unique in that they contribute 2 conserved SNARE motifs 
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to the complex.  This allows for the complex to be made up of 3 SNAREs as opposed to 
the 4 presumed to be required for formation of a 4-alpha helix bundle.  SNAP23 is an 
ortholog to the well studied synaptic SNARE SNAP25.  SNAP23 has been identified as a 
key SNARE in immune cell secretion pathways.  Vti1b and SNAP23 were measured for 
mRNA expression at 48hrs.  Samples were made up in SYBR green (Roche, USA) and 
analysed on an ABI Prism 7500.  Samples were measured in triplicate and results are 
representative of 3 experiments, an NTC was included in the analysis of both targets. 
No significant difference was detected for the mRNA expression of SNAP23 or Vti1b in 
Th17 cells when compared to Th1 cells at 48hrs [Figure 4.6]. 
4.2.7 – CYTOKINE mRNA EXPRESSION LEVELS IN NAÏVE, Th1 
AND Th17 CELLS AT 48hrs.  
Having identified differences in mRNA expression of SNARE proteins between Th1 and 
Th17 cells subsets at 48hrs, we next wanted to compare the expression of these SNAREs 
in Th1 and Th17 cells with unstimulated naïve CD4+ T-cells in order to determine if they 
were up-regulated in these differentiated cells.  Before this was carried out we confirmed 
the expression of IFN-γ and IL-17 in the cell subsets, to include the naïve sample set.  
Th1 and Th17 Cells were generated as described above in 4.2.2.  Naïve CD4+ T-cells 
were isolated as in 4.2.2 but were not activated.  2x106 cells were collected by 
centrifugation (1200RPM for 5 mins) and stored in RA1 buffer and 3.5µl DTT and mixed 
well before storing at -20OC.  Th1 and Th17 cells were collected after 48hrs and stored 
the same as naïve cells.  RNA was isolated using the Nucleospin® RNA II kit according 
to the manufacturer’s instructions.  The cDNA was generated using the High Capacity 
cDNA Reverse Transcriptase Kit (Applied Biosystems, USA) and random primers.  The 
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cDNA was diluted 1/12 in DEPC treated water as in 4.2.2.  qPCR was carried out on the 
ABI Prism 7500 using Roche SYBR green mastermix and primers from IDT and Sigma.   
Samples were measured in triplicate for each assay and a non-template control was 
included for each target assay.  Sample Ct values were normalised against TBP.  After 
normalisation of the samples, IFN-γ expression was calculated using the relative 
expression method and the naïve cell subset was used as a calibrator giving the 
expression of the target gene in naïve cells a value of 1.0 and calculating the expression 
in Th1 and Th17 cells relative to this value.  There was a significant increase in IFN-γ 
expression in the Th1 subset when compared to the naïve sample set and the Th17 subset 
[Figure 4.7(a)].  
Expression of IL-17 was measured the same way; however there was no expression 
measured for the naïve sample subset, therefore expression levels in Th17 cells were 
normalised to the Th1 subset [Figure 4.7(B)].  The Th17 subset showed a significant 
increase in IL-17 mRNA expression when compared to the Th1 subset [Figure 4.7(B)].   
The expression levels of the cytokines IFN-γ and IL-17 in the naïve Th1 and Th17 
subsets show high expression of IFN-γ in Th1 cells and high expression of IL-17 in the 
Th17 cells subset.  The next step in the analysis of these subsets was to measure SNARE 
expression at this time point. 
4.2.8 – SNARE mRNA EXPRESSION LEVELS IN NAÏVE, Th1 AND 
Th17 CELLS AT 48hrs.  
The samples generated in section 4.2.7 were used to analyse the differences in SNARE 
expression between the naïve, Th1 and Th17 subsets of cells.  We selected SNAREs that 
were significantly different in their expression between Th1 and Th17 cells in the 
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previous experiments [Section 4.2.4-6 above].  These include the R-SNARE VAMP2 
[Section 4.2.4], the Qa-SNAREs STX2 and STX11 [Section 4.2.5] and the control Qbc-
SNAREs SNAP23 and Vti1b which showed no change in expression, but have been 
linked to cytokine secretion in a number of immune cells [Section 4.2.6].  
Samples were measured in triplicate for each assay and a non-template control was 
included for each target gene.  Sample Ct values were normalised against TBP.  After 
normalisation of the samples, expression was calculated for each target SNARE using the 
relative expression method and the naïve cell subset was used as a calibrator giving the 
expression of the target gene in naïve cells a value of one and calculating the expression 
in TH1 and TH17 cells relative to this value [Figure 4.8]. 
Figure 4.8 shows that the expression of VAMP2 in Th17 cells is increased compared to 
Th1 cells which confirmed previous results.  It is also increased in the Th17 cells 
compared to the naïve cells but this was not statistically significant.  
The expression of STX2 was significantly increased in Th17 cells compared to Th1 cells 
confirming the previous experiment. Expression in Th17 cells was the same as that of the 
naïve cells, however the expression of STX2 in the Th1 cells was decreased compared to 
the naïve cells.  This indicates that the expression of STX2 SNARE mRNA is reduced in 
Th1 cells but remains unchanged in Th17 cells when normalised to naïve cells.   
STX 11 expression was not detected in naïve cells and therefore the relative expression of 
STX 11 was calibrated by normalising the expression of STX11 in Th1 cells to one and 
calculating the relative expression in the Th17 cells.  STX11 expression is significantly 
increased in Th17 cells compared to Th1 cells as previously shown in earlier 
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experiments.  There was very low or no expression of STX11 mRNA in naïve cell 
samples [Figure 4.8]. 
The last group to be measured were the Qb and Qbc SNAREs SNAP-23 and Vti1b.  
Although these SNAREs did not show a significant change in expression in the previous 
screening using Th1 and Th17 cells, it was important to include SNAREs that did not 
show any change in expression as a control group.  These SNAREs have also been 
implicated in cytokine secretion in other cells of the immune system (Suzuki & Verma 
2008; Martín-Martín et al. 2000).  There was no significant change in expression of 
SNAP23 between Th1 and Th17 cell subsets [Figure 4.8].  There was also no significant 
change in expression between the three subsets for Vti1b relative to naïve cells [Figure 
4.8].  
These data confirm that STX11 is increased following activation and polarisation into a 
Th17 cell subset.  Although there are small differences in expression for STX2, VAMP2 
and SNAP23, STX11 is of particular interest as it indicates an increase in the Th17 subset 
alone.  STX11 was therefore hypothesized as a potential target for involvement in IL-17 
secretion from T-cells.  If STX11 is important in Th17 cells it should therefore also be 
up-regulated in inflammatory disease and infection where Th17 plays in important role.   
The next step in the study was to examine the role of STX11 in two murine models of 
colitis.   
4.2.9 – STX11 mRNA EXPRESSION IN MOUSE MODELS OF 
COLITIS.  
We examined the expression of STX11 and a number of other SNARE proteins in mouse 
models of inflammatory disease.  To our knowledge there are no previous studies 
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examining the expression of these trafficking proteins in any inflammatory disease.  The 
dextran sodium sulfate (DSS) model is well established as a chemically induced model of 
colitis in mice.  It is believed to confer colitis like symptoms through direct toxicity to 
epithelial cells in the basal crypts situated in the gut, leading to a loss in mucosal barrier 
integrity and subsequent infiltration and inflammation (Wirtz et al. 2007). DSS induced 
colitis is a well studied model and a number of publications have identified a Th1/Th17 
cell involvement in progression of disease (Alex et al. 2009; Ito et al. 2008).  The DSS 
model was carried out in collaboration with Silvia Melgar in the Alimentary 
Pharmabiotic Centre, University College Cork.  C57BL mice were randomly split into 5 
groups.  A control groups with 6 mice and 4 test groups with 6-8 mice. DSS (Sigma) was 
prepared fresh every day at a final concentration of 3% and administered to mice for 5 
days ad libitum.  The early acute mice were culled at day 7, late acute culled at day 12 
and chronic mice culled at day 26.  Mice were weighed and scored for daily disease 
activity (DDAI) based on stool composition, fur texture and posture every 3-4 days to 
monitor symptoms of gut inflammation.  As expected, the control group maintained a 
healthy weight gain over 26 days.  The DSS treated groups immediately began to lose 
weight with the biggest loss in weight observed at day 7, when the early acute mice were 
culled.  Following this, late acute and chronic mice began to recover and gain weight.  
Late acute mice were culled at day 12 with a minor recovery in weight, while the chronic 
mice recovered to their original weight with a slight gain before day 26 [Figure 4.9(a)].  
The DDAI showed a similar pattern of disease.  No disease activity was observed in the 
control mice but there is a rapid increase in disease activity in all groups with mild 
recovery in the chronic group before the end point [Figure 4.9(b)].  When each group 
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came to the end-point of the experiment, two control mice were culled for analysis along 
with the treated group.  The colons of each animal were removed and cleaned before 
measuring and weighing each colon individually.  The weight and length of the colon are 
indicators of inflammation in the gut as the cell infiltration and inflammation increases 
the weight of the colon and also shrinks the colon in length.  The colon length and weight 
from all treatment groups showed signs of inflammation with a significant increase in 
weight and decrease in colon length [Figure 4.9(d),(e)].  There was a minor increase in 
the average length of colons in the chronic group indicating a moderate recovery which is 
consistent with the rest of the data [Figure 4.9(d)].  After weighing and measuring colon 
length, a small section of distal colon was removed for histology.  The tissue was cast in 
optimal cutting temperature (OCT) compound and snap frozen in liquid nitrogen before 
cutting into sections on a cryostat.  The slides were then H&E stained for histological 
analysis.  The H&E staining shows a healthy colon in the control group with good crypt 
formation and no infiltrating cells in the lower muscle layer of the gut.  The early and late 
acute H&E staining shows a breakdown of crypt structures and infiltration of cells 
(purple spots) in the muscular layer with the worst infiltration evident in the late acute 
group.  The chronic group shows some mild recovery with crypt structure evident and 
less infiltrating cells in the muscular layer consistent with the rest of the data [Figure 
4.9(e)].  Collectively these results indicate a DSS induced model of colitis in the mice, 
with clear stages of colitis associated inflammation of the gut.  A piece of the distal colon 
tissue was also removed and homogenised in order to extract RNA for qPCR analysis.  
The first parameters measured were the Th1 and Th17 cytokines IFN-γ and IL-17.  The 
levels of expression in control mice were normalised to one and the other groups 
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measured were calculated as fold change in expression relative to the control group.  IL-
17 mRNA shows a significant 10-fold increase (p<0.001) in expression in the early acute 
group which is then significantly reduced in the late acute and chronic mice (p<0.01) 
[Figure 4.10].  IFN-γ mRNA expression is significantly increased 10-fold (p<0.05) in the 
late acute mice.  These results indicate that IL-17 and IFN-γ are predominantly expressed 
at different stages of the disease; an early acute IL-17 response which is then followed by 
a late acute and recovering IFN-γ response in the DSS induced colitis mice [Figure 4.10]. 
Having established the cytokine mRNA expression at the different stages of the DSS 
induced colitis, the SNARE targets identified as potential candidates involved in their 
secretion were assessed for mRNA expression levels.  Syntaxin 11 mRNA expression 
was significantly increased in early acute DSS treated mice (p<0.05).  This was 
concurrent with the increase in IL-17 mRNA expression observed at this stage of the 
disease.  The level of STX11 then decreased to normal, if not reduced levels of mRNA 
expression at later stages of disease [Figure 4.11].   A significant increase in VAMP7 
mRNA expression levels was observed at the late acute stage of disease (p<0.01).  These 
levels remained high in the chronic DSS treated mice [Figure 4.11] and correlated with 
an increase in IFN-γ at these stages. There was no significant change measured in the 
mRNA expression levels of STX2, VAMP2, SNAP23 and Vti1b SNARES in the DSS 
colitis model at any stage of disease [Figure 4.11].  
Having identified the expression of IFN-γ and IL-17 in the stages of DSS colitis, and the 
relative expression levels of SNARE proteins in these mice it was clear that there was a 
correlation.  IL-17 and IFN-γ are however expressed by a number of cells in the innate 
and adaptive immune system and the results obtained were from the whole tissue of a 
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distal portion of the colon.  Therefore, the remainder of the colon was digested in order to 
remove the endothelial layers of cells and isolate the lamina propria.  This layer of cells 
was then stained for with an anti-CD4 antibody in order to assess the percentage of CD4+ 
cells present in the colon at the different stages of disease observed in DSS induced 
colitis.  There was a significant increase in the number of CD4+ cells from 5% in the 
control mice, to >20% of the total population of cells in the lamina propria of all 
treatment groups.  Therefore, there is a significant number of CD4+ cells T-cells in tissue 
isolated from the acute and chronic stages of disease in which the the levels of IFN-γ, IL-
17 and SNARE mRNA expression levels were measured [Figure 4.12].  Taken together 
this model corroborates the in vitro findings suggesting a link between IL-17 expression 
and STX11 expression.  In order to confirm this link we looked at the Th17 dependent 
Citrobacter rodentium infection mouse model of colitis.  C. rodentium is a pathogen that 
resides in the gut and induces transient colitis in healthy mice.  Infection is usually 
cleared after 21 days (MacDonald et al. 2003; Bhinder et al. 2013). 
C. rodentium work was carried out as before in collaboration with Silvia Melgar in the 
Alimentary Pharmabiotic Centre, University College Cork.  C57BL mice in groups of 6-8 
were inoculated orally by a 200µl gavage of approximately 200x109 CFU C. rodentium. 
Mice were sacrificed at 9, 14, 21 and 28 days for tissue processing.  The colons were 
removed and washed and the length and weight of each colon was measured individually 
as an indication of inflammation of the gut.  There was a significant increase (p<0.001) in 
the colon weight at day 9 infected mice with recovery at days 14, 21 and 28 [Figure 
4.13].  The average colon length in the infected mice was also significantly decreased at 
day 9 (p<0.05), with mild recovery at days 14, 21 and 28 [Figure 4.13].  These 
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parameters suggest colitis like symptoms of inflammation in the C. rodentium infected 
mice.  Sections of the distal colon were homogenised and RNA was isolated for qPCR 
analysis. 
The mRNA levels of expression for IFN-γ and IL-17 were assessed and a significant 
increase was observed in IL-17 mRNA expression at day 9 of the infection (p<0.05) 
[Figure 4.14].  This was decreased in the later stages of the infection with significantly 
decreased mRNA expression day 25 when compared to control mice (p<0.01).  IFN-γ 
mRNA was not detected at significant levels at any stage of the infection [Figure 4.14].  
Candidate SNARES were assessed for levels of mRNA expression in the C. rodentium 
infected mice.  There was a significant increase in STX11 mRNA expression in day 9 
infected mice which was then reduced to control levels later in the infection (p<0.01) 
[Figure 4.15].  This correlated with the increase in IL-17 observed at day 9 which 
subsequently decreased on days 14, 21 and 25 in the infection model.  Interestingly, 
VAMP7 is significantly decreased on day 9 of infection (p<0.05) and levels remain low 
although not significant over the following days [Figure 4.15].  VAMP2 (p<0.05), 
SNAP23 (p<0.01) and Vti1b (p<0.05) show a decrease in expression at day 9 of 
infection.  However levels of expression return to normal in SNAP23 and VAMP2 with 
Vti1b mRNA expression remaining low in the later stages of C. rodentium infection.  
STX2 was increased on day 21 in infected mice (p<0.05) [Figure 4.15]. 
 143 
IL-17
2hr 6hr 12hr 24hr 48hr 72hr
0
2000
4000
6000
8000
10000
Th1
Th17
Time (hours)
pg
/m
l
IFN-γ
2hr 6hr 12hr 24hr 48hr 72hr
0
2000
4000
6000
8000
40000
60000
80000
100000
Th1
Th17
Time (hours)
pg
/m
l
Figure 4.1 - Time course analysis of IFN-gamma and IL-17 secretion levels from T-cell 
subsets.  CD4+ cells were isolated from the spleens of BALB/c mice using the easysep 
magnetic isolation kit (stemcell cat#19752).  Cells were plated at 2x106/ml in a 24 well 
plate.  Cells were stimulated with plate-bound anti-CD3 (5 ug/ml) plus anti-CD28 (2.5 
ug/ml) in Th1 or Th17 polarising conditions for 3 days.  Cells were collected at 2hrs, 6hrs, 
12hrs, 24hrs, 48hrs and 72hrs.  Cells were centrifuged at 2000RPM for 10mins and 
supernatants were collected and stored at -20oC before measuring for cytokine 
concentration by ELISA (R&D Duoset). A) IFN-γ levels measured in Th1 and Th17 
polarised CD4+ T-cells.  B) IL-17 levels measured in Th1 and Th17 polarised CD4+ T-cells.  
A) 
B) 
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Figure 4.2 - Cytokine secretion 48hrs post stimulation Th1 vs Th17.   CD4+ cells were isolated from the 
spleens of female BALB/c mice aged 12-14 weeks using the easysep magnetic isolation kit.  Cells were 
plated at 2x106 cells/ml in a 24-well plate in either Th1 conditions: IL-2 (10ng/ml), IL-12 (10ng/ml) and 
anti-IL4 (10µg/ml) or Th17 conditions: IL1β (10ng/ml), IL-6 (20ng/ml), IL-23 (20ng/ml),TGF-β 
(0.2ng/ml), anti-IL-4 (10µg/ml) and anti-IFNγ (10µg/ml) and stimulated with coated anti-CD3 (5µg/ml) 
and anti-CD28 (2.5µg/ml) for 48 hours.  Supernatants were collected and measured for IFN-γ, IL-4 and IL-
17 cytokines using ELISA (R&D Duo sets).  A) IFN-γ, IL-4 and IL-17 levels measured in Th1 polarised 
CD4+ T-cells at 48hours.  B) IFN-γ, IL-4 and IL-17 levels measured in Th17 polarised CD4+ T-cells at 
48hours.  Experiment is representative of at least 3 individual experiments.  Error bars represent the 
standard deviation of 3 technical replicates.   
A) B) 
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Figure 4.3 – Comparing mRNA expression of signature cytokines IFNγ and IL-17 in Th1 and Th17 
cell subsets at 48hrs.  CD4+ cells were isolated from the spleens of female BALB/c mice aged 12-14 
weeks using the easysep magnetic isolation kit.  Cells were plated at 2x106 cells/ml in a 24-well plate in 
either Th1 conditions: Il-2 (10ng/ml), IL-12 (10ng/ml) and anti-IL4 (10µg/ml) or Th17 conditions: IL1β 
(10ng/ml), IL-6 (20ng/ml), IL-23 (20ng/ml),TGF-β (0.2ng/ml), anti-IL-4 (10µg/ml) and anti-IFNγ 
(10µg/ml) and stimulated with coated anti-CD3 (5µg/ml) and anti-CD28 (2.5µg/ml) for 48 hours.  The 
RNA was extracted from samples using nucleospin RNAII isolation columns (Macherey-Nage), equalised 
and converted to cDNA using the high capacity cDNA reverse transcription kit (Applied Biosystems).  The 
cDNA was mixed with primers for Ifnγ (Sigma) and Il17 (IDT) and FAST SYBR Mastermix (Roche) 
before analysing samples on the ABI Prism 7500.  Groups were compared using relative quantitation; after 
normalising samples to TBP and GusB, Th1 was normalised to 1.0 and the expression in other groups is 
shown relative to this value. Results are means ±SD of 7 samples generated in 3 independent experiments 
measured in triplicate.  An unpaired T-test was used to determine if differences between Th1 and Th17 
groups were significantly different (***p<0.001). 
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Figure 4.4 - R-SNARE mRNA expression in Th1 vs Th17 polarised T-helper cell subsets - CD4+ cells 
were isolated from the spleens of female BALB/c mice aged 12-14 weeks using the easysep magnetic 
isolation kit.  Cells were plated at 2x106 cells/ml in a 24-well plate in either Th1 conditions: Il-2 (10ng/ml), 
IL-12 (10ng/ml) and anti-IL4 (10µg/ml) or Th17 conditions: IL1β (10ng/ml), IL-6 (20ng/ml), IL-23 
(20ng/ml),TGF-β (0.2ng/ml), anti-IL-4 (10µg/ml) and anti-IFNγ (10µg/ml) and stimulated with coated anti-
CD3 (5µg/ml) and anti-CD28 (5µg/ml) for 48 hours.  Cells were collected and centrifuged at 1200RPM for 
5mins, supernatant was removed for cytokine analysis.  The RNA was extracted from samples using 
nucleospin RNAII isolation columns (Macherey-Nage), equalised and converted to cDNA using the high 
capacity cDNA reverse transcription kit (Applied Biosystems).  The cDNA was mixed with primers for R-
SNARE targets, and FAST SYBR Mastermix (Roche) before analysing samples on the ABI Prism 7500.  
Groups were compared using relative quantitation; after normalising samples to TBP and GusB, Th1 was 
normalised to 1.0 and the expression in other groups is shown relative to this value. Results are means ±SD 
of 7 samples generated in 3 independent experiments measured in triplicate.  An unpaired T-test was used 
to determine if differences between Th1 and Th17 groups were significantly different (*p<0.05, 
**p<0.01and ***p<0.001). 
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Figure 4.5 - Qa-SNARE mRNA expression in Th1 vs Th17 T-helper cell subsets - CD4+ cells were 
isolated from the spleens of female BALB/c mice aged 12-14 weeks using the easysep magnetic isolation 
kit.  Cells were plated at 2x106 cells/ml in a 24-well plate in either Th1 conditions: Il-2 (10ng/ml), IL-12 
(10ng/ml) and anti-IL4 (10µg/ml) or Th17 conditions: IL1β (10ng/ml), IL-6 (20ng/ml), IL-23 
(20ng/ml),TGF-β (0.2ng/ml), anti-IL-4 (10µg/ml) and anti-IFNγ (10µg/ml) and stimulated with coated anti-
CD3 (5µg/ml) and anti-CD28 (5µg/ml) for 48 hours.  Cells were collected and centrifuged at 1200RPM for 
5mins, supernatant was removed for cytokine analysis.  The RNA was extracted from samples using 
nucleospin RNAII isolation columns (Macherey-Nage) and converted to cDNA using the high capacity 
cDNA reverse transcription kit (Applied Biosystems).  The cDNA was mixed with primers for Qa SNARE 
targets (IDT) and FAST SYBR Mastermix (Roche) before analysing samples on the ABI Prism 7500.  
Groups were compared using relative quantitation; after normalising samples to TBP and GusB, Th1 was 
normalised to 1.0 and the expression in other groups is shown relative to this value. Results are means ±SD 
of 7 samples generated in 3 independent experiments and measured in triplicate.  An unpaired T-test was 
used to determine if differences between Th1 and Th17 groups were significantly different (***p<0.001). 
 148 
Vti1b
Th
1
Th
17
0.0
0.5
1.0
1.5
Fo
ld
 
ch
an
ge
SNAP23
Th
1
Th
17
0.0
0.5
1.0
1.5
Fo
ld
 
ch
an
ge
 
Figure 4.6 – Qb and Qbc SNARE mRNA expression in Th1 vs Th17 polarised T-helper cell subsets - 
CD4+ cells were isolated from the spleens of female BALB/c mice aged 12-14 weeks using the easysep 
magnetic isolation kit.  Cells were plated at 2x106 cells/ml in a 24-well plate in either Th1 conditions: Il-2 
(10ng/ml), IL-12 (10ng/ml) and anti-IL4 (10µg/ml) or Th17 conditions: IL1β (10ng/ml), IL-6 (20ng/ml), 
IL-23 (20ng/ml),TGF-β (0.2ng/ml), anti-IL-4 (10µg/ml) and anti-IFNγ (10µg/ml) and stimulated with 
coated anti-CD3 (5µg/ml) and anti-CD28 (5µg/ml) for 48 hours.  Cells were collected and centrifuged at 
1200RPM for 5mins, supernatant was removed for cytokine analysis.  The RNA was extracted from 
samples using nucleospin RNAII isolation columns (Macherey-Nage)and 1µg of RNA was converted to 
cDNA using the high capacity cDNA reverse transcription kit (Applied Biosystems).  The cDNA was 
mixed with primers for Vti1b and SNAP23 targets (IDT) and FAST SYBR Mastermix (Roche) before 
analysing samples on the ABI Prism 7500.  Groups were compared using relative quantitation; after 
normalising samples to TBP and GusB, Th1 was normalised to 1.0 and the expression in other groups is 
shown relative to this value. Results are means ±SD of 7 samples generated in 3 independent experiments 
measured in triplicate.  An unpaired T-test was used to determine if differences between Th1 and Th17 
groups were significantly different. 
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Figure 4.7 – Cytokine mRNA expression levels in Naïve, Th1 and Th17 cells at 48hrs.   CD4+ cells 
were isolated from the spleens of female BALB/c mice aged 12-14 weeks using the easysep magnetic 
isolation kit.  Naïve cells were collected after isolation and prepped for RNA isolation by suspending in 
RA1 lysis buffer supplied by the RNAII nucleospin RNA isolation column kit.  Remaining cells were 
plated at 2x106 cells/ml in a 24-well plate in either Th1 conditions: Il-2 (10ng/ml), IL-12 (10ng/ml) and 
anti-IL4 (10µg/ml) or Th17 conditions: IL1β (10ng/ml), IL-6 (20ng/ml), IL-23 (20ng/ml),TGF-β 
(0.2ng/ml), anti-IL-4 (10µg/ml) and anti-IFNγ (10µg/ml) and stimulated with coated anti-CD3 (5µg/ml) 
and anti-CD28 (5µg/ml) for 48 hours.  Cells were collected and centrifuged at 1200RPM for 5mins, 
supernatant was removed for cytokine analysis.  The RNA was extracted from samples using nucleospin 
RNAII isolation columns (Macherey-Nage) and normalised amounts of RNA were converted to cDNA 
using the high capacity cDNA reverse transcription kit (Applied Biosystems).  The cDNA was mixed with 
primers for IFNγ (Sigma) and IL-17 (IDT) and FAST SYBR Mastermix (Roche) before analysing samples 
on the ABI Prism 7500.  Groups were compared using relative quantitation; after normalising samples to 
TBP and GusB, Th1 was normalised to 1.0 and the expression in other groups is shown relative to this 
value. Results are means ±SD of 7 samples generated in 3 independent experiments measured in triplicate.  
An unpaired T-test was used to determine if differences between Th1 and Th17 groups were significantly 
different (***p<0.001). 
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Figure 4.8 - SNARE mRNA expression levels in naïve, Th1 and Th17 cell lysates for targets of 
interest.  CD4+ cells were isolated from the spleens of female BALB/c mice aged 12-14 weeks using the 
easysep magnetic isolation kit.  Naïve cells were collected after isolation RNA was isolated with the 
nucleospin RNAII isolation column kit.  Remaining cells were plated at 2x106 cells/ml in a 24-well plate in 
either Th1 conditions: Il-2 (10ng/ml), IL-12 (10ng/ml) and anti-IL4 (10µg/ml) or Th17 conditions: IL1β 
(10ng/ml), IL-6 (20ng/ml), IL-23 (20ng/ml),TGF-β (0.2ng/ml), anti-IL-4 (10µg/ml) and anti-IFNγ 
(10µg/ml) and stimulated with coated anti-CD3 (5µg/ml) and anti-CD28 (2.5µg/ml) for 48 hours.  The 
RNA was extracted from samples and converted to cDNA using the high capacity cDNA reverse 
transcription kit (Applied Biosystems).  The cDNA was mixed with primers for each SNARE mRNA target 
and FAST SYBR Mastermix (Roche) before analysing samples on the ABI Prism 7500.  Groups were 
compared using relative quantitation; after normalising samples to TBP and GusB, Th1 was normalised to 
1.0 and the expression in other groups is shown relative to this value. Results are means ±SD of 7 samples 
generated in 3 independent experiments measured in triplicate.  An unpaired T-test was used to determine if 
differences between Th1 and Th17 groups were significantly different (***p<0.001). 
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Figure 4.9 - Disease associated symptoms in the DSS colitis model – C57BL mice were grouped into a 
control group of 6 mice and 4 test groups.  DSS was administered to mice in the drinking water for 5 days 
at a final concentration of 3%.  Mice were weighed and disease scored based on fur texture/posture for a 
daily disease activity index (DDAI) every 3-4 days (A).  The average % weight change of the 4 groups is 
plotted to the end point for each group.  The starting weight on Day 0 is plotted as 100% of the weight with 
the rest of the weight relative to this value.  Two control mice were culled at the end point for each test 
group.  There is a drop in body weight for all test groups after day 0 and a healthy gain in weight for 
control mice (B).  At the end point of each group the length (C) and weight (D) of each removed and 
washed colon was measured and used as an indication of inflammation in the colon.  Sections of the distal 
colon were removed for histology and H&E staining in order to confirm inflammation.  The control shows 
a healthy colon while infiltration and loss of crypt structure is evident in the acute slides with recovery in 
the chronic slides as expected (E).  Results are means ±SD of at least 5 mice, an unpaired T-test was used 
to determine if differences between groups were significant (*p<0.05, **p<0.01). 
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Figure 4.10 - cytokine mRNA in mouse model of colitis - C57BL mice were grouped into a control group 
of 6 mice and 4 test groups; early acute culled at day 7, late acute culled at day 12 and chronic mice culled 
at day 26.  Tissue from each sample was weighed and homogenised using the Qiagen TissueLyser LT with 
stainless steel beads (5mm).  Following homogenisation, RNA was extracted and quantitated on the nano-
drop and equalised amounts of RNA were converted to cDNA using the high capacity cDNA mastermix 
(roche).  The cDNA was mixed with primers for IFNγ (Sigma) and IL-17 (IDT) and FAST SYBR 
Mastermix (Roche) before analysing samples on the ABI Prism 7500.  Groups were compared using 
relative quantitation; after normalising samples to TBP and GusB, the control group was normalised to 1.0 
and the expression in other groups is shown relative to this value. Results are means ±SD of at least 5 mice 
measured in triplicate.  An unpaired T-test was used to determine if differences between groups were 
significantly different (*p<0.05, **p<0.01, ***p<0.001). 
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Figure 4.11 – SNARE mRNA analysis in DSS mouse model of Colitis - C57BL mice were grouped into 
a control group of 6 mice and 4 test groups; early acute culled at day 7, late acute culled at day 12 and 
chronic mice culled at day 26.  DSS was administered to mice in the drinking water for 5 days at a final 
DSS concentration of 3%.  Tissue from each sample was weighed and homogenised using the Qiagen 
TissueLyser LT with stainless steel beads (5mm).  Following homgenisation, RNA was extracted and 
quantitated on the nano-drop and equalised amounts of RNA were converted to cDNA using the high 
capacity cDNA mastermix (roche).  The cDNA was mixed with primers for each SNARE target mRNA 
and FAST SYBR Mastermix (Roche) before analysing samples on the ABI Prism 7500.  Groups were 
compared using relative quantitation; after normalising samples to TBP and GusB, the control group was 
normalised to 1.0 and the expression in other groups are shown relative to this value. Results are means 
±SD of at least 5 mice measured in triplicate.  An unpaired T-test was used to determine if difference in 
expression between groups were significantly different (*p<0.05, **p<0.01). 
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Figure 4.12 - CD4 expression in DSS model of Colitis – C57BL mice were grouped into a control group 
of 6 mice and 4 test groups; early acute culled at day 7, late acute culled at day 12 and chronic mice culled 
at day 26.  DSS was administered to mice in the drinking water for 5 days.  DSS water was prepared fresh 
every day with tap water and a final DSS concentration of 3%.  Mice were weighed and disease scored 
based on fur texture/posture for a daily disease activity index every 3-4 days.  The colon was removed from 
the mouse and disgested in enzymes to remove the endothelial layer of cells and isolate lamina propria 
cells.  Cells were then stained for 30 mins with an anti-CD4 PE primary conjugated antibody (BD 
Bioscience) at 0.25µg/ml at room temperature.  Cells were washed 3 times and analysed on the BD FACS 
Aria.  Cells were gated to remove debris and gating shown indicates the percentage population positive for 
CD4 staining.  The number of CD4+ cells increases in the test groups when compared to the control group.   
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Figure 4.13 - Colon weight of mice infected with Citrobacter rodentium - C57BL mice were housed in 
groups of 6-8 mice and test mice were  inoculated with C. rodentium orally by a 200µl gavage of 
approximately 200x109 CFU C. rodentium. Mice were sacrificed at 9, 14, 21 and 28 days.  Colons were 
collected from mice and the contents carefully removed before washing and patting dry.  At the end point 
of each group the length and weight of each colon was measured individually and used as an indication of 
colitis in the mouse model.  There is a significant increase in colon weight at day 9 with a recovery in the 
later days.  There is a significant increase in colon length at day 9 with moderate recovery in the following 
days.  Results are means ±SD of at least 5 mice, an unpaired T-test was used to determine if differences 
between groups were significant (*p<0.05, ***p<0.001). 
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Figure 4.14 – Cytokine mRNA detection in C. rodentium infection model of colitis - C57BL mice were 
housed in groups of 6-8 mice and test mice were  inoculated with a bioluminescent C. rodentium derivative 
orally by a 200µl gavage of approximately 200x109 CFU C. rodentium. Mice were sacrificed at 9, 14, 21 
and 28 days.  %.  The colon of each mouse was removed and the contents cleaned out in PBS before patting 
dry.  The colon length and weight was measured and 0.5cm of distal colon was collected and stored in 
RNA later at 4oC.  The tissue from each sample was weighed and homogenised in RA1 buffer from the 
nucleospin RNAII isolation columns kit (Macherey-Nagel).  Samples were homogenised using the Qiagen 
TissueLyser LT with stainless steel beads (5mm).  Following homgenisation, RNA was extracted and 
quantitated on the nano-drop and 1µg of RNA was converted to cDNA using the high capacity cDNA 
reverse transcription kit (Applied Biosystems).  The cDNA was mixed with primers for IL-17 (IDT) and 
FAST SYBR Mastermix (Roche) before analysing samples on the ABI Prism 7500.  Groups were 
compared using relative quantitation; after normalising samples to TBP and GusB, the control group was 
normalised to 1.0. Results are means ±SD of at least 5 mice measured in triplicate.  An unpaired T-test was 
used to determine if difference in expression between groups were significantly different (*p<0.05, 
**p<0.01). 
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Figure 4.15 - SNARE mRNA analysis in C. rodentium infection model of colitis - - C57BL mice were 
housed in groups of 6-8 mice and test mice were  inoculated with a bioluminescent C. rodentium derivative 
orally by a 200µl gavage of approximately 200x109 CFU C. rodentium. Mice were sacrificed at 9, 14, 21 
and 28 days.  %.  The colon of each mouse was removed and the contents cleaned out in PBS before patting 
dry.  The colon length and weight was measured and 0.5cm of distal colon was collected and stored in 
RNA later at 4oC.  The tissue from each sample was weighed and homogenised in RA1 buffer from the 
nucleospin RNAII isolation columns kit (Macherey-Nagel).  Samples were homogenised using the Qiagen 
TissueLyser LT with stainless steel beads (5mm).  Following homgenisation, RNA was extracted, 
quantitated on the nano-drop and converted to cDNA using the high capacity cDNA reverse transcription 
kit (Applied Biosystems)  The cDNA was mixed with primers for IL-17 (IDT) and FAST SYBR 
Mastermix (Roche) before analysing samples on the ABI Prism 7500.  Groups were compared using 
relative quantitation; after normalising samples to TBP and GusB, the control group was normalised to 1.0. 
Results are means ±SD of at least 5 mice measured in triplicate.  An unpaired T-test was used to determine 
if difference in expression between groups were significantly different (*p<0.05, **p<0.01). 
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4.3 – DISCUSSION  
Upon activation by anti-CD3 and anti-CD28 antibodies, T-cells undergo three phases of 
response leading to a polarised T-cell subset; activation, proliferation and polarisation.  In 
order to polarise into Th1 and Th17 cells, naïve CD4+ T-helper cells are activated in an 
environment containing recombinant cytokines which induce transcription factors and 
commit cells to the production of specific cytokines at the different stages of activation 
(Jelley-Gibbs et al. 2000).  In order to analyse the differences in SNARE transcription 
and regulation between IFN-γ producing Th1 cells and IL-17 producing Th17 cells, it 
was necessary to identify a point at which each of these cytokines were highly expressed 
in their respective subset.  The production of IFN-γ and IL-17 was assessed in polarised 
Th1 and Th17 cells over a 72 hour period.  IFN-γ was produced early in activated T-
helper cells, this has been shown by others and IFN-γ production is enhanced by the 
presence of IL-12 which activates STAT4 and is the first step in polarising T-cells to a 
Th1 subtype.(Schulz et al. 2009).  IFN-γ production increased significantly at 48 hours 
and continued to increase at 72 hours.  This is consistent with the study by Schulz et al 
(2009) showing a second significant increase in IFN-γ mRNA expression at 48 hours 
following commitment of Th1 cell polarisation and T-bet expression due to IL-12 
signalling through the up-regulated IL-12Rβ2.  This early IFN-γ response was not 
observed in the T-helper cells activated in Th17 conditions.  Th17 cells had little or no 
IFN-γ or IL-17 production until 24 hours; neutralising IFN-γ antibody was included in 
the conditions for driving Th17 conditions and prevented the activation of T-bet via IFN-
γ activation of STAT4.   
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T-bet represses Th17 differentiation through suppression of Runx1, the transcription 
factor activating RORγt (Lazarevic et al. 2011).  Anti-IFN-γ antibody was included in the 
Th17 polarising conditions to inhibit T-bet expression, while the addition of IL-6 and 
TGF-β activates the Th17 master regulator RORγt.  This resulted in IL-17 production at 
24 hours with a significant increase measured at 48 hours.  This is consistent with 
detailed studies of gene regulation describing induction of the signature cytokine mRNA 
Il17a at 20hrs post activation (Yosef et al. 2013).  The cytokine and transcription factor 
data indicated 48hrs as an ideal time point to look at SNARE expression related to IFN-γ 
and IL-17 production.  Furthermore, increased mRNA expression for the signature 
cytokines IFN-γ and IL17 were confirmed in their respective T-helper subset.   
The SNARE family of proteins is defined by a conserved coiled-coil motif that is 
necessary for SNARE complex formation and membrane fusion.  SNAREs are divided 
into 2 main families; R-SNARES are usually found on the vesicular membrane and have 
arginine (R) as the central functional residue in the SNARE motif.  Q-SNARES are 
mainly found on the target membrane and are defined by a central glutamine (Q) residue.  
In order to form a complex and mediate membrane fusion, four SNARE motifs are 
required; one R-SNARE and two or three Q-SNAREs (Jahn & Scheller 2006).  The R-
SNARE family currently consists of seven proteins, all of which are vesicle associated 
membrane proteins (VAMPs) (Krzewski et al. 2011).  VAMPs consist of a conserved 
family of proteins involved in constitutive and regulated release from a number of 
different cell types.  VAMP1 and VAMP2 are conserved neuronal proteins involved in 
synaptic release (Trimble et al. 1988; Raptis et al. 2005).  Although they have been 
shown to play a role in protein release from immunological cells, VAMP1 has not been 
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widely reported in immune cells and only in regulated release mechanisms (Mollinedo et 
al. 2006).  Therefore VAMP1 was not included in this study.  VAMP2 mRNA expression 
was increased in Th17 cells when compared to Th1 cells and may play a part in Th17 
polarisation and/or exocytosis.  VAMP2 is more widely distributed than VAMP1 and has 
been previously shown to play a role in small secretory vesicle release from neutrophils 
and eosinophils (Logan et al. 2006).  In eosinophils VAMP2 was localised on small 
secretory vesicles that were rapidly mobilised following IFN-γ stimulation to release 
RANTES (Lacy et al. 2001).  This secretion is regulated but demonstrates a role for 
VAMP2 in exocytosis of vesicles at the plasma membrane of an immunological cell.  
VAMP2 could act as the R-SNARE required to form a SNARE complex in Th1 or Th17 
related constitutive cytokine release, however no significant change in VAMP2 was 
observed in the DSS model of colitis.  Furthermore, VAMP2 was decreased in the C. 
rodentium infection model at day 9 and did not correlate with the in vitro study.  A study 
in CD8+ cytotoxic T-cells did not show accumulation of VAMP2 at the immunological 
synapse after activation, suggesting that it does not play a role in the final stages of 
exocytosis in T-cells (Pattu et al. 2012).   
There was a small but significant decrease in VAMP7 expression in Th17 polarised cells 
compared to Th1 cells at 48 hours.  An increase in mRNA expression of VAMP7 was 
observed in the late acute stage of DSS colitis, correlating with an increase in IFN-γ 
mRNA.  Furthermore, VAMP7 mRNA was decreased in Th17 cells when compared to 
Th1 cells in vitro, and decreased on day 9 in the Th17 mediated C. rodentium infection in 
vivo when IFN-γ expression is absent.  However, VAMP7 mRNA expression was not 
significantly increased in Th1 cells when compared to naïve CD4+ T-cells in vitro and did 
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not correlate with the in vivo data showing regulation of VAMP7.  Interestingly VAMP7 
has been implicated in the secretion of de novo IFN-γ in NK T-cells.  Knock-down of 
VAMP7 but not VAMP4 led to a decrease in IFN-γ secretion in response to different 
stimuli on NK cells.  The ability of the cell to produce IFN-γ was not effected, but the 
IFN-γ was unable to leave the cells suggesting that VAMP7 is involved in its exocytosis 
from the cell (Krzewski et al. 2011).  It is possible that VAMP7 may play a role in IFN-γ 
production in T-helper cells showing conservation between T-helper and NK T-cells.  
However, VAMP7 has been shown to be involved in other mechanisms in different cell 
types including degranulation in neutrophils and eosinophils (Mollinedo et al. 2006; 
Logan et al. 2006) and may have a number of roles depending on different cell types.  
The involvement of VAMP7 in de novo IFN-γ secretion warrants further investigation 
based on this study and those of others described but the lack of correlation between the 
in vitro and in vivo data did not make this a strong candidate to study further.   
 
The Q-SNARE family is further divided into three sub-families Qa, Qb and Qc.  One 
member of each is required to form a complex with R-SNAREs in a stable RQabc four 
helical bundle (Bock et al. 2001).  Some SNAREs such as SNAP23 can contribute Qbc 
and form a complex with three members.  The Qb and Qbc SNAREs SNAP23 and Vti1b 
showed no changes in expression between Th1 and Th17 cells at 48hours.   
The syntaxin family of SNARE contribute the Qa-SNARE to the RQabc complex.  
Syntaxins 2, 4, 5a, 5L, 6 and 11 were assessed for changes in expression between Th1 
and Th17 cells as these SNAREs have been reported to be involved in protein trafficking 
in immunological cells (Chen et al. 2000; Lowe et al. 2004; Murray, Wylie, et al. 2005; 
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Prekeris et al. 2000).  The mRNA expression of STX2 was significantly increased in 
Th17 cells when compared to Th1 at 48hours.  STX2 was originally believed to play a 
role in regulated granule release in platelets (Chen et al. 2000).  However, this was later 
disputed when platelets from STX2 deficient mice indicated no loss of platelet secretory 
function and they went on further to show that the antibody used in the previous study 
was cross-reactive with STX11.  Further analysis of STX2 mRNA expression in Th1 and 
Th17 polarised cells, compared to naïve CD4+ T-helper cells showed a significant 
decrease in STX2 expression in the Th1 cell subset but no difference in expression 
between Th17 and naïve cells.  Furthermore, there was no significant change in STX2 
expression at any stage in the DSS model of colitis, indicating no correlation with the in 
vitro model.  A small increase in mRNA expression was measured late in disease in the 
C. rodentium model.  There is currently no evidence to suggest a role for STX2 in 
constitutive cytokine secretion in immune cells.  STX2 has been identified in CTLs, but 
was not localised at the immunological synapse upon stimulation (Pattu et al. 2012).  
STX2 has also been localised on the membrane of platelet cells, although its function on 
the extracellular membrane still remains unclear, it is though to play a role in platelet-
platelet fusion (Flaumenhaft et al. 2007).  STX2 was not investigated further as a 
candidate for regulating cytokine secretion.    
STX11 mRNA was significantly up-regulated in Th17 cells when compared to Th1 cells 
at 48 hours in vitro.  When assessing SNAREs that exhibited a significant difference in 
expression between Th1 and Th17 subsets further, STX11 was the only SNARE that 
demonstrated little or no expression in naïve cells and was up-regulated in activated cells.  
STX11 and VAMP2 were the only SNAREs that demonstrated a significant increase in 
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expression in Th17 cells when compared to naïve T-helper cells.  STX11 is an atypical 
SNARE in that it does not have a transmembrane domain to facilitate insertion into 
membrane structures.  It is abundant in the immune system and is enriched in, but not 
exclusive to the thymus, spleen and lymph nodes (Prekeris et al. 2000). It has been 
identified as playing a role in a number of immune mechanisms (Bryceson et al. 2007; Ye 
et al. 2012; D’Orlando et al. 2013).  Immune phagocytic cells are enriched in STX11 and 
early characterisation studies localised it on post-golgi compartments where it was 
hypothesized to play a regulatory role in SNARE complex formation (Prekeris et al. 
2000).  The Stx11 gene mutation was recently identified as the cause of a rare autosomal 
recessive disorder; familial hemaphagocytic lymphohistocytosis (FHL) type-4 (zur Stadt 
et al. 2005).  FHL is usually diagnosed within the first year of life in pediatric cases and 
patients with FHL present with high fever, hepatosplenomegaly and cytopenia.  One of 
the hallmarks of the disease is hyperinflammation in patients which leads to 
hemophagocytosis, a condition in which the phagocytic immune cells begin to 
uncontrollably engulf host erythrocytes, leukocytes and platelets.  Interestingly, other 
symptoms of FHL-4 are excessive production of pro-inflammatory cytokines but an 
inability to clear infections (Gholam et al. 2011).  All of these symptoms suggest a 
dysregulation in cytokine production in STX11 deficient patients.  It is clear that STX11 
plays an important and specialised role in the immune system and may play involved in 
regulating intracellular trafficking in T-helper cells.   
 
Importantly, this study shows a correlated increase in STX11 and IL-17 mRNA 
expression at the same stages of disease in both the DSS and C. rodentium models of 
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colitis. Analysis of mRNA expression in colonic tissue over the course of the DSS 
induced colitis revealed an initial increase in IL-17 mRNA expression in the early acute 
phase of disease on day 7 that decreased at later stages of disease.  This was in parallel 
with a significant increase in STX11 mRNA expression at the same stage of disease and a 
decrease at later stages.  This correlation was not seen for other SNAREs.  These results 
suggest a link between IL-17 secretion and STX11 expression.  Although IL-17 may be 
secreted from other cells present in the colonic tissue, we have also demonstrated that 
CD4+ cells make up 22% of the cells in the lamina propria in treated mice.  This increase 
in T-helper cell infiltration has been confirmed by others and studies have also indicated 
that the Th1/Th17 adaptive immune response plays a central role in inducing and 
sustaining IBD (Hall et al. 2011; Alex et al. 2009; Zenewicz et al. 2009; Liu et al. 2009; 
Abraham & Cho 2009).  Furthermore, some of these studies describe an early Th17 
response that induces IL-12 and IL-23 expression and initiates a late Th1 T-helper 
response (Feng et al. 2011; Ahern et al. 2010).  Our data agrees with this as DSS induced 
colitis appears to switch to a Th1/IFN-γ response in the later stages of disease with a 
higher mRNA expression of IFN-γ in the late acute mice.  This has been attributed in the 
literature to a class switch in IL-17 producing Th17 cells to IL17/IFN-γ double producing 
Th17 cells in vivo as discussed in Chapter 3 (Ahern et al. 2010; Feng et al. 2011).   
The DSS model of colitis shows that the initial IL-17/Th17 cell response correlates with 
an increase in STX11 in the early acute phase of the disease.  Furthermore, the results 
from the DSS model concur well with the increased STX11 expression observed in the 
IL-17 producing Th17 cells in vitro.   
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The well established C. rodentium model of colitis further substantiated the association 
observed between STX11 and IL-17.  C. rodentium is a natural rodent pathogen that 
inhabits the gut and induces transient distal colitis in healthy mice (MacDonald et al. 
2003).  C. rodentium was originally thought to be a Th1 inducing infection; however the 
discovery of the Th17 subset of cells led to this theory being revisited.  A study of Th17 
cells in IL-23-receptor knockout mice (Il-23R-/-) infected with C. rodentium resulted in 
the discovery a central role for Th17 cells in clearing infection.  In the study the Th17 
response was shown to be independent of the IL-23R, but a sustained Th17 response was 
demonstrated to be dependent on IL-23R signalling (Mangan et al. 2006).  This was later 
shown to be due to the necessity of IL-23R signalling in committing cells into a Th17 
lineage after initial polarisation (McGeachy et al. 2009).  High levels of Th17 cells were 
present in the colon at the height of the inflammatory response to infection on day 8.  A 
lack of Il-23R in these mice led to a reduced ability to clear the infection highlighting the 
importance of Th17 cells in clearing C. rodentium infection (Mangan et al. 2006).  In this 
chapter a significantly high level of IL-17 mRNA expression was measured at day 9 as 
expected and in agreement with the results in the study by Mangan et al (2006).  There is 
a significant increase in STX11 mRNA expression on day 9 correlating with the increase 
in IL-17 mRNA expression.  IL-17 expression is less prominent in the later stages of 
infection, and begins to drop off with a significant decrease on day 26.  STX11 mRNA 
expression levels also return to control expression levels in parallel with the decreased 
IL-17 mRNA expression.   
This chapter demonstrated that STX11 is up-regulated in Th17 cells in vivo and its 
expression is correlated to that of IL-17 in two in vivo models of inflammatory disease.   
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To our knowledge, this is the first time that a SNARE protein has been shown to be 
regulated during inflammatory disease of the gut and suggests a role for STX11 in Th17 
cells.  The next chapter will further explore the potential role for STX11 in Th17 cells.
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CHAPTER 5 
 
 
 
THE ROLE OF STX11 IN Th17 
CELLS 
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5.1 – INTRODUCTION 
In the previous chapter we demonstrated a clear correlation between increased IL-17 
mRNA expression and increased STX11 mRNA expression in Th17 cells in vitro.  
STX11 expression in Th17 cells was also increased relative to the naïve T-helper cells 
suggesting a regulatory role in activated cells.  Furthermore, STX11 mRNA expression is 
increased in parallel with IL-17 mRNA in two models of inflammation in vivo and is 
decreased in later stages of disease when IL-17 mRNA expression is low.        
Recently a STX11 deficient (Stx11-/-) mouse was generated and a murine model of FHL-4 
was established in order to further explore the mechanisms by which STX11 regulates 
immune function.  Studies using Stx11-/- cells confirmed the essential role for STX11 in 
NK and CTL function.  Interestingly a study by D’Orlando et al (2013) looked in detail at 
the IFN-γ secretion in CD8+ CTL cells in Stx11-/- mice.  This study confirmed the well 
recognised deficiency in granule release, but surprisingly showed that the cells also 
exhibited an over expression of IFN- γ, suggesting a loss in regulation of cytokine 
exocytosis (D’Orlando et al. 2013).  High serum levels of circulating IFN-γ is a 
recognised symptom of FLH-4 and has also been shown to contribute to increased 
macrophage activation and phagocytosis, a hallmark of FHL (Sepulveda et al. 2013; 
Zhang et al. 2008).  Taking this recent study into account and the results obtained in the 
previous chapter, we propose two possible roles for STX11 in T-helper cells.  It is clear 
that there is a relationship between Th17 orchestrated IL-17 release and Stx11 mRNA 
expression as shown in the previous chapter in vitro and in vivo.  These data would 
suggest that STX11 is actively involved in transport and/or exocytosis of IL-17 from 
Th17 cells.  However, given that STX11 has been implicated in negative regulation of 
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cellular processes and secretion through atypical SNARE behaviour, there is also a 
possibility that STX11 plays a role in negatively regulating IFN-γ.  IFN-γ is typically not 
expressed in Th17 cells and therefore a negative regulatory role could explain the 
increase in STX11 in these cells observed in the previous chapter.  The previous chapter 
also demonstrated that IL-17 is up-regulated in parallel with STX11 in the DSS and C. 
rodentium models of colitis in the early stages of disease.  Interestingly, IFN-γ levels at 
these time points was low or not-detected.  Furthermore, IFN-γ mRNA is expressed in the 
late acute stage of DSS and there is a return to control levels of STX11 mRNA 
expression.  Therefore STX11 may play a role directly in Th17 secretion through 
regulation and transport of IL-17 from these cells; conversely, it may be involved in 
negatively regulating IFN-γ release, which may have consequences for Th17 cells.  There 
is not enough evidence to suggest a prominence for either mechanism.  In order to 
investigate these possible mechanisms and confirm the specific role for STX11 in Th17 
cells, STX11 deficient mice (Stx11-/-) developed by Udo Zur Stadt, were obtained 
through a collaboration with Silvia Bulfone-Paus at the Borstel Research Centre, 
Hamburg, Germany.  CD4+ cells from these mice were isolated and polarised into Th1 
and Th17 cells and characterised in vitro. 
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5.2 – RESULTS 
5.2.1 – CYTOKINE SECRETION FROM CD4+ T-HELPER CELLS 
ISOLATED FROM WILD TYPE AND Stx11-/- MICE AND 
CULTURED IN Th17 POLARISING CONDITIONS IN VITRO. 
Having identified a potential role for STX11 in Th17 polarised cells, Stx11-/- mice were 
obtained from Silvia Bulfone-Paus’ group in the Borstel Research Institute, Hamburg, 
Germany.  Cells were isolated and cultured in vitro in Th1 and Th17 conditions 
optimised in the previous chapters and cell supernatants were assessed for cytokine 
secretion. 
Spleenocytes and mesenteric lymph nodes from wild type (WT) and Stx11-/- mice were 
obtained from the Bulfone-Paus lab.  CD4+ cells were isolated from the spleens and 
lymph nodes using the EasySep Mouse CD4+ T Cell Enrichment Kit (Stemcell).  Naïve 
CD4+ T-cells were also isolated from the spleenocytes using the EasySep Mouse Naïve 
CD4+ T Cell Enrichment Kit (Stemcell ).  Cells were counted and plated at 2x106cells/ml 
in 24 well plates in Th17 polarising conditions.  Cells were stimulated with anti-CD3 
(5µg/ml) and anti-CD28 (2.5µg/ml) for 4 days.  Supernatants were collected and assessed 
for levels of IFN-γ, IL-17, IL-2, IL-10, IL-21 and TNF-α using ELISA duosets (R&D) 
and IL-21 using the Ready, Set, Go ELISA (eBioscience).   
IL-17 cytokine levels in the naïve Th17 polarised cells were significantly reduced 
(p<0.001) and IFN-γ levels were significantly increased in the cells from Stx11-/- mice 
compared to the wild type (p<0.05) [Figure 5.1].  While levels of IFN-γ are low in the 
WT cells as expected for a Th17 cell, but the Stx11-/- cells produced two-fold the amount 
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of IFN-γ [Figure 5.1].   Interestingly, IL-21 levels were completely reduced in Stx11-/- 
cells (p<0.001).  IL-21 is a key cytokine produced early in polarised Th17 cells and is 
necessary for committing cells to this subset.  IL-10 (p<0.001) and TNF-α (p<0.05) were 
also significantly reduced in Stx11-/- cells.  IL-2 cytokine concentrations were at very low 
levels as expected in Th17 polarised cells, and there was no significant differences 
between WT and Stx11-/- cells [Figure 5.1]. 
CD4+ T-cells isolated from the spleens of WT and Stx11-/- mice were cultured under the 
same conditions.  Unlike the naïve CD4+ T-cells, there was no change observed in the 
levels of IL-17 cytokine secreted, with high concentrations of ~10ng/ml in WT and Stx11-
/-
 cells.  IFN-γ was significantly increased in the Stx11-/- CD4+ splenic cells (P<0.001).  
There was little or no IL-2 observed in the wild-type Th17 splenic T-cells as expected, 
however levels of IL-2 in the cells of Stx11-/- mice were significantly higher, this was also 
the case for IL-10 (p<0.001).  TNF-α was moderately increased in the cells from Stx11-/- 
mice (p<0.01), while IL-21 levels were similar in WT and Stx11-/- cells [Figure 5.2].   
CD4+ T-cells were enriched from the mesenteric lymphnodes of WT and Stx11-/- mice 
and cultured in the same conditions as the naïve and splenic CD4+ T-cells over four days.  
Analysis of the cytokines in the supernatants show once again, a significant increase in 
the IFN-γ production in the Th17 polarised cells from Stx11-/- mice (p<0.001).  There was 
no significant change observed in the supernatants from Stx11-/- cells for IL-17, IL-2 or 
TNF-α production.  IL-10 production was increased in Stx11-/- cells (p<0.05), but there 
was a significant difference in the levels of IL-21 in the Th17 polarised lymph node cell 
supernatants.  IL-21 was almost undetectable in the cell from WT mice and was increased 
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significantly in the Stx11-/- cell supernatants, this is in contrast to the naïve and splenic 
CD4+ cells supernatants measured [Figure 5.3].   
5.2.2 – CYTOKINE SECRETION FROM CD4+ T-HELPER CELLS 
ISOLATED FROM WILD TYPE AND Stx11-/- MICE AND 
CULTURED IN Th1 POLARISING CONDITIONS IN VITRO. 
Th17 polarised cells indicated some clear differences between secreted cytokine 
concentrations in WT and Stx11-/- cell supernatants.  In order to ensure that the changes 
identified were specific to Th17 cells, Th1 cells were generated from WT and Stx11-/- 
mice as a comparison.  Naïve CD4+ cells were isolated from the spleen and CD4+ cells 
were isolated from the spleens and lymph nodes using Easysep negative isolation kits 
(stemcell).  Cells were plated at 2x106 cells/ml and stimulated with plate bound 5µg/ml 
anti-CD3 and 2.5µg/ml soluble anti-CD28 antibodies for four days in Th1 polarising 
conditions.  IL-2 was not added as a proliferative factor in the media so that IL-2 
secretion from the cells could be accurately assessed.  Supernatants from the Th1 
polarised naïve CD4+ enriched cells showed no difference in the levels of IFN-γ, IL-17 or 
TNF-α after four days [Figure5.4].  There was a significant increase in the concentration 
of IL-10 (p<0.01) and IL-21 (p<0.05) measured Stx11-/- cell supernatants.  Concentrations 
of IL-2 were significantly reduced in Stx11-/- naïve Th1 polarised cells supernatants 
(P<0.001) [Figure 5.4]. 
Splenic CD4+ Th1 polarised cells show a similar trend for IL-17, IFN-γ and TNF-α with 
no difference between WT and Stx11-/- supernatants [Figure 5.5].  Again there was a 
decrease in the concentration of IL-2 from Stx11-/- cells (p<0.05) and an increase in IL-10 
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(p<0.001).  There was no change in IL-21 levels between WT and Stx11-/- splenic CD4+ 
isolated cells in contrast to the naïve cells [Figure 5.5]. 
Th1 polarised CD4+ cells from the lymph nodes of WT and Stx11-/- mice showed no 
significant change in the concentrations of IFN-γ, IL-17, IL-21 and IL-2 [Figure 5.6].  
TNF-α was significantly increased in the Stx11-/- cell (p<0.05) and IL-10 was also 
increased (p<0.001) in the Stx11-/- Th1 supernatants, similar to the naïve and splenic Th1 
cell supernatants [Figure 5.6]. 
5.2.3 – INTRA-CELLULAR CYTOKINE STAINING OF CD4+ T-
HELPER CELLS ISOLATED FROM WILD TYPE AND Stx11-/- MICE 
AND CULTURED IN Th17 POLARISING CONDITIONS IN VITRO. 
In order to determine the percentage of cells secreting IFN-γ and IL-17 from the total 
population, cells were stained for intracellular cytokines.  Intracellular staining involves 
permeabilising the cell membrane using detergents to create pores and allow cytokine 
targeted antibodies to enter the cell.  However, once cytokines leave the golgi apparatus 
in vesicles they are relatively unstable and are also able to leave the cells via the pores 
created by permeabilisation.  In order to account for this and accurately stain cells for 
cytokines they produce, the cells are stimulated with PMA and ionomycin to aggressively 
activate the cells to produce cytokine.  During this activation monensin is added to the 
cell culture.  Monensin is a transport inhibitor that blocks intracellular transport and 
causes cytokines to accumulate in the golgi complex where they are less likely to leave 
the cells resulting in detectability being greatly increased (Prussin & Metcalfe 1995).  
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This method allows for single cell analysis of cytokine secretion.  Cells were double 
stained and assessed for the percentage of cells producing IL-17 or IFN-γ or both.   
WT and Stx11-/- cells were stimulated and stained for intracellular cytokines after four 
days of culture in Th17 polarising conditions.  The cells were analysed on the BD FACS 
Aria and analysed using FlowJo software (Treestar).  The gates were set using 
fluorescence minus one (FMO) controls to take into account autofluorescence and 
spilling of dyes into other channels.  There were less IL-17 producing cells in the naïve 
CD4+ population of Stx11-/- cells with 10.1% in the WT and only 6.24% of the population 
in the Stx11-/- cells producing IL-17 [Figure 5.7].  This decrease was also observed in the 
lymph nodes with the WT cells having 0.19% and the Stx11-/- cells 0.48% [Figure 5.7] 
The IFN-γ producing cell population was increased in the Stx11-/- cells isolated from the 
spleen (0.3% to 0.77%) and the lymph nodes (0.019% to 0.048%). 
No IFN-γ/IL-17 double producing cells (>0.1%) were detected in any of the cell 
populations [Figure 5.7].  
5.2.4 – INTRA-CELLULAR CYTOKINE STAINING OF CD4+ T-
HELPER CELLS ISOLATED FROM WILD TYPE AND Stx11-/- MICE 
AND CULTURED IN Th1 POLARISING CONDITIONS IN VITRO. 
Isolated cells were activated in Th1 polarising conditions for four days before re-
activating with PMA and ionomycin in the presence of monensin.  Cells were then 
stained with anti-IFN-γ and IL-17 primary conjugated antibodies and analysed on the BD 
FACS Aria.  The data were analysed using FlowJo software (Treestar).   
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There was a significant increase in the Stx11-/- Th1 polarised naive cells with a large 
increase in the number of IFN-γ producing cells.  The WT cells had an 18.5% IFN-γ 
producing population and the Stx11-/- had a 32.2% IFN-γ producing population, an almost 
2-fold increase [Figure 5.8].  This increase was not evident in the spleen and lymph node 
CD4+ cells.  Very small numbers (<1%) of cells were identified as IL-17 producing cells 
in any of the WT and Stx11-/- cells populations [Figure 5.8]. 
5.2.5 – RORγt STAINING OF CD4+ T-HELPER CELLS ISOLATED 
FROM WILD TYPE AND Stx11-/- MICE AND CULTURED IN Th17 
AND Th1 POLARISING CONDITIONS IN VITRO. 
The previous sections have described a significant decrease in the concentration of IL-17 
in the supernatants of Stx11-/- cells polarised in Th17 conditions for four days in vitro 
[section 5.2.1].  We have also shown that the number of IL-17 producing cells is 
decreased in some Th17 polarised cell populations, particularly the naïve cell population 
[section 5.2.3].  In order to attribute this reduction in IL-17 secretion to dysregulation in 
cytokine trafficking due to a lack of STX11, it was necessary to confirm the commitment 
of the cells to a Th17 subset.  RORγt expression is required for the polarisation of a Th17 
cells from naïve T-helpers (Ivanov et al. 2006).  Therefore, the expression of the master 
regulator and transcription factor RORγt was assessed in Th1 and Th17 polarised cells 
from WT and Stx11-/- mice.  Chapter 2 of this study and work by others has shown that 
RORγt expression peaks at 18hrs after stimulation in Th17 polarising conditions (Yosef 
et al. 2013).  At this time point cells were removed from culture and fixed with 3% PAF 
and permeabilised with 1% Tween-20.  Cells were then stained with an APC conjugated 
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anti-RORγt antbody and analysed on the FACS Aria.  Data were analysed using FlowJo 
software (Treestar).  The data are presented as the percentage of RORγt expressing cells 
in the total cell population following 18hrs stimulation in either Th1 or Th17 polarising 
conditions.  
The naïve Th17 polarised cells were 21.5% positive for RORγt expression in the WT 
population.  This was significantly reduced to 5.2% in the Stx11-/- cells [Figure 5.9).  A 
similar reduction was observed in the splenic CD4+ cells, with a 22.4% positive RORγt 
population in the WT cells and 8% RORγt positive population in the Stx11-/- cells, and the 
CD4+
 
T-cells isolated from the lymph nodes, with 29.5% of the population of RORγt 
positive cells compared to 20.8% in the Stx11-/- cells [Figure5.9].  RORγt expression was 
also measured in the Th1 polarised cell populations.  10% of the WT naïve Th1 polarised 
cells stained positive for RORγt expression.  This was decreased to 5.9% in the Stx11-/- 
cells [Figure 5.10].  No change was observed in the splenic isolated CD4+ T-cells and the 
lymph node CD4+ cells had a 10.7% RORγt population, which was marginally increased 
to 12.4% in the Stx11-/- cells [Figure5.10]. 
5.2.6 – PROLIFERATION OF Th17 POLARISED CELLS ISOLATED 
FROM WILD TYPE AND Stx11-/- MICE. 
Proliferation is an important factor in T-cell activation and polarisation.  Levels of 
cytokines accumulated over four days show differences between polarised cells from WT 
and Stx11-/- mice.  However, an increased proliferation rate would result in more 
generations of cytokine producing cells which may not be reflected in the cell number or 
viability due to increased cell cycling.  This may have an impact on the results observed 
in the supernatant cytokine measurements.  In order to assess the effects lack of STX11 
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on proliferation rates in Th1 and Th17 polarised cells, the cells were stained with CFSE 
as described previously [section 3.2.6].  Cells were removed from culture daily and 
stained with propidium iodide in order to exclude the dead cells.  Cells were analysed on 
the BD FACS Aria and the data were analysed using FlowJo software (Treestar).  The 
histograms show the number of peaks measured on day one, two and three of cell culture.  
Each peak represents a generation of cells.  The raw data was anaylsed using the 
proliferation analysis algorithm on the FlowJo software which calculates the approximate 
number of cells in each generation of cells.  The data is represented in three graphs 
comparing the WT and Stx11-/- cells.  The percentage divided is the total number of cells 
in the population which underwent proliferation.   
In the WT Th17 cells on day four, 70% of the total cells had divided compared to just 
40% of the Stx11-/- cells [Figure 5.11].  A reduction was also observed in the division 
index.  The division index is the average number of divisions that the cells undergo.  This 
includes the undivided peak and is therefore representative of the whole system and not 
just the dividing system.  The bottom graph represents the profile of proliferation to allow 
easy comparison between WT and Stx11-/- cells where each point represents the total 
percentage of cells in each generation of divided cells.  It is clear from these profiles that 
more of the WT cells were in later generations and had undergone more divisions 
[Figure 5.11].  The effect was not as significant in splenic and lymph node CD4+ cells; 
however the trend was the same.  The percentage divided and the division index was 
decreased in the Stx11-/- cells for both populations and the profiles indicated more cells in 
the later generations of WT cells compared to Stx11-/- cells [Figure 5.12 and 5.13].  
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Therefore, in the absence of STX11, proliferation was affected in all populations of 
isolated Th17 polarised cells and was most evident in naïve Th17 polarised cells. 
5.2.7 – PROLIFERATION OF Th1 POLARISED CELLS ISOLATED 
FROM WILD TYPE AND Stx11-/- MICE. 
We also examined the effect of STX11 deficiency on the proliferation of T1 polarised 
cells.  Th1 naïve Stx11-/- cells had a reduced percentage of total cells divided; 35% 
compared to the 74% in the WT [Figure 5.14].  The division index was also reduced.  
The proliferation profile comparing the WT and Stx11-/- cells demonstrates the significant 
difference between the profiles of these cells, with the majority of the Stx11-/- cells having 
a low number of divisions [Figure 5.14].  This difference in proliferation was not 
observed in the splenic or lymph node isolated CD4+ cells [Figure 5.15 and 5.16].  The 
percentage divided and division index were similar for both the splenic and lymph node 
isolated cells and the proliferation profile for splenic and lymph node cell populations 
were almost identical for the WT and Stx11-/- cells [Figure 5.15 and 5.16].   
5.2.8 – CELL COUNTS AND VIABILITY OF Th1 And Th17 
POLARISED CELLS ISOLATED FROM WILD TYPE AND Stx11-/- 
MICE. 
Having identified differences between proliferation in Th1 and Th17 cell subsets from 
WT and Stx11-/- cells, the viability and cells numbers was assessed to identify any other 
differences in the absence of STX11 in order to correctly interpret the data collected. 
The numbers of cells in culture following four days of stimulation in Th1 or Th17 
conditions were counted using a haemocytometer and trypan blue dead cell exclusion.  
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The numbers were graphed comparing WT and Stx11-/- cells in both Th1 and Th17 cells.  
The naïve Th1 cells had similar numbers in the WT and Stx11-/- cells [Figure 5.17].  The 
naïve Th17 polarised cells however had a significant difference in the cell numbers on 
day four.  The WT cell numbers were almost 3-fold higher than the Th17 polarised Stx11-
/- cells [Figure 5.17].  The cell viability was assessed using PI staining, and cells were 
analysed on the BD FACS Aria flow cytometer.  Live cells do not allow PI to enter the 
cells and stain the nucleus, therefore cells negative for PI staining were gated and the 
graph represents the percentage of viable cells from the total number of cells measured.  
The viability of the naïve Th1 polarised Stx11-/- cells was increased compared to the wild 
type with  58% viability measured in the Stx11-/- cells compared to 43% in the WT cells 
[Figure 5.17].  There was no difference in the Th17 polarised cells between WT and 
Stx11-/-.  Finally the viability of the cells over the four days was plotted and WT and 
Stx11-/- cell viability was compared in both Th1 and Th17 polarised cells.  There was an 
increase in viability in the Th1 polarised naïve cells from Stx11-/- mice on days 2, 3 and 4, 
while the WT Th17 cells had a higher viability then the Stx11-/- mice on days 1, 2 and 3 
[Figure 5.17].   
There are no significant changes observed between the WT and Stx11-/- cell counts in the 
splenic CD4+ cells [Figure 5.18].  The cell viability was similar between WT and Stx11-/- 
Th1 polarised cells over the four days, while the WT Th17 polarised cells appear to have 
higher viability on days 1 and 2 with similar viability to Stx11-/- cells on days 3 and 4 
[Figure 5.18].  The lymph node isolated CD4+ cells show an increased cell viability in 
the Th1 polarised WT cells compared to the cells from Stx11-/- mice on days 2 an 3 with 
similar levels on day 4.  The Th17 polarised WT cells have an increased viability on days 
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2 and 3 with similar viability on day 4 with no significant increase compared to Th1 
polarised Stx11-/- cells [Figure 5.19].  
5.2.9 – mRNA EXPRESSION OF SIGNATURE Th17 GENES AND 
CONFIRMATION OF Th17 POLARISATION IN NAÏVE CELLS 
FROM WT MICE. 
These results on cell numbers and viability and the previous sections assessing 
proliferation must be taken in to account when analysing and interpreting the 
concentrations of IFNγ and IL-17 secreted in the supernatants over the four days of cell 
culture.  Over the four days the cells undergo a number of changes in gene regulation and 
cytokine secretion. Gene expression differences between the WT and Stx11-/- cells can 
give an indication on the state of the cell after four days in culture.  mRNA expression 
was therefore assessed in naïve polarised T-helper cells in order to collect more 
information on the effects of STX11 deficiency on cytokine gene expression, and 
polarisation of the cells.    
The splenic naïve T-cells represent a pure population of cells which were then polarised 
into Th1 and Th17 cells.  The splenic and lymph node cell populations contain central 
and effector memory cells which may already be differentiated into Th1 and Th17 cells 
and therefore may affect the results observed in the Stx11-/- cells on differentiation or 
cytokine regulation.  Differences in cell differentiation and proliferation were previously 
detected in section 5.2.3, 4, 6 and 7 in the naïve cells, which were not as evident in the 
CD4+ isolated cells from spleen and lymph nodes.  Therefore, the mRNA expression 
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from cytokine and transcription factor genes was analysed in the pure naïve polarised cell 
populations in order to identify differences between WT and Stx11-/- cells. 
RNA was isolated from the Naïve CD4+ WT cells using the RNA II  Nucleospin® kit 
(Macherey-Nage) according to the manufacturer’s instructions.  The cDNA was 
generated from 0.5µg of RNA using the High Capacity cDNA Reverse Transcriptase Kit 
(Applied Biosystems, USA) and random primers.  The cDNA was diluted 1/10 in DEPC 
treated water and qPCR was carried out on the ABI Prism 7500 using Roche SYBR green 
mastermix and primers directed to the targets were obtained from sigma or IDT as listed 
in Appendix C.  We first examined the Th1 and T17 profiles in the WT cells to establish 
that we had a distinct fully polarised Th1 and Th17 population.  Th17 cells showed high 
expression of IL-17, IL-21 and RORγt and low expression of IFN-γ and T-bet [Figure 
5.20].  The Il-23 receptor, which is critical for maintenance and commitment of Th17 
cells, had similar expression in Th1 and T17 cells [Figure 5.20].  These results were in 
agreement with the cytokine data generated for the Th17 cells showing high production 
of IL-17 and IL-21, and low production of IFN-γ in these cells.  The RORγt mRNA 
expression levels also corroborated the intracellular staining of RORγt protein in the 
naïve WT cells.  Having confirmed the Th17 profile of cells using mRNA, expression of 
STX11 was measured to confirm the results observed in our previous studies using naïve 
CD4+ cells.  STX11 expression was significantly increased in the Th17 polarised cells 
(P<0.001).  STX11 expression was also measured in the Stx11-/- cells and was not 
detected as expected.  The RNA generated was used to assess genes associated with 
cytokine production, polarisation and cell phenotype in order to identify differences in 
gene expression between the WT and Stx11-/- cells.   
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 5.2.10 – mRNA EXPRESSION OF TRANSCRIPTION FACTOR 
GENES IN POLARISED NAÏVE CELLS FROM WT AND Stx11-/- 
MICE.  
The mRNA expression levels of the master regulator genes RORγt (Th17), T-bet (Th1) 
and Foxp3 (Treg) were assessed in the cells stimulated in Th17 polarising conditions.  
The expression measured in the Stx11-/- cells were expressed relative to WT Th17 cells 
which were normalised to one.   The Th17 cells surprisingly show a small increase in 
RORγt expression on day four (1-1.5-fold), this is despite a decrease at 18hrs as shown 
by intracellular protein staining, when RORγt is highly expressed during polarisation.  
There was a significant increase in the expression of T-bet and Foxp3 [Figure 5.22].   
Suggesting a difference in phenotype between the WT and Stx11-/- cells activated in Th17 
polarising conditions.   
No significant difference in the mRNA expression of the transcription factors RORγt, T-
bet or FoxP3 were observed on day four in Th1 polarised naïve T-cells from WT and 
Stx11-/- mice [Figure 5.23]. 
5.2.11 – mRNA EXPRESSION OF CYTOKINE GENES IN 
POLARISED NAÏVE CELLS FROM WT AND Stx11-/- MICE.  
IL-17 is the key cytokine secreted by Th17 cells and as observed in the previous sections 
IL-17 secretion is down-regulated in naïve Th17 cells in the absence of STX11.  To 
assess cytokine gene expression in these cells, qPCR was used to measure mRNA 
expression in Th17 polarised cells from WT and Stx11-/- mice.  In agreement with the 
previous results, IL-17 mRNA expression was significantly lower in cells from Stx11-/- 
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mice.  IFN-γ mRNA expression was significantly increased (8-fold) in the Stx11-/- cells in 
agreement with earlier results showing an increase in IFN-γ in cell supernatants collected 
over the four days.  mRNA expression of the Il21 gene, necessary for early Th17 
polarisation, was significantly decreased in Stx11-/- cells compared to WT Th17 polarised 
cells.  IL-2 mRNA expression was also significantly decreased in the Stx11-/- cells.  There 
was no change observed in IL-10 mRNA expression in the Stx11-/- cells [Figure 5.24].   
Taken together these results show a decrease in IL-17 and IL-21 at gene expression level 
while IFN-γ expression is significantly increased.  This would indicate a difference in the 
cell phenotypes following activation in these conditions, and a dysregulation of Th17 
polarisation in the absence of STX11. 
 
We also examined the cytokine expression in Th1 cells and showed that there was a 
similar increase in IFN-γ mRNA expression in the Stx11-/- cells (P<0.01) [Figure 5.25].  
This correlates with the measured increase in IFN-γ secretion in the supernatants from 
these cells and the increase in IFN-γ producing cells observed in the earlier intracellular 
staining.  Surprisingly, IL-2 was higher in the Stx11-/- cells compared to the WT on day 
four [Figure 5.25].  IL-21 mRNA expression is increased in the Stx11-/- cells (>15-fold) 
[Figure 5.25].  IL-21 is secreted late in Th1 cells and this significant increase in IL-21 at 
the gene level is in agreement with the earlier ELISA carried out on the supernatants of 
these cells.  IL-21 production has been reported to induce IL-10 mRNA expression, 
which we also showed to be increased in the Stx11-/- cells [Figure 5.25] and was also in 
agreement with the earlier ELISA data. 
 184 
5.2.12 – mRNA EXPRESSION OF CYTOKINE RECEPTOR GENES 
IN POLARISED NAÏVE CELLS FROM WT AND Stx11-/- MICE.  
Cytokine receptors are indicative of the phenotypic state of a cell and increases in 
receptor proteins on the surface can be a result of polarisation, activation or cell 
exhaustion.  In order to assess the state of these cells the cytokine receptors for IL-23, IL-
2 (CD25) and IFN-γ were compared in Th17 polarised cells from WT and Stx11-/- mice.  
IFN-γR has been indentified on late stage Th17 cells which can class switch to a double 
producing cell.  IFN-γR1 mRNA expression levels were significantly reduced in Th17 
polarised cells from Stx11-/- mice (p<0.001) [Figure 5.26].  IL-23 receptor signalling on 
T-cells is necessary for lineage commitment and expansion of Th17 cells.  There is a 
significant decrease in the expression of IL-23R in the cells from Stx11-/- mice (P<0.001) 
[Figure 5.26].  There was no significant difference observed in the IL-2Ra mRNA 
expression levels comparing naïve Stx11-/- cells to WT cells [Figure 5.26]. 
 
The mRNA expression of the cell surface receptor genes for IFN-γR1, IL-2RA and IL-
23R were also assessed in the Th1 polarised cells from WT and Stx11-/- mice.  IFN-γR1 is 
significantly reduced in the Stx11-/- cells (P<0.001) [Figure 5.27].  This is concurrent 
with a minor reduction in IL-2RA which is responsible for proliferation and maintenance 
of Th1 cells.  There is no significant difference in IL-23R mRNA expression between the 
WT and Stx11-/- cells [Figure 5.27].   
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Figure 5.1 – Cytokine concentration in supernatants from wild type and Stx11-/- naive splenic CD4+ 
T-cells activated in Th17 polarising conditions and measured by ELISA.   Spleens were isolated from 8 
wild type and 8 Stx11-/- mice.  Spleenocytes were enriched for Naïve CD4+ T-cells using the EasySep™ 
Mouse Naïve CD4+ T-Cell Isolation Kit (Stemcell).  Cells were counted and plated at 2x106 cells/ml and 
stimulated with plate bound anti-CD3 antibody (5µg/ml) and soluble anti-CD28 antibody (2.5µg/ml) in 
Th17 conditions: IL1β (10ng/ml), IL-6 (20ng/ml), IL-23 (20ng/ml),TGF-β (0.2ng/ml), anti-IL-4 (10µg/ml) 
and anti-IFNγ (10µg/ml) for 4 days.  Cells were centrifuged (2000RPM for 10 mins) and supernatants were 
collected and assessed for concentrations of IFN-γ, IL-17, IL-2, IL-10 and TNF-α using R&D duoset 
ELISA kits.  IL -21 was assessed using the IL-21 ready, set, go ELISA kit (eBioscience).  Results are 
means ±SEM of three groups each consisting of cells pooled from two mice and measured in triplicate.  An 
unpaired T-test was used to determine if differences between WT and Stx11-/- mice were significantly 
different (*p<0.05 and ***p<0.001). 
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Figure 5.2- Cytokine concentrations in supernatants from wild type and Stx11-/- CD4+ T- splenic cells 
activated in Th17 polarising conditions and measured by ELISA.  Spleens were isolated from 8 wild 
type and 8 Stx11-/- mice.  Spleenocytes were enriched for CD4+ T-cells using the EasySep™ Mouse CD4+ 
T-Cell Isolation Kit (Stemcell).  Cells were counted and plated at 2x106 cells/ml and stimulated with plate 
bound anti-CD3 antibody (5µg/ml) and soluble anti-CD28 antibody (2.5µg/ml) in Th17 conditions: IL1β 
(10ng/ml), IL-6 (20ng/ml), IL-23 (20ng/ml), TGF-β (0.2ng/ml), anti-IL-4 (10µg/ml) and anti-IFNγ 
(10µg/ml) for 4 days.  Cells were centrifuged (2000RPM for 10 mins) and supernatants were collected and 
assessed for concentrations of IFN-γ, IL-17, IL-2, IL-10 and TNF-α using R&D duoset ELISA kits.  Il-21 
was assessed using the IL-21 ready, set, go ELISA kit (eBioscience).  Results are means ±SEM of three 
groups each consisting of cells pooled from two mice and measured in triplicate.  An unpaired T-test was 
used to determine if differences between WT and Stx11-/- mice were significantly different (**p<0.01and 
***p<0.001). 
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Figure 5.3 - Cytokine concentration in supernatants from wild type and Stx11-/- lymph node CD4+ T-
cells activated in Th17 polarising conditions and measured by ELISA.  Mesenteric lymph nodes were 
isolated from 8 wild type and 8 Stx11-/- mice.  Lymph nodes were enriched for CD4+ T-cells using the 
EasySep™ Mouse CD4+ T-Cell Isolation Kit (Stemcell).  Cells were counted and plated at 2x106 cells/ml 
and stimulated with plate bound anti-CD3 antibody (5µg/ml) and soluble anti-CD28 antibody (2.5µg/ml) in 
Th17 conditions: IL1β (10ng/ml), IL-6 (20ng/ml), IL-23 (20ng/ml),TGF-β (0.2ng/ml), anti-IL-4 (10µg/ml) 
and anti-IFNγ (10µg/ml) for 4 days.  Cells were centrifuged (2000RPM for 10 mins) and supernatants were 
collected and assessed for concentrations of IFN-γ, IL-17, IL-2, IL-10 and TNF-α using R&D duoset 
ELISA kits.  Il-21 was assessed using the IL-21 ready, set, go ELISA kit (eBioscience).  Results are means 
±SEM of three groups each consisting of cells pooled from two mice and measured in triplicate.  An 
unpaired T-test was used to determine if differences between WT and Stx11-/- mice were significantly 
different (*p<0.05 and ***p<0.001). 
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Figure 5.4 - Cytokine concentrations in supernatants from wild type and Stx11-/- naïve CD4+ T-cells 
activated in Th1 polarising conditions and measured by ELISA.  Spleens were isolated from 8 wild 
type and 8 Stx11-/- mice.  Spleenocytes were enriched for Naïve CD4+ T-cells using the EasySep™ Mouse 
Naïve CD4+ T Cell Isolation Kit (Stemcell).  Cells were counted and plated at 2x106 cells/ml and 
stimulated with plate bound anti-CD3 antibody (5µg/ml) and soluble anti-CD28 antibody (2.5µg/ml) in Th1 
polarising conditions: IL12 (10ng/ml) and anti-IL-4 (10µg/ml) for 4 days.  Cells were centrifuged 
(2000RPM for 10 mins) and supernatants were collected and assessed for concentrations of IFN-γ, IL-17, 
IL-2, IL-10 and TNF-α using R&D duoset ELISA kits.  Il-21 was assessed using the IL-21 ready, set, go 
ELISA kit (eBioscience).  Results are means ±SEM of three groups each consisting of cells pooled from 
two mice and measured in triplicate.  An unpaired T-test was used to determine if differences between WT 
and Stx11-/- mice were significantly different (*p<0.05, **p<0.01  and ***p<0.001). 
 
 189 
Th1 cells - IFN-γ production
WT
-
/-
Stx
11
0
100000
200000
300000
pg
/m
l
Th1 cells - IL-17 production
WT
-
/-
Stx
11
0
200
400
600
800
1000
pg
/m
l
Th1 cells - IL-2 production
WT
-
/-
Stx
11
0
10000
20000
30000
40000
*
pg
/m
l
Th1 cells - IL-10 production
WT
-
/-
Stx
11
0
2000
4000
6000
8000
10000 ***
pg
/m
l
Th1 cells - IL-21 production
WT
-
/-
Stx
11
0
1000
2000
3000
4000
pg
/m
l
Th1 cells - TNF- α production
WT
-
/-
Stx
11
0
500
1000
1500
2000
pg
/m
l
 
Figure 5.5 - Cytokine concentrations in supernatants from wild type and Stx11-/- splenic CD4+ T-cells 
activated in Th1 polarising conditions and measured by ELISA.  Spleens were isolated from 8 wild 
type and 8 Stx11-/- mice.  Spleenocytes were enriched for CD4+ T-cells using the EasySep™ Mouse CD4+ 
T-Cell Isolation Kit (Stemcell).  Cells were counted and plated at 2x106 cells/ml and stimulated with plate 
bound anti-CD3 antibody (5µg/ml) and soluble anti-CD28 antibody (2.5µg/ml) in Th1 polarising 
conditions: IL12 (10ng/ml) and anti-IL-4 (10µg/ml) for 4 days.  Cells were centrifuged (2000RPM for 10 
mins) and supernatants were collected and assessed for concentrations of IFN-γ, IL-17, IL-2, IL-10 and 
TNF-α using R&D duoset ELISA kits.  Il-21 was assessed using the IL-21 ready, set, go ELISA kit 
(eBioscience).  Results are means ±SEM of three groups each consisting of cells pooled from two mice and 
measured in triplicate.  An unpaired T-test was used to determine if differences between WT and Stx11-/- 
mice were significantly different (*p<0.05 and ***p<0.001). 
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Figure 5.6 - Cytokine concentration in supernatants from wild type and Stx11-/- lymph node CD4+ T-
cells activated in Th1 polarising conditions and measured by ELISA.  Mesenteric lymph nodes were 
isolated from 8 wild type and 8 Stx11-/- mice.  Lymph nodes were enriched for CD4+ T-cells using the 
EasySep™ Mouse CD4+ T-Cell Isolation Kit (Stemcell).  Cells were counted and plated at 2x106 cells/ml 
and stimulated with plate bound anti-CD3 antibody (5µg/ml) and soluble anti-CD28 antibody (2.5µg/ml) in 
Th17 conditions: Th1 polarising conditions: IL12 (10ng/ml) and anti-IL-4 (10µg/ml) for 4 days.  Cells were 
centrifuged (2000RPM for 10 mins) and supernatants were collected and assessed for concentrations of 
IFN-γ, IL-17, IL-2, IL-10 and TNF-α using R&D duoset ELISA kits.  Il-21 was assessed using the IL-21 
ready, set, go ELISA kit (eBioscience).  Results are means ±SEM of three groups each consisting of cells 
pooled from two mice and measured in triplicate.  An unpaired T-test was used to determine if differences 
between WT and Stx11-/- mice were significantly different (*p<0.05 and ***p<0.001). 
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Figure 5.7 - Intracellular cytokine staining of cells isolated from wild type and Stx11-/- mice and 
activated in Th17 polarising conditions in vitro.  Spleens and mesenteric lymph nodes were isolated from 
8 wild type and 8 Stx11-/- mice.  Spleenocytes were enriched for Naïve CD4+ T-cells and spleenocytes and 
lymph nodes were enriched for CD4+ T-cells using Easysep isolation kits (stemcell)   Cells were counted 
and plated at 2x106 cells/ml and stimulated with plate bound anti-CD3 antibody (5µg/ml) and soluble anti-
CD28 antibody (2.5µg/ml) in Th17 polarising conditions for 4 days.  On day 4, cells were stimulated with 
PMA (1µg/ml) and ionomycin (50ng/ml) for 4 hours.  Monensin was added for the last 2 hours.  Cells were 
the centrifuged and fixed with 3% PAF and permeabilised with saponin (0.5%).  Cells were double stained 
with FITC conjugated anti-IFN-γ and PE conjugated PE antibodies.  Cells were analysed on the FACS aria 
(BD) and data were analysed using Flowjo software.  Plots show the percentage of cells expressing IFN-γ, 
IL-17 or both.  Representative graphs are shown comparing the percentage of IL-17 and IFN-γ expressing 
cells isolated from WT vs. Stx11-/- mice.  
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Figure 5.8- Intracellular cytokine staining of cells isolated from wild type and Stx11-/- mice and 
activated in Th1 polarising conditions in vitro.  Spleens and mesenteric lymph nodes were isolated from 
8 wild type and 8 Stx11-/- mice.  Spleenocytes were enriched for Naïve CD4+ T-cells and spleenocytes and 
lymph nodes were enriched for CD4+ T-cells using Easysep isolation kits (stemcell)   Cells were counted 
and plated at 2x106 cells/ml and stimulated with plate bound anti-CD3 antibody (5µg/ml) and soluble anti-
CD28 antibody (2.5µg/ml) in Th1 polarising conditions for 4 days.  On day 4, cells were stimulated with 
PMA (1µg/ml) and ionomycin (50ng/ml) for 4 hours.  Monensin was added for the last 2 hours.  Cells were 
the centrifuged and fixed with 3% PAF and permeabilised with saponin (0.5%).  Cells were double stained 
with FITC conjugated anti-IFN-γ and PE conjugated PE antibodies.  Cells were analysed on the FACS aria 
(BD) and data were analysed using Flowjo software.  Plots show the percentage of cells expressing IFN-γ, 
IL-17 or both.  Representative graphs are shown comparing the percentage of IL-17 and IFN-γ expressing 
cells isolated from WT vs. Stx11-/- mice.    
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Figure 5.9 - Intracellular transcription factor staining of cells isolated from wild type and Stx11-/- 
mice and activated in Th17 polarising conditions in vitro.  Spleens and mesenteric lymph nodes were 
isolated from 8 wild type and 8 Stx11-/- mice.  Spleenocytes were enriched for Naïve CD4+ T-cells and 
spleenocytes and lymph nodes were enriched for CD4+ T-cells using Easysep isolation kits (stemcell)   
Cells were counted and plated at 2x106 cells/ml and stimulated with plate bound anti-CD3 antibody 
(5µg/ml) and soluble anti-CD28 antibody (2.5µg/ml) in Th17 polarising conditions for 18hrs.  Cells were 
then centrifuged and fixed with 3% PAF and permeabilised with triton-x100 (1%).  Cells were stained with 
APC conjugated anti-RORγt antibody.  Cells were analysed on the FACS aria (BD) and data were analysed 
using Flowjo software.  Plots show the percentage of cells expressing RORγt.  Representative graphs are 
shown comparing the percentage of RORγt expressing cells isolated from WT vs. Stx11-/- mice   
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Figure 5.10 - Intracellular transcription factor staining of RORγt in cells isolated from wild type and 
Stx11-/- mice and activated in Th1 polarising conditions in vitro.  Spleens and mesenteric lymph nodes 
were isolated from 8 wild type and 8 Stx11-/- mice.  Spleenocytes were enriched for Naïve CD4+ T-cells and 
spleenocytes and lymph nodes were enriched for CD4+ T-cells using Easysep isolation kits (stemcell)   
Cells were counted and plated at 2x106 cells/ml and stimulated with plate bound anti-CD3 antibody 
(5µg/ml) and soluble anti-CD28 antibody (2.5µg/ml) in Th1 polarising conditions for 18hrs.  Cells were 
then centrifuged and fixed with 3% PAF and permeabilised with triton-x100 (1%).  Cells were stained with 
APC conjugated anti-RORγt antibody.  Cells were analysed on the FACS aria (BD) and data were analysed 
using Flowjo software.  Plots show the percentage of cells expressing RORγt.  Representative graphs are 
shown comparing the percentage of RORγt expressing cells isolated from WT vs. Stx11-/-   
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Figure 5.11 - Proliferation study of naïve cells isolated from wild type and Stx11-/- mice activated in 
Th17 polarising conditions.  Spleens were isolated from 8 wild type and 8 Stx11-/- mice.  Spleenocytes 
were enriched for Naïve CD4+ T-cells using Easysep isolation kits (Stemcell).  Cells were stained with 
CFSE dye for 5 mins in PBS/FBS at RT before washing twice in PBS.  Cells were counted and plated at 
2x106 cells/ml and stimulated with plate bound anti-CD3 antibody (5µg/ml) and soluble anti-CD28 
antibody (2.5µg/ml) in Th17 polarising conditions.  Cells were sampled daily removing 50µl of cells and 
staining with propidium iodide immediately before analysis on the BD FACS Aria.  The data was analysed 
using FlowJo analysis software (Treestar).  Cells were gated on live cells and CFSE was plotted and 
analysed using the proliferation algorithm on the FlowJo software in order to calculate the percentage of 
divided cells, the proliferation index and the number of cells in each generation of day four of cell culture.       
WT 
Stx11-/- 
 
 196 
 
Percentage divided
Wi
ld 
Ty
pe (-/
-
)
ST
X1
1
0
20
40
60
80
%
 
o
f c
el
ls
 
di
vi
de
d
Division index
Wi
ld 
Ty
pe (-/
-
)
ST
X1
1
0.0
0.5
1.0
1.5
Ar
ib
ta
ry
 
u
n
its
 
Proliferation profile
0 1 2 3 4
0
10
20
30
40
Wild Type
Stx11-/-
Divisions
%
T-
ce
lls
 
Figure 5.12 - Proliferation study of splenic CD4+ cells isolated from wild type and Stx11-/- mice 
activated in Th17 polarising conditions.  Spleens were isolated from 8 wild type and 8 Stx11-/- mice.  
Spleenocytes were enriched for CD4+ T-cells using Easysep isolation kits (Stemcell).  Cells were stained 
with CFSE dye for 5 mins in PBS/FBS at RT before washing twice in PBS.  Cells were counted and plated 
at 2x106 cells/ml and stimulated with plate bound anti-CD3 antibody (5µg/ml) and soluble anti-CD28 
antibody (2.5µg/ml) in Th17 polarising conditions.  Cells were sampled daily removing 50µl of cells and 
staining with propidium iodide immediately before analysis on the BD FACS Aria.  The data was analysed 
using FlowJo analysis software (Treestar).  Cells were gated on live cells and CFSE was plotted and 
analysed using the proliferation algorithm on the FlowJo software in order to calculate the percentage of 
divided cells, the proliferation index and the number of cells in each generation of day four of cell culture.       
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Figure 5.13 - Proliferation study of mesenteric lymph node CD4+ cells isolated from wild type and 
Stx11-/- mice activated in Th17 polarising conditions.  Mesenteric lymph nodes were isolated from 8 wild 
type and 8 Stx11-/- mice.  The mesenteric lymph nodes cell solution was enriched for CD4+ T-cells using 
Easysep isolation kits (Stemcell).  Cells were stained with CFSE dye for 5 mins in PBS/FBS at RT before 
washing twice in PBS.  Cells were counted and plated at 2x106 cells/ml and stimulated with plate bound 
anti-CD3 antibody (5µg/ml) and soluble anti-CD28 antibody (2.5µg/ml) in Th17 polarising conditions.  
Cells were sampled daily removing 50µl of cells and staining with propidium iodide immediately before 
analysis on the BD FACS Aria.  The data was analysed using FlowJo analysis software (Treestar).  Cells 
were gated on live cells and CFSE was plotted and analysed using the proliferation algorithm on the 
FlowJo software in order to calculate the percentage of divided cells, the proliferation index and the 
number of cells in each generation of day four of cell culture 
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Figure 5.14 - Proliferation study of naïve cells isolated from wild type and Stx11-/- mice activated in 
Th1 polarising conditions.  Spleens were isolated from 8 wild type and 8 Stx11-/- mice.  Spleenocytes were 
enriched for Naïve CD4+ T-cells using Easysep isolation kits (Stemcell).  Cells were stained with CFSE 
dye for 5 mins in PBS/FBS at RT before washing twice in PBS.  Cells were counted and plated at 2x106 
cells/ml and stimulated with plate bound anti-CD3 antibody (5µg/ml) and soluble anti-CD28 antibody 
(2.5µg/ml) in Th1 polarising conditions.  Cells were sampled daily removing 50µl of cells and staining with 
propidium iodide immediately before analysis on the BD FACS Aria.  The data was analysed using FlowJo 
analysis software (Treestar).  Cells were gated on live cells and CFSE was plotted and analysed using the 
proliferation algorithm on the FlowJo software in order to calculate the percentage of divided cells, the 
proliferation index and the number of cells in each generation of day four of cell culture.       
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Figure 5.15 - Proliferation study of splenic CD4+ cells isolated from wild type and Stx11-/- mice 
activated in Th1 polarising conditions.  Spleens were isolated from 8 wild type and 8 Stx11-/- mice.  
Spleenocytes were enriched for CD4+ T-cells using Easysep isolation kits (Stemcell).  Cells were stained 
with CFSE dye for 5 mins in PBS/FBS at RT before washing twice in PBS.  Cells were counted and plated 
at 2x106 cells/ml and stimulated with plate bound anti-CD3 antibody (5µg/ml) and soluble anti-CD28 
antibody (2.5µg/ml) in Th1 polarising conditions.  Cells were sampled daily removing 50µl of cells and 
staining with propidium iodide immediately before analysis on the BD FACS Aria.  The data was analysed 
using FlowJo analysis software (Treestar).  Cells were gated on live cells and CFSE was plotted and 
analysed using the proliferation algorithm on the FlowJo software in order to calculate the percentage of 
divided cells, the proliferation index and the number of cells in each generation of day four of cell culture 
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Figure 5.16 - Proliferation study of mesenteric lymph node CD4+ cells isolated from wild type and 
Stx11-/- mice activated in Th1 polarising conditions.  Mesenteric lymph nodes were isolated from 8 wild 
type and 8 Stx11-/- mice.  The mesenteric lymph nodes cell solution was enriched for CD4+ T-cells using 
Easysep isolation kits (stemcell).  Cells were stained with CFSE dye for 5 mins in PBS/FBS at RT before 
washing twice in PBS.  Cells were counted and plated at 2x106 cells/ml and stimulated with plate bound 
anti-CD3 antibody (5µg/ml) and soluble anti-CD28 antibody (2.5µg/ml) in Th1 polarising conditions.  
Cells were sampled daily removing 50µl of cells and staining with propidium iodide immediately before 
analysis on the BD FACS Aria.  The data was analysed using FlowJo analysis software (treestar).  Cells 
were gated on live cells and CFSE was plotted and analysed using the proliferation algorithm on the 
FlowJo software in order to calculate the percentage of divided cells, the proliferation index and the 
number of cells in each generation of day four of cell culture 
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Figure 5.17 - Cell viability study of naive CD4+ cells isolated from WT and Stx11-/- mice activated in 
Th1 and Th17 polarising conditions.  Spleens were isolated from 8 wild type and 8 Stx11-/- mice.  
Spleenocytes were enriched for Naïve CD4+ T-cells using Easysep isolation kits (Stemcell).  Cells were 
counted and plated at 2x106 cells/ml and stimulated with plate bound anti-CD3 antibody (5µg/ml) and 
soluble anti-CD28 antibody (2.5µg/ml) in Th1 polarising conditions.  Cells were sampled daily removing 
50µl of cells and staining with propidium iodide immediately before analysis on the BD FACS Aria.  The 
data was analysed using FlowJo analysis software (Treestar).  Cells were gated on live cells and the 
percentage of non-stained cells was plotted daily.  On day four cells were counted using a haemocytometer 
and trypan blue dead cell exclusion.  Cell numbers and viability on day four are means ±SEM of three 
groups each consisting of cells pooled from two mice.  An unpaired T-test was used to determine if 
differences between WT and Stx11-/- mice were significantly different (**p<0.01 and ***p<0.001). 
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Figure 5.18 - Cell viability study of splenic CD4+ cells isolated from WT and Stx11-/- mice activated in 
Th1 and Th17 polarising conditions.  Spleens were isolated from 8 wild type and 8 Stx11-/- mice.  
Spleenocytes were enriched for CD4+ T-cells using Easysep isolation kits (Stemcell).  Cells were counted 
and plated at 2x106 cells/ml and stimulated with plate bound anti-CD3 antibody (5µg/ml) and soluble anti-
CD28 antibody (2.5µg/ml) in Th1 polarising conditions.  Cells were sampled daily removing 50µl of cells 
and staining with propidium iodide immediately before analysis on the BD FACS Aria.  The data was 
analysed using FlowJo analysis software (Treestar).  Cells were gated on live cells and the percentage of 
non-stained cells was plotted daily.  On day four cells were counted using a haemocytometer and trypan 
blue dead cell exclusion.  Cell numbers and viability on day four are means ±SEM of three groups each 
consisting of cells pooled from two mice.  An unpaired T-test was used to determine if differences between 
WT and Stx11-/- mice were significantly different. 
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Figure 5.19 - Cell viability study of mesenteric lymph node CD4+ cells isolated from WT and Stx11-/- 
mice activated in Th1 and Th17 polarising conditions.  Mesenteric lymph nodes were isolated from 8 
wild type and 8 Stx11-/- mice.  The mesenteric lymph node cell solution was enriched for CD4+ T-cells 
using Easysep isolation kits (Stemcell).  Cells were counted and plated at 2x106 cells/ml and stimulated 
with plate bound anti-CD3 antibody (5µg/ml) and soluble anti-CD28 antibody (2.5µg/ml) in Th1 polarising 
conditions.  Cells were sampled daily removing 50µl of cells and staining with propidium iodide 
immediately before analysis on the BD FACS Aria.  The data was analysed using FlowJo analysis software 
(Treestar).  Cells were gated on live cells and the percentage of non-stained cells was plotted daily.  On day 
four cells were counted using a haemocytometer and trypan blue dead cell exclusion.  Cell numbers and 
viability on day four are means ±SEM of three groups each consisting of cells pooled from two mice.  An 
unpaired T-test was used to determine if differences between WT and Stx11-/- mice were significantly 
different 
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Figure 5.20 – mRNA expression of genes specific for Th1 and Th17 subsets in polarised cells from 
wild type mice.  Spleens were isolated from 8 wild type and 8 Stx11-/- mice.  Spleenocytes were enriched 
for Naïve CD4+ T-cells using Easysep isolation kits (Stemcell).  Cells were counted and plated at 2x106 
cells/ml and stimulated with plate bound anti-CD3 antibody (5µg/ml) and soluble anti-CD28 antibody 
(2.5µg/ml) in Th1 or Th17 polarising conditions for four days.  RNA was purified using the using 
nucleospin RNAII isolation columns (Macherey-Nage) and equalised amounts of RNA were converted to 
cDNA using the high capacity cDNA mastermix (Roche).  The cDNA was mixed with primers for Il17, 
Tbx21, Rorc, Il21, Il23r (IDT) and Ifnγ  (Sigma) and FAST SYBR Mastermix (Roche) before analysing 
samples on the ABI Prism 7500.  Groups were compared using relative quantitation; after normalising 
samples to TBP and GusB, the Th1 control group was normalised to 1.0 and the expression in other groups 
is shown relative to this value. Results are means ±SD of 3 groups with 2 mice in each group and measured 
in triplicate.  An unpaired T-test was used to determine if differences between groups were significantly 
different (***p<0.001). 
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Figure 5.21 - STX11 mRNA expression expression in Th1 and Th17 polarised cells from wild type 
and Stx11-/- mice.  Spleens were isolated from 8 wild type and 8 Stx11-/- mice.  Spleenocytes were enriched 
for Naïve CD4+ T-cells using Easysep isolation kits (Stemcell).  Cells were counted and plated at 2x106 
cells/ml and stimulated with plate bound anti-CD3 antibody (5µg/ml) and soluble anti-CD28 antibody 
(2.5µg/ml) in Th1 or Th17 polarising conditions for four days.  RNA was purified using the using 
nucleospin RNAII isolation columns (Macherey-Nage) and equalised amounts of RNA were converted to 
cDNA using the high capacity cDNA mastermix (Roche).  The cDNA was mixed with primers for Stx11 
(IDT) and FAST SYBR Mastermix (Roche) before analysing samples on the ABI Prism 7500.  Groups 
were compared using relative quantitation; after normalising samples to TBP and GusB, the Th1 control 
group was normalised to 1.0 and the expression in other groups is shown relative to this value. Results are 
means ±SD of 3 groups with 2 mice in each group and measured in triplicate.  An unpaired T-test was used 
to determine if differences between groups were significantly different (***p<0.001). 
 
 206 
RORγt
Wi
ld 
Ty
pe (-/
-
)
ST
X1
1
0.0
0.5
1.0
1.5
2.0
**
Re
la
tiv
e 
Ex
pr
es
si
o
n
T-Bet
Wi
ld 
Ty
pe (-/
-
)
ST
X1
1
0
1
2
3
4
5
**
Re
la
tiv
e 
Ex
pr
es
si
o
n
FoxP3
Wi
ld 
Ty
pe (-/
-
)
ST
X1
1
0
1
2
3
4
***
Re
la
tiv
e 
Ex
pr
es
si
o
n
 
Figure 5.22 – Transcription factors mRNA expression in Th17 polarised cells from wild type and 
Stx11-/- mice.  Spleens were isolated from 8 wild type and 8 Stx11-/- mice.  Spleenocytes were enriched for 
Naïve CD4+ T-cells using Easysep isolation kits (Stemcell).  Cells were counted and plated at 2x106 
cells/ml and stimulated with plate bound anti-CD3 antibody (5µg/ml) and soluble anti-CD28 antibody 
(2.5µg/ml) in Th17 polarising conditions for four days.  RNA was purified using the using nucleospin 
RNAII isolation columns (Macherey-Nage) and equalised amounts of RNA were converted to cDNA using 
the high capacity cDNA mastermix (Roche).  The cDNA was mixed with primers for Rorc, Tbx21 and 
Foxp3 (IDT) and FAST SYBR Mastermix (Roche) before analysing samples on the ABI Prism 7500.  
Groups were compared using relative quantitation; after normalising samples to TBP and GusB, the Th1 
control group was normalised to 1.0 and the expression in other groups is shown relative to this value. 
Results are means ±SD of 3 groups with 2 mice in each group and measured in triplicate.  An unpaired T-
test was used to determine if differences between groups were significantly different (**p<0.01 and 
***p<0.001). 
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Figure 5.23 – Transcription factors mRNA expression in Th1 polarised cells from wild type and 
Stx11-/- mice.  Spleens were isolated from 8 wild type and 8 Stx11-/- mice.  Spleenocytes were enriched for 
Naïve CD4+ T-cells using Easysep isolation kits (Stemcell).  Cells were counted and plated at 2x106 
cells/ml and stimulated with plate bound anti-CD3 antibody (5µg/ml) and soluble anti-CD28 antibody 
(2.5µg/ml) in Th1 polarising conditions for four days.  RNA was purified using the using nucleospin 
RNAII isolation columns (Macherey-Nage) and equalised amounts of RNA were converted to cDNA using 
the high capacity cDNA mastermix (Roche).  The cDNA was mixed with primers for Rorc, Tbx21 and 
Foxp3 (IDT) and FAST SYBR Mastermix (Roche) before analysing samples on the ABI Prism 7500.  
Groups were compared using relative quantitation; after normalising samples to TBP and GusB, the Th1 
control group was normalised to 1.0 and the expression in other groups is shown relative to this value. 
Results are means ±SD of 3 groups with 2 mice in each group and measured in triplicate.  An unpaired T-
test was used to determine if differences between groups were significantly different (**p<0.01 and 
***p<0.001). 
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Figure 5.24 – Cytokine mRNA expression in Th17 polarised cells from wild type and Stx11-/- mice.  
Spleens were isolated from 8 wild type and 8 Stx11-/- mice.  Spleenocytes were enriched for Naïve CD4+ T-
cells using Easysep isolation kits (Stemcell).  Cells were counted and plated at 2x106 cells/ml and 
stimulated with plate bound anti-CD3 antibody (5µg/ml) and soluble anti-CD28 antibody (2.5µg/ml) in 
Th17 polarising conditions for four days.  RNA was purified using the using nucleospin RNAII isolation 
columns (Macherey-Nage) and equalised amounts of RNA were converted to cDNA using the high 
capacity cDNA mastermix (Roche).  The cDNA was mixed with primers for Il17, Il2, Il21, Il10 (IDT) and 
Ifnγ (Sigma) and FAST SYBR Mastermix (Roche) before analysing samples on the ABI Prism 7500.  
Groups were compared using relative quantitation; after normalising samples to TBP and GusB, the Th1 
control group was normalised to 1.0 and the expression in other groups is shown relative to this value. 
Results are means ±SD of 3 groups with 2 mice in each group and measured in triplicate.  An unpaired T-
test was used to determine if differences between groups were significantly different (*p<0.05, **p<0.01 
and ***p<0.001). 
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Figure 5.25 – Cytokine mRNA expression in Th1 polarised cells from wild type and Stx11-/- mice.  
Spleens were isolated from 8 wild type and 8 Stx11-/- mice.  Spleenocytes were enriched for Naïve CD4+ T-
cells using Easysep isolation kits (Stemcell).  Cells were counted and plated at 2x106 cells/ml and 
stimulated with plate bound anti-CD3 antibody (5µg/ml) and soluble anti-CD28 antibody (2.5µg/ml) in Th1 
polarising conditions for four days.  RNA was purified using the using nucleospin RNAII isolation columns 
(Macherey-Nage) and equalised amounts of RNA were converted to cDNA using the high capacity cDNA 
mastermix (Roche).  The cDNA was mixed with primers for Il17, Il2, Il21, Il10 (IDT) and Ifnγ (Sigma) and 
FAST SYBR Mastermix (Roche) before analysing samples on the ABI Prism 7500.  Groups were 
compared using relative quantitation; after normalising samples to TBP and GusB, the Th1 control group 
was normalised to 1.0 and the expression in other groups is shown relative to this value. Results are means 
±SD of 3 groups with 2 mice in each group and measured in triplicate.  An unpaired T-test was used to 
determine if differences between groups were significantly different (*p<0.05, **p<0.01 and ***p<0.001). 
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Figure 5.26 – cytokine receptor Cytokine mRNA expression Th17 polarised cells from wild type and 
Stx11-/- mice.  Spleens were isolated from 8 wild type and 8 Stx11-/- mice.  Spleenocytes were enriched for 
Naïve CD4+ T-cells using Easysep isolation kits (Stemcell).  Cells were counted and plated at 2x106 
cells/ml and stimulated with plate bound anti-CD3 antibody (5µg/ml) and soluble anti-CD28 antibody 
(2.5µg/ml) in Th17 polarising conditions for four days.  RNA was purified using the using nucleospin 
RNAII isolation columns (Macherey-Nage) and equalised amounts of RNA were converted to cDNA using 
the high capacity cDNA mastermix (Roche).  The cDNA was mixed with primers for Ifnγrα, Il2r,and Il23r 
(IDT) and FAST SYBR Mastermix (Roche) before analysing samples on the ABI Prism 7500.  Groups 
were compared using relative quantitation; after normalising samples to TBP and GusB, the Th1 control 
group was normalised to 1.0 and the expression in other groups is shown relative to this value. Results are 
means ±SD of 3 groups with 2 mice in each group and measured in triplicate.  An unpaired T-test was used 
to determine if differences between groups were significantly different (***p<0.001). 
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Figure 5.27 – cytokine receptor Cytokine mRNA expression Th1 polarised cells from wild type and 
Stx11-/- mice.  Spleens were isolated from 8 wild type and 8 Stx11-/- mice.  Spleenocytes were enriched for 
Naïve CD4+ T-cells using Easysep isolation kits (Stemcell).  Cells were counted and plated at 2x106 
cells/ml and stimulated with plate bound anti-CD3 antibody (5µg/ml) and soluble anti-CD28 antibody 
(2.5µg/ml) in Th1 polarising conditions for four days.  RNA was purified using the using nucleospin 
RNAII isolation columns (Macherey-Nage) and equalised amounts of RNA were converted to cDNA using 
the high capacity cDNA mastermix (Roche).  The cDNA was mixed with primers for Ifnγrα Il2r,and Il23r 
(IDT) and FAST SYBR Mastermix (Roche) before analysing samples on the ABI Prism 7500.  Groups 
were compared using relative quantitation; after normalising samples to TBP and GusB, the Th1 control 
group was normalised to 1.0 and the expression in other groups is shown relative to this value. Results are 
means ±SD of 3 groups with 2 mice in each group and measured in triplicate.  An unpaired T-test was used 
to determine if differences between groups were significantly different (***p<0.001). 
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5.3– DISCUSSION 
The results from chapter 4 propose a regulatory function for STX11 in Th17 cells.  
STX11 is up-regulated in Th17 cells when compared to Th1 cells suggesting a role for 
STX11 in IL-17 trafficking.  STX11 is enriched in immune cells and is expressed at high 
levels in the thymus, spleen and lymph nodes (Prekeris et al. 2000).  The importance of 
STX11 in the immune system is highlighted by a deficiency in humans that results in the 
immune deficiency syndrome, hemophagocytic lymphohistiocytosis (HLH).  In 
particular, a familial form of HLH (FHL-4) is characterised by a mutation in Stx11.  
Infection in patients with FHL-4 can lead to uncontrolled and ineffective immune 
responses with symptoms including hyperinflammation, cytopenias and 
haemophagocytosis.  Hemophagocytosis is a characteristic feature of the syndrome and 
although it may be initially absent, it is the primary manifestation of FHL and 
distinguishes it from other immune deficiency syndromes (Janka 2012).  Identification of 
FHL-4 as a STX11 autosomal recessive disorder led to cells from these patients being 
used to investigate dysfunctions in the immune response in the absence of STX11, 
particularly CTLs, NK cells and phagocytic macrophages.   
A mouse model of FHL-4 was recently established in two independent labs using Stx11-/- 
mice generated in-house.  Infection of STX11 deficient mice with the lymphocytic 
choriomeningitis virus (LCMV) reproduced manifestations of FHL (Kögl et al. 2013; 
Sepulveda et al. 2013).  The mice were generated by the deletion of exon 3 (the only 
coding  exon in Stx11) in a C57BL/6 background which led to a STX11 protein 
expression defect (Sepulveda et al. 2013).  The mice had normal immune cell 
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development and proportions of NK, B, T and APC cells in the thymus, lymph nodes and 
spleen.  Furthermore, normal ratios of CD8+ to CD4+ T-cells were observed (Sepulveda 
et al. 2013).  When infected with LCMV the mice displayed impaired degranulation in 
CTL and NK cells associated with HLH.  The role of CD4+ T-cells in this model was not 
investigated despite the vital role of CD4+ T-cells in inflammation, a clear role of other 
T-cells in the progression of this disease, and the possible haemopoetic conservation of 
mechanisms between CD4+ and CD8+ T-cells (Starr et al. 2003).  Through collaboration 
with Silvia Bulfone-Paus in the Borstel Research Centre in Germany cells from Stx11-/- 
mice were obtained in order to investigate the regulatory role of STX11 in CD4+ T-helper 
cells.  CD4+ T-cells were isolated from the spleen and mesenteric lymph nodes of wild 
type and Stx11-/- mice.  Given that Th17 cells play a central role in gut immune regulation 
and that the in vivo data collected from the colitis models in the previous chapter 
indicated an increase in STX11 mRNA expression when IL-17 is highly expressed, both 
spleen and mesenteric lymph node cells (MLN) were isolated for comparison.  MLNs are 
the draining lymph nodes located along the colon and contain high amounts of CD4+ T-
cells.  CD4+ T-cells were isolated from the spleen and MLNs using the Easysep negative 
isolation kit (stemcells).  The CD4+ enriched cell solution consisted of naïve and memory 
phenotype CD4+ T-cells.  Memory phenotype cells are generated during an immune 
response when cells react to an antigen during inflammation.  Some of these responders 
survive and form antigen-specific memory T-cells that can mount an efficient immune 
response following future interactions with the antigen.  However, memory T-cells are 
also found in small numbers in normal naïve mice, accounting for 10-20% of T-cells in 
young mice (Sprent & Surh 2011).  This conversion into a memory phenotype is due in 
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part to environmental antigens, but also priming by self antigens, as these cells are 
present in neonates and mice maintained in germ and antigen free environments (Sprent 
& Surh 2011).  These cells consist of central and effector memory cells that may be 
already committed to a specific T-helper cell lineage.  The presence of these cells can 
influence the polarisation and cytokine secretion of the cells in culture.  Therefore, naïve 
isolated T-helper cells were enriched to exclude central and effector memory CD4+ cells.  
When polarised they represent pure subsets with minimal contaminating cells secreting 
cytokines that could influence the cells polarisation or mask the pure naïve polarised cell 
response.  These cells represent a small percentage of the total spleenocytes (5-10%) but 
they are capable of cloning into measured responses and can produce high levels of 
cytokine.  Although these cells are isolated from the spleen, they will be referred to as the 
naïve cell population, while CD4+ cell populations from the spleen and mesenteric lymph 
nodes will be referred to as splenic and MLN populations. 
Using these populations from WT and Stx11-/-
 
mice, the cytokine secretion levels were 
evaluated following four days of culture in Th1 or Th17 polarising conditions.  The naïve 
WT cells cultured and polarised in Th17 conditions produced high levels of IL-17 as 
expected.  This was dramatically reduced in the Stx11-/- naïve Th17 cells.  Taken in 
isolation, this would suggest that STX11 is involved in secretion of IL-17 as the results in 
the previous chapter would suggest.  However, this reduction in IL-17 secretion was not 
observed in the splenic or MLN Th17 polarised cells.  As this population contains central 
and effector memory cells that are already committed to the Th17 lineage, and secreting 
IL-17, it is possible that the lack of Stx11-/- may not have a specific effect on trafficking 
of IL-17 in CD4+ T-helper cells, but rather affect the polarisation and commitment to a 
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Th17 subset.  Indeed, the IL-17 cytokine levels measured in the Th1 polarised cells from 
naïve, splenic and MLN populations were low as expected but no significant change 
observed between the cell populations, further indicating no effect on the secretion of IL-
17 in the absence of STX11. 
The reduction in cytokine levels in the naïve Th17 cells from Stx11-/- mice was not 
exclusive to IL-17.  IL-10, TNF-α and IL-21 were all significantly reduced in the cells 
isolated from Stx11-/- mice.  However, IFN-γ was significantly increased in Th17 
polarised cells from Stx11-/- mice.  Although levels were low in comparison to Th1 cells, 
the concentration in the supernatants of cells from Stx11-/- mice was 2-fold higher 
compared to the WT cells.  Furthermore, IFN-γ was also significantly increased in both 
the splenic and MLN CD4+ Th17 polarised cells from Stx11-/- mice, showing consistency 
in both the naïve and memory cells.  Surprisingly, this increase was not observed in the 
supernatants from Stx11-/- mice polarised into IFN-γ producing Th1 cells from the naïve, 
splenic or MLN populations.   
The decrease in IL-17 is specific to the naïve Th17 cells from Stx11-/- mice but not the 
mixed naïve and memory populations.  Furthermore, the lack of IL-17 secretion and 
measured increase in IFN-γ would suggest that these are not in fact Th17 polarised cells 
despite the environment in which they were stimulated.  There is a significant reduction 
in the concentration of IL-21 measured in the supernatants from the naïve Stx11-/- Th17 
polarised cells which would also suggest a problem with the polarisation of these cells.  
Upon activation in the presence of IL-6, T-helper cells induce IL-21 production which 
initiates a positive feed back loop in Th17 cell polarisation and drives IL-17 production in 
a STAT3 dependant manner (Wei et al. 2007).  There is no difference in the IL-21 
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concentration measured in the supernatants of CD4+ splenic cells from WT and Stx11-/- 
mice and there is an increase in IL-21 in the MLN supernatants from Stx11-/- mice.  There 
is also no change in the IL-17 levels in these cells which would again suggest inhibition 
of Th17 polarisation of naïve cells from the Stx11-/- mice alone.  The presence of effector 
memory cells in the splenic and MLN CD4+ population is the main difference between 
these cells and the naïve population.  Given that they secrete IL-17 and IL-21 at normal 
levels, perhaps they are only mildly affected by the lack of STX11 due to the presence of 
memory Th17 cells.   
TNF-α is significantly reduced in the Stx11-/- cells, at less than half the concentration 
measured for the WT Th17 polarised cells.  TNF-α production has been reported in Th17 
cells and a study by Veldhoen et al (2006) demonstrated that the addition of TNF-α can 
augment the IL-17 response from Th17 cells.  However, a previous study using TNF-α-/- 
mice has shown that TNF-α is not necessary for the generation of IL-17 producing cells 
(Nakae et al. 2002), leading Veldhoen et al (2006) to surmise that TNF-α secreted 
primarily from APCs aids in the augmentation of Th17 responses.  However, despite 
there being no apparent requirement for TNF-α in the polarisation of Th17 cells, it is 
possible that TNF-α secreted by Th17 cells acts in an autocrine manner to enhance IL-17 
production in these cells.  TNF-α secretion is indeed decreased in the naïve Stx11-/- cells 
but is increased in the supernatants from the splenic CD4+ Th17 polarised cells from 
Stx11-/- mice.  This may be due to other sources of TNF-α in the mixed cell population.   
IL-10 production was initially associated with Th2 cells and identified as having a 
suppressive effect on the Th1 population (Fiorentino 1989).   IL-10 is also a characteristic 
cytokine of Tregs which suppresses T-helper cells in the immune response, particularly 
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Th17 cells, and controls inflammation (Wing & Sakaguchi 2010).  Recently IL-10 
production has been associated with Th1 polarised cells and is thought to act through a 
self-limiting, negative feed back loop late in T-cell activation.  IL-10 suppression 
contracts the Th1 cell population following the immune response and controls 
inflammation when clearing infection (Trinchieri 2007).  IL-10 secretion is not limited to 
Th1 and Th2 cells, and Th17 cells have been demonstrated to secrete IL-10 in what is 
thought to be part of a self-limiting mechanism.  A detailed epigenetic study of the Th17 
cell polarisation programme demonstrated the induction of IL-10 family regulatory 
cytokines in the “transition to late phase” stage of polarisation (Yosef et al. 2013).  
Furthermore, in pathogenic models of disease, IL-10 secretion from Th17 cells was 
demonstrated following continuous antigen stimulation in which Th17 cells down-
regulated IL-17 production and up-regulated IL-10 (Zielinski et al. 2012).  This IL-10 
secretion in the late stage of the inflammation is thought to be more prevalent in non-
pathogenic Th17 cells that do not switch to IFN-γ/IL-17 double producers.  As discussed 
in earlier chapters these cells are programmed in the absence of TGF-β, however IL-β has 
also been linked to this control during infection in vivo (Zielinski et al. 2012) and was 
present in the Th17 polarising cocktail when these cells were activated.  IL-10 production 
is significantly reduced in the naïve Stx11-/- Th17 polarised cells.  The fact that Il10 gene 
induction occurs early (t=20hr) in the Th17 cell polarisation programming (Yosef et al. 
2013), and is significantly reduced in these cells, indicates further the inhibition of Th17 
cell polarisation as the reason for the reduction in IL-17 production.   
In order to investigate the loss of IL-17, and the hypothesis that Th17 differentiation in 
the naïve cells from the Stx11-/- mice is inhibited, the cells were stained for the 
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transcription factor RORγt.  The cells were stained at 18hr, the point at which Th17 
polarised cells highly express RORγt as shown in chapter 3 and by others (Yosef et al. 
2013).  In agreement with the cytokine analysis of these cells, there were fewer RORγt 
expressing cells in not only the naïve, but also the splenic and MLN Th17 polarised cells 
from the Stx11-/- mice.  This under expression of the master regulator for Th17 cells at 
18hrs would indicate that the polarisation of the Th17 cells was affected in the absence of 
STX11.  As IL-17 production is controlled by the transcription of RORγt via activation of 
STAT3 and transcription of the Il17a gene, this would directly effect IL-17 production 
and offer an explanation for the significant decrease in IL-17 concentration in the 
supernatant of these cells.   
To confirm the decrease in IL-17 production in the naïve Th17 polarised cells from Stx11-
/-
 mice, the cells were re-stimulated with PMA and ionomycin in the presence of 
monensin, trapping any cytokine produced by the cell in the golgi apparatus.  The cells 
produce cytokine according to their transcriptional programming and the cytokine is 
trapped in the golgi apparatus allowing for stable intracellular cytokine staining.  This 
allows for the assessment of the percentage of the cell population producing IFN-γ and 
IL-17 after four days of culture in vitro.  Intracellular staining for IL-17 and IFN-γ in the 
naïve Th17 polarised cells from the WT and Stx11-/- mice confirmed the decrease in IL-
17 producing cells.  This decrease was not observed in the mixed CD4+ splenic and MLN 
isolated cells suggesting that this is a result of the naïve cells not polarising into IL-17 
producing cells.  Also of interest was the IFN-γ production from these cells.  Although 
IFN-γ is produced in very small amounts in Th17 polarising conditions, there was an 
increase in the percentage of IFN-γ producing cells in the CD4+ splenic and MLN 
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isolated Th17 polarised cells.  This result was also supported by the increase in the 
concentration of IFN-γ in the supernatants of Th17 polarised cells from Stx11-/- mice.  
However, despite the significant increase in IFN-γ in the supernatants of naïve Th17 
polarised Stx11-/- cells, there was no increase observed in the percentage of IFN-γ 
producing naïve Th17 polarised cells.   
Intracellular staining of the naïve Th1 polarised cells demonstrated an almost 2-fold 
increase in the number of IFN-γ producing cells from Stx11-/- mice compared to WT.  
This was not reflected in the supernatants collected from these cells after four days 
culture in vitro.  This increase in IFN-γ producing cells was also not observed in the 
CD4+ splenic and MLN cells isolated from Stx11-/- mice.  It is possible that there is a 
suppressive effect on the cells from a population of central or effector memory cells that 
is not present in the naïve cell population, or that the cells have undergone a high number 
of cell divisions and this has lead to a decreased ability to produce IFN-γ at gene 
expression level.  The MLN and splenic cells contain a complex mix of memory and 
naïve phenotype cells that make it difficult to come to a conclusion without defining 
these cell populations.  
In order to determine if the cell viability or proliferation was affected by STX11 
deficiency, the proliferation and cell numbers of the different cell populations were 
studied in more detail.  CFSE stably labels cytosolic molecules in the cell and the 
division of cells equally divides the dye resulting in a sequential halving of fluorescence.  
This allows for quantitation of the number of dividing cells in each generation of stained 
cells (Quah et al. 2007).  Using this information it is possible to build a proliferation 
profile in order to compare the proliferation of polarised cells from WT and Stx11-/- mice.  
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The number of cells and viability over the four days of in vitro culture were also assessed 
for all WT and Stx11-/- cells from naïve, splenic and MLN populations.  The naïve Th17 
polarised cells show an immediate difference in the proliferation profiles of the cells from 
WT and Stx11-/- mice.  The number of cells divided and the division index is significantly 
reduced.  These cells show a similar viability >90% following four days in vitro, however 
when the cells were counted on day four, there is almost 3-fold increase in the number of 
WT naïve Th17 polarised cells compared to those isolated from Stx11-/- mice.  Therefore, 
the proliferation of these cells is greatly affected in the absence of STX11.  This may be 
due to the apparent inhibitory effects of STX11 deficiency on Th17 differentiation.  The 
commitment and expansion of Th17 cells is dependant on the IL-23 receptor (IL-23R) 
(McGeachy et al. 2009) and its expression is significantly down-regulated in Th17 
polarised cells from Stx11-/- mice.  The inhibition of Th17 differentiation in these cells 
seems to have led to IL-23R not being up-regulated and not allowing the cells to expand, 
however still maintaining cell viability.  In the absence of Th17 polarisation, our data 
shows that the growth factor IL-2 can expand undifferentiated cells, this has been also 
been shown by others (Liao et al. 2011). However, supernatants measured from these 
cells show low levels of IL-2 in WT and Stx11-/- samples.  Therefore the reduction in cell 
numbers can be explained by the inhibition of Th17 cell polarisation of these cells.  This 
would also contribute to the reduced levels of IL-17 measured in the supernatants of these 
cells.  This abated proliferation of the naïve Th17 polarised cells from the Stx11-/- mice is 
also seen to a lesser extent in the CD4+ cells isolated from the spleen and MLN of these 
mice.   
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The increase in the percentage of IFN-γ producing cells in the naïve Th1 polarised cells 
from Stx11-/- mice is contradictory to the measured levels of IFN-γ in the supernatants 
from these cells.  Measured concentrations of IFN-γ in supernatants from Th1 Stx11-/- 
cells show no significant change when compared to Th1 polarised cells from WT mice.  
However, the proliferation profile of the naïve cells revealed a deficiency in the 
proliferation of naïve Th1 polarised cells from Stx11-/- mice.  The naïve cells show a 
dramatically reduced proliferation rate with the percentage of divided cells dropping from 
75% in the WT cells to just 35% in the cells from Stx11-/- mice.  The division index is 
also reduced from 1.3 to just 0.5 average divisions per cell.  This was not observed in the 
splenic or MLN CD4+ isolated cells.  There is a measured increase in the number of IFN-
γ producing cells following re-stimulation on day four, as well as an increase in IFN-γ 
mRNA expression.  However, proliferation deficiency may account for no measured 
increase in IFN-γ in the supernatants from naïve Th1 Stx11-/- cells.  Over-expression of 
IFN-γ by the naïve Th1 Stx11-/- cells may induce an early T-cell phenotype change.  This 
would account for the lack of proliferation despite the similar cell numbers and viability 
compared to the cells from the WT mice.  Th1 cells undergo a change in phenotype 
following constant antigenic stimulation and secretion.  This cell phenotype is 
characterised by production of IL-10 which is increased in concentration in the 
supernatants from the Stx11-/- cells.  Interestingly, Th1 cells have been shown to have an 
increased capacity to produce IFN-γ following successive rounds of proliferation (Gett 
1998).  It is possible that the over-expression of IL-10 in the Stx11-/- cells triggers an 
early phenotypic change usually controlled by over production of IFN-γ in proliferating 
Th1 cells.  The Stx11-/- cells also have a measured increase in IL-21, which has also been 
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demonstrated to be secreted in high levels by late Th1 polarised cells in infection (Sarra 
et al. 2010).  IL-21 induces IL-10 secretion and may act in a self limiting negative feed 
back loop with IL-10.  Switching off of IL-2 production is also a hallmark of T-cell 
exhaustion (Wherry 2011) and this is demonstrated in these cells by a reduction in the 
measured levels of IL-2 in the supernatants from the naïve Th1 polarised cells from 
Stx11-/- mice.   
The data suggest that there is a dysregulation in the IFN-γ secretion from the naïve Th1 
and Th17 polarised cells from Stx11-/- mice which is causing over secretion of IFN-γ in 
the Th1 cells and also causing inhibition of Th17 differentiation in vitro.  To investigate 
this inhibition of Th17 polarisation and the effects of over expression of IFN-γ in Th1 
cells, RNA was isolated from the naïve Th1 and Th17 polarised, WT and Stx11-/- cells.  
mRNA levels were assessed to determine gene expression following four days of  in vitro 
cell culture.  The Th17 polarised Stx11-/- cells showed a significant increase in T-bet and 
FoxP3 mRNA expression relative to the WT cells.  Flow analysis of these cells clearly 
indicated a measured decrease in RORγt expression at 18hrs compared to the WT cells.  
From these results it would seem that the Stx11-/- cells are unable to effectively 
differentiate into Th17 cells when stimulated in polarising conditions due to the presence 
of over produced IFN-γ.  It is clear that these cells did not polarise into a classical Th17 
subset of cells in the absence of STX11.   
Taking these results together there is clear evidence for dysregulation of IFN-γ secretion 
in Th1 and Th17 cells lacking STX11.  In Naïve T-helper cells this has the effect of 
driving Th1 into a self limiting phenotype producing IL-21 and IL-10 and down-
regulating activating surface markers IFN-γR1 and IL-2Rα, leading to a suppression of 
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proliferation in vitro.  These cells are still capable of producing IFN-γ when restimulated 
directly via PKC in contrast to the splenic and MLN cells which have undergone 4-5 
rounds of division.   
In Th17 polarised cells, the apparent lack of control of IFN-γ in cells from Stx11-/- mice at 
the early stages of polarisation disrupts the programming of these cells into Th17 cells.  
The presence of IFN-γ inhibits Th17 polarisation and this is evident by the decrease in 
RORγt expression at 18hrs and a decrease in IL-17 and IL-21 production, which was 
confirmed at mRNA level.  This is supported by a decrease in IL-23R and IL-17 mRNA 
expression in the Stx11-/- cells.  Increased expression of FoxP3 and T-bet in the Stx11-/- 
cells were also indicative of a non-classical Th17 polarised phenotype of cells.   
Taken together, results obtained in the Th1 and Th17 models individually indicate a 
regulatory role for STX11 in IFN-γ secretion.  This suggests an early requirement for 
STX11 induction in naïve T-helper cells necessary for polarisation of cells into a Th17 
cell subtype via control of IFN-γ secretion.   
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6.1– GENERAL DISCUSSION 
Th17 cells are essential in the clearance of extracellular pathogens.  They maintain gut 
homeostasis in a careful balance with regulatory T-cells, but in their capacity to produce 
IL-17 and other pro-inflammatory cytokines needed to clear infection, they have also been 
implicated in the induction of several autoimmune diseases (Bettelli et al. 2007).  Cytokine 
signalling from Th17 and other T-helper cells is central to the regulation of the adaptive 
immune response but despite this, there is little known about the trafficking pathways 
involved in cytokine exocytosis from these cells.  SNAREs have been identified as 
fundamental trafficking proteins required for intracellular membrane-membrane fusion 
events in eukaryotic cells (Jahn & Scheller 2006).  Furthermore they are localised and carry 
out their function in specific organelles which has allowed researchers to “map out” the 
specific trafficking pathway of cytokines from immune cells.  This has led to the mapping 
of TNF-α secretion from macrophages and elucidation of an original exocytotic pathway 
through recycling endosomes that is implicitly linked to the phagocytic activity of these 
cells (Stow et al. 2006).  Identification of these trafficking pathways and the proteins that 
regulate them will lead to a better understanding of cytokine secretion  during inflammation 
and may present potential therapeutic targets in disease.   
In this study we have identified a regulatory requirement for the SNARE syntaxin 11 
(STX11) in IFN-γ control in T-helper cells.  Further more there is a requirement for STX11 
regulation of IFN-γ for naïve T-helper cells to undergo efficient Th17 cell polarisation.  
IFN-γ is a potent inhibitor of Th17 cell polarisation via its suppression of the master 
regulator transcription factor RORγt.  IFN-γ induces T-bet expression in activated T-helper 
cells and this inhibits RORγt expression driving T-cells in the direction of a Th1 phenotype  
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and in order to efficiently polarise a Th17 cell population in vitro, antibodies are added to 
neutralise IFN-γ activity (Lazarevic et al. 2011).  Activated T-helper cells are capable of 
producing large amounts of IFN-γ within hours of TCR activation and Ifnγ gene expression 
is not repressed in polarised Th17 cells until the late to transition phase of the 
differentiation programme at 20hrs when the Il17 cytokine gene is induced (Yosef et al. 
2013).  Therefore further regulatory mechanisms are required to control early secretion of 
IFN-γ and allow naïve T-helper cells to polarise into a Th17 cell subset. 
STX11 is not like a typical syntaxin SNARE as it lacks a transmembrane domain.  Despite 
this fact, STX11 still appears to be a syntaxin protein in that it is ~35kDa in size with two 
identified regions capable of forming coiled-coil structures to facilitate zippering with other 
SNARE proteins.  It has been shown to bind with SNAP23 and VAMP2 efficiently in vitro 
demonstrating typical SNARE behaviour (Valdez et al. 1999).  STX11 has also been 
localised on cell membranes despite the absence of an anchoring domain.  This may be due 
in part to the presence of a C-terminal cysteine rich domain which is an ideal target site for 
palmitoylation.  Palmitoylation is not unusual in SNARE regulation and has been studied in 
the SNAP25 family, including the immune rich variant SNAP23 (Pallavi & Nagaraj 2003).  
Although STX11 has a cysteine rich domain that is a putative palmitoylation site, Prekeris 
et al (2000) demonstrated that this site was not necessary for STX11 to associate with the 
membrane.  Instead they show that STX11 binds to other SNARE proteins and that its 
membrane association is dependant on this interaction.  Furthermore, they show that in the 
presence of α-SNAP and NSF, when NSF activity is inhibited STX11 is not assembled in a 
20S complex with other SNAREs.  The authors discovered that STX11 dissociated to its 
monomeric form and did not form part of a complex suggesting that STX11, despite its 
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ability to bind to other SNAREs, does not form part of a typical SNARE complex.  In this 
study Prekeris et al (2000) suggested that STX11 may play a regulatory role by competing 
with transmembrane bound SNAREs and preventing SNARE assembly and fusing of 
membranes. 
The idea that STX11 can act in a regulatory manner was later explored in a study in which 
Offenhäuser et al (2011) demonstrated that STX11 binds to Vti1b and makes Vti1b 
unavailable for the formation of membrane fusing SNARE complex’s in macrophages.  
The authors show that Vti1b is involved in late endosome, lysosome and membrane 
transport, and that a loss of STX11 results in an increase in this trafficking to the cell 
surface, contributing to increased phagocytosis (Offenhäuser et al. 2011).  Offenhäuser et 
al  (2011) also showed that in normal conditions STX11 forms part of a large SNARE 
complex.  However, when NSF activity is inhibited using NEM, SNAREs remain in a trans 
SNARE complex and STX11 is eluted in a smaller monomeric form, not forming part of a 
typical complex.  This corroborates the observations made by Prekeris et al (2000) and 
their hypothesis that STX11 plays a regulatory role in immune cell function through 
competitive binding of fusogenic SNAREs preventing complex formation (Prekeris et al. 
2000). 
Our data has shown that in vitro Th17 polarised cells increased expression of STX11 
following activation but levels remain low in naïve and IFN-γ producing Th1 cells.  
Furthermore, the expression of STX11 is increased in Th17 mediated models of 
inflammation in vivo when levels of IL-17 mRNA are increased and there is little or no 
IFN-γ mRNA expression.  To our knowledge, this is the first study showing regulation of a 
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SNARE protein in a model of inflammatory disease and suggests that STX11 is involved in 
regulating the Th17 response in vivo.   
Our data also shows that naïve T-helper cells from STX11 deficient mice were unable to 
efficiently differentiate into a Th17 subset in vitro compared to wild type cells.  Cells from 
Stx11-/- mice had a reduced number of IL-17 producing cells, decreased expression of 
RORγt  and low mRNA expression of essential Th17 related genes expressing IL-23R and 
IL-21.  Interestingly this population also had increased numbers of IFN-γ producing cells, 
higher levels of secreted IFN-γ in the supernatant and increased IFN-γ and T-bet mRNA 
expression compared to WT cells.  Furthermore, Th1 polarised cells from the Stx11-/- mice 
showed a significant increase in the number of IFN-γ producing cells.  Dysregulation of 
IFN-γ production in T-cells from Stx11-/- mice has been previously described.  In two 
studies confirming STX11 involvement in dysfunctional degranulation from CD8+ T-cells, 
the authors also describe significantly increased levels of IFN-γ from these cells (Kögl et 
al. 2013; D’Orlando et al. 2013).   
IFN-γ inhibits the differentiation of purified naïve CD4+ T-cells into a Th17 cell subset 
(Lazarevic et al. 2011).  We propose that in order to effectively polarise into Th17 cells, 
naïve T-cells activated in Th17 conditions upregulate STX11 in order to control basal 
secretion of IFN-γ production and prevent inhibition of Th17 differentiation.  RORγt 
expression is decreased in Stx11-/- mice at 18hrs indicating that early stage Th17 
polarisation may be inhibited by the increased levels of IFN-γ present; therefore STX11 
expression is required early in the differentiation programme.  Interestingly, STAT3 
deficient mice fail to upregulate IL-17 and fail to induce severe disease in an EAE mouse 
model of multiple sclerosis (MS) (Yang et al. 2007).  Early STAT3 activation is critical and 
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can be provided by a combination of IL-1, IL-6 and IL-21.  Naïve CD4+ T-cells are capable 
of differentiating into Th17 cells in the absence of IL-6 once IL-21, IL-23 and TGF-β are 
present (Korn et al. 2007).  Similarly, Th17 cells can be generated in vivo in Il21-/- or Il21R-
/-
 mice when IL-1β, IL-6 and TNFα are present (Sonderegger et al. 2008).  These conditions 
resulted in diminished Th17 responses, and strong STAT3 activation may be required to 
increase STX11 expression and the regulation of IFN-γ necessary for efficient Th17 
polarisation.   
Our data shows that TGF-β1 is also dispensable in the generation of Th17 cells in the 
presence of IL-6, IL-1β and IL-23; however, the total numbers of IL-17 producing cells 
were significantly reduced.  This is in agreement with a study by Ghoreschi et al (2010) 
who also demonstrated that Th17 cells generated in the absence of TGF-β1 expressed both 
RORγt and T-bet transcription factors.  As well as demonstrating a reduced number of IL-
17 producing cells, of particular interest is the fact that these cells were shown to be 
capable of becoming double producers of IFN-γ and IL-17 (Ghoreschi et al. 2010).  
Interestingly, in our study and the study carried out by Ghoreschi et al (2010), an anti-IFN-
γ antibody was used to neutralise its activity in vitro to generate Th17 cells in the absence 
of TGF-β1.  We would therefore suggest that TGF-β may responsible for driving STX11 
expression in order to regulate IFN-γ expression.   
In fact the naïve T-helper cells from Stx11-/- mice polarised in Th17 conditions show the 
same characteristics as the Th17 cells generated in the absence of TGF-β1 described in 
detail by Ghoreschi et al (2010).  Rorc (RORγt) and Il17 promoter region trimethylation 
was decreased in the cells polarised in the absence of TGF-β.  Rorc mRNA expression was 
also reduced (Ghoreschi et al. 2010), correlating with our data showing reduced Rorc and 
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Il17 mRNA expression in Stx11-/- Th17 polarised cells.  Our data also shows that naïve 
Th17 polarised Stx11-/- cells had reduced numbers of IL-17 producing cells and increased 
IFN-γ and T-bet mRNA expression, as well as a measured increase in IFN-γ in the 
supernatants from these cells.  Furthermore, Ghoreschi et al (2010) showed that cells 
generated in the absence of TGF-β1 do not express IL-10.  Our data shows that 
supernatants from Stx11-/- cells activated in Th17 polarising conditions have a significanlty 
reduced concentration of IL-10, and IL-10 mRNA expression in these cells is also 
significantly decreased compared to the wild type cells.  Therefore naïve Th17 cells  
polarised in the absence of TGF-β1 have the same characterisitcs as naïve Th17 Stx11-/- 
cells and TGF-β signalling may lead to increased expression of STX11 to control IFN-γ 
production in Th17 polarisation.  The exact role of TGF-β in Th17 differentiation is not 
fully understood and it is believed to inhibit T-bet expression in order to allow RORγt 
transcription and polarisation of a Th17 subset (Lee et al. 2009).  TGF-β1 has been shown 
to inhibit Th1 cell development which is in part due to the suppression of T-bet (I.-K. Park 
et al. 2005).  IFN-γ is a potent activator of T-bet and TGF-β may also induce STX11 
expression in order to control IFN-γ production and break the feedback loop.  Furthermore, 
studies in mice expressing a mutant form of TGF-β subunit receptor II (dnTGF-βRII) on T-
cells demonstrate that it interferes with the generation of Th17 cells in an EAE mouse 
model of MS (Ghoreschi et al. 2010).  The lamina propria of these mice had reduced 
numbers of IL-17 producing CD4+ T-cells.  Interestingly, there was also increased 
proportions of IFN-γ producing CD4+ T-cells in the dnTGF-βRII mice compared to wild 
type, which was also confirmed in mice lacking TGF-R1 on CD4+ T-cells (Ghoreschi et al. 
2010). 
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Systematically high concentrations of IFN-γ are also found in patients with the STX11 
deficiency culminating in the autoimmune disorder Familial hemophagocytic 
lymphohistiocytosis – 4 (FHL-4).  These patients present with fever, cytopenia and hyper-
inflammation and are prone to autoimmune disease.  Characteristic traits of disease are 
over-activation of macrophages leading to hemophagocytosis, and impaired CD8+ T-cells 
and NK cell cytotoxicity (Janka 2012).   
As discussed above, loss of STX11 regulation in macrophages leads to the increased 
phagocytosis and TNF-α secretion that is observed in FHL-4 patients (Offenhäuser et al. 
2011).  The authors also suggested a role for STX11 in regulation of dendritic cells (DCs).  
STX11 transcription and protein expression is up-regulated in bone marrow-derived DCs 
(BMDCs) within 24hrs suggesting STX11 is regulated in these cells (Offenhäuser et al. 
2011).  Work in our own lab has demonstrated an increase in STX11 mRNA expression in 
the JAWS DC cell line within 1 hr of activation with toll like receptor (TLR) agonists 
(Collins., unpublished).  Interestingly BMDCs stimulated with TLR agonists produce low 
levels of IFN-γ, and are capable of increased production when stimulated in the presence of 
IL-12 (Hochrein et al. 2001).  STX11 may therefore play a similar regulatory role in IFN-γ 
regulation in DCs, indeed BMDCs isolated from Stx11-/- mice in our lab show increased 
levels of IFN-γ production compared to wild type controls when stimulated with TLR 
agonists (Collins., unpublished). 
Extracellular pathogens have been described and implicated in cases of FHL including 
protozoa, bacterial and fungal infections.  In fact, untreated FHL is rapidly fatal and most 
patients die from bacterial or fungal infections attributed in part to neutropenia (Janka 
2012).  Neutrophils have emerged as important mediators of Th17 controlled immune 
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resistance to extracellular pathogens (Mantovani et al. 2011).  Th17 cells produce CXCL8, 
a neutrophil chemo-attractant which is not produced by Th1 cells (Pelletier et al. 2010).  
IL-17A and IL-17F also stimulate epithelial cells to secrete granulopoietic factors and 
chemokines that favour recruitment, activation and prolonged survival of neutrophils in 
inflammation (Mantovani et al. 2011).  Our data shows that in the absence of STX11, Th17 
differentiation of T-cells is inhibited which may impair neutrophil recruitment and may in 
part explain the inability of FHL-4 patients lacking functional STX11 to clear fungal 
infections.  To our knowledge there are currently no data published on the CD4+ T-helper 
populations present in FHL-4 patients and further study is required to establish if decreased 
CD4+ IL-17 producing populations play a role in progression of disease.   
 
Our data shows that there is an increase in the number of IFN-γ producing cells in Stx11-/- 
Th1 polarised CD4+ T-cells compared to wild type cells.  This has been previously 
described in CD8+ T-cells, suggesting that T-cells share a common regulatory mechanism 
(D’Orlando et al. 2013; Kögl et al. 2013).  Contrary to this finding, naïve Th1 Stx11-/- cells 
had reduced levels of measured IFN-γ in supernatants despite increased mRNA expression 
of IFN-γ.  Interestingly, these cells had drastically reduced proliferation rates compared to 
wild type cells despite an increase in cell viability.  Significantly high levels of IL-10 and 
IL-21 were measured in the supernatants from the Th1 Stx11-/- cells, mRNA expression of 
these genes were also increased significantly.  IL-10 and IL-21 expression have been 
associated with Th1 cells late in development and are associated with an exhaustive T-cell 
state that acts as a self limiting mechanism to control the immune response (Salek-
Ardakani & Schoenberger 2013; Saraiva et al. 2009).  It is possible that the suppressive 
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effects of these cytokines inhibited proliferation of these cells in vitro.  A mouse model of 
FHL-4 has been generated by infecting Stx11-/- mice with lymphocytic choriomeningitis 
virus (LCMV) which present all clinical and lab features of hemophagocytic 
lymphohistiocytosis (HLH) (Kögl et al. 2013; Sepulveda et al. 2013).  Interestingly, Kögl 
et al (2013) showed that in contrast to mice with HLH caused by a lack in CD8+ associated 
perforin, the Stx11-/-
 
mouse model was non-fatal and unable to clear LCMV infection; this 
was attributed to an exhausted phenotype in CD8+ CTLs.  Despite elevated levels of IFN-γ 
producing cells and IFN-γ serum levels in early disease, CD8+ CTLs from Stx11-/-
 
mice 
took on an exhausted phenotype which could be reversed by blocking inhibitory pathways.  
An exhausted phenotype has been described in CD8+ and CD4+
 
T-cells and interestingly 
IFN-γ production is correlated with an advanced state of exhaustion before deletion (Yi et 
al. 2010) explaining the ability of these suppressed cells to be stimulated to secrete IFN-γ.  
In our experiment the inhibitory pathways were bypassed by the stimulation of the cells 
with PMA and ionomycin, as they are direct chemical inducers of protein kinase c and 
intracellular calcium channels (Carter et al. 2002).   
These data begin to suggest a role for T-helper cells in developing FHL-4 in STX11 
deficient patients.  This work and others have shown that STX11 is critical for regulating 
IFN-γ secretion in T-cells.  We have also shown that this inhibits the generation of Th17 
cells in vitro.  Among the clinical feature of HLH are high serum levels of pro-
inflammatory cytokines including IFN-γ.  HLH is usually fatal in early infants if untreated, 
however, HLH in STX11 deficient patients develop less severe disease associated with late 
onset, alleviated symptoms and longer periods of disease free remission compared to 
patients with perforin deficiency (Kögl et al. 2013).  Th1 responses are responsible for 
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clearance of intracellular pathogens and secrete large amounts of pro-inflammatory 
cyokines in order to mediate clearance.  Inability to control Th1 cells leads to severe 
autoimmune inflammation (Cope et al. 2011) thus, the reduced severity in FHL-4 patients 
could be attributed to an induced CD4+ exhausted phenotype in Th1 cells deficient in 
STX11.  Furthermore, patients are unable to clear extracellular pathogens which can result 
in onset of symptoms and death, this may be attributed to a lack of a Th17 driven immune 
response.  The exact mechanism for T-cell switching to an exhausted phenotype is not well 
understood but may be related to STX11 regulation, trafficking in the cell or IFN-γ 
secretion and signalling.  The use of these Stx11-/- cells may present a good model for 
studying the T-cell exhaustion pathway and provide some answers on its mechanism. 
 
While our data outline a possible regulatory function for STX11 in the differentiation of 
Th17 cells, further investigation is required to study this mechanism in vivo.  These data 
suggest that there is a role for T-helper cells in FHL-4 and it will be of great interest to 
further investigate Th17 cells in patients and murine models of disease.  Furthermore, 
although the DSS and C. rodentuim Th17 mediated models of inflammatory disease in this 
study agree with the in vitro data and clearly show a regulated increase of STX11 in 
correlation with IL-17 production and reduced IFN-γ; there is a need to investigate Th17 
differentiation of CD4+ cells in isolation in vivo.  Adoptive transfer of CD45RBHI cells 
from wild type mice into immune deficient mice lacking mature B- and T-cell lymphocytes 
leads to the development of colitis (Ostanin et al. 2009).  The adoptive transfer model of 
colitis is well studied and inflammation has been linked to the development of Th17 cells in 
the gut of the immune deficient mice (Shale et al. 2013).  Adoptive transfer of naïve cells 
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from Stx11-/- mice into immune deficient mice presents an ideal model for in vivo study of 
STX11 regulation in Th17 differentiation of CD4+ T-helper cells.        
In summary we propose a novel mechanism that upon activation in Th17 polarising 
conditions, STAT3 or more than likely TGF-β1 mediated signalling induces CD4+ T-cells 
to upregulate the expression of STX11.  STX11 then inhibits IFN-γ production preventing 
the T-bet mediated inhibition of RORγt and allows cells to differentiate into a Th17 
phenotype.  Furthermore we suggest a role for CD4+ T-cells in FHL-4 STX11 deficient 
patients in which CD4+ Th1 cells become exhausted due to dysregulated IFN-γ production 
and suppress the immune response leading to decreased severity in disease.  In parallel, 
inhibition of Th17 cell leaves patients susceptible to extracellular pathogens.  Further study 
of the mechanics of STX11 regulation in Th17 and Th1 cells will lead to elucidation of the 
trafficking pathways in these cells and a better understanding of their regulation in disease.   
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APPENDIX A – MEDIA AND BUFFERS  
 
 
COMPLETE RPMI 1640 500 ml 
 
Heat inactivated Foetal bovine serum (FBS)    10% 
Penicillin/streptomycin/L-glutamine Culture Cocktail  2% 
(Gives a final concentration of 2 mM L-glutamine, 
100 μg/ml penicillin and 100 U/ml streptomycin) 
PHOSPHATE BUFFERED SALINE (PBS) 
Na2HPO4.2H2O       8.0 mM  
KH2PO4        1.5 mM 
NaCl        137 mM 
KCl         2.7 mM 
Dissolve in H2O and pH to 7.4 
TRIS BUFFERED SALINE (TBS) pH 7.6 
NaCl         1.5 M 
Trizma Base        0.2 M 
Dissolve dH2O pH to 7.6 
TBST 
Add 0.05% Tween-20 to 1x TBS 
FACS BUFFER 
FCS     2% 
NaN3    0.05% 
Dissolved in PBS 
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SORTING BUFFER 
FCS     1% 
EDTA    1 mM 
HEPES   25 mM    
Dissolved in PBS 
TAE BUFFER 
TRIS    40 mM 
ACETIC ACID  20 mM 
EDTA    1 mM     
Dissolved in H2O 
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APPENDIX B – PRIMER EFFICIENCY CURVES 
TBP
10 -11 10-10 10 -9 10 -8 10-7 10 -6 10-5 10 -4 10-3
10
20
30
40
Quantity
Ct
 
GusB
10 -11 10 -10 10 -9 10 -8 10 -7 10 -6 10-5 10 -4 10 -3
10
20
30
40
Quantity
Ct
GAPDH
10 -11 10 -10 10 -9 10 -8 10 -7 10 -6 10-5 10 -4 10 -3
10
20
30
40
Quantity
Ct
 
 
 
 
 
 
R2 = 0.9937  Efficiency = 93.8% 
 
Dynamic Range = 14-28 Ct 
 
 
 
R2 = 0.9925  Efficiency = 100.5% 
 
Dynamic Range = 14-30 Ct 
 
 
R2 = 0.9989  Efficiency = 99.7% 
 
Dynamic Range = 19-32 Ct 
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Vti1a
10 -11 10-10 10 -9 10-8 10 -7 10-6 10 -5 10 -4 10-3
10
20
30
40
Quantity
Ct
 
 
Vti1b
10 -11 10 -10 10 -9 10 -8 10 -7 10 -6 10 -5 10 -4 10 -3
10
20
30
40
Quantity
Ct
 
SNAP23
10 -11 10-10 10 -9 10-8 10 -7 10-6 10 -5 10 -4 10-3
10
20
30
40
Quantity
Ct
 
 
 
R2 = 0.9976  Efficiency = 94.5% 
 
Dynamic Range = 23-33 Ct 
 
 
 
R2 = 0.9989  Efficiency = 94.3% 
 
Dynamic Range = 17-35 Ct 
 
 
 
R2 = 0.9908  Efficiency = 99.3% 
 
Dynamic Range = 21-35 Ct 
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VAMP 1
10 -11 10 -10 10 -9 10 -8 10 -7 10 -6 10 -5 10 -4 10 -3
10
20
30
40
Quantity
Ct
 
VAMP 2
10-11 10-10 10-9 10-8 10-7 10-6 10-5 10 -4 10 -3
10
20
30
40
Quantity
Ct
 
VAMP 7
10 -11 10 -10 10 -9 10 -8 10 -7 10 -6 10 -5 10 -4 10 -3
10
20
30
40
Quantity
Ct
 
 
 
 
 
 
R2 = 0.9933  Efficiency = 100.2% 
 
Dynamic Range = 15-35 Ct 
 
 
 
R2 = 0.9733  Efficiency = 93.6% 
 
Dynamic Range = 25-35 Ct 
 
 
 
R2 = 0.9922  Efficiency = 96.9% 
 
Dynamic Range = 19-35 Ct 
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VAMP 8
10-11 10 -10 10 -9 10-8 10 -7 10 -6 10-5 10 -4 10 -3
10
20
30
40
Quantity
Ct
 
 
 
R2 = 0.9997  Efficiency = 91.4% 
 
Dynamic Range = 14-28 Ct 
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STX1
10-11 10-10 10-9 10 -8 10 -7 10 -6 10 -5 10 -4 10 -3
10
20
30
40
Quantity
Ct
STX2
10 -11 10-10 10-9 10 -8 10 -7 10 -6 10 -5 10 -4 10-3
10
20
30
40
Quantity
Ct
STX3
10 -11 10-10 10-9 10 -8 10 -7 10 -6 10 -5 10 -4 10-3
10
20
30
40
Quantity
Ct
 
 
 
 
 
 
 
 
 
 
R2 = 0.9760  Efficiency = 93.6% 
 
Dynamic Range = 30-34 Ct 
 
 
 
 
R2 = 0.9760  Efficiency = 101.7% 
 
Dynamic Range = 25-35 Ct 
 
 
 
R2 = 0.9894  Efficiency = 102.9% 
 
Dynamic Range = 16-28 Ct 
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STX4a
10-11 10-10 10-9 10-8 10-7 10-6 10-5 10-4 10-3
10
20
30
40
Quantity
Ct
 
 
STX5a
10-11 10 -10 10-9 10 -8 10-7 10-6 10 -5 10 -4 10-3
10
20
30
40
Quantity
Ct
STX5L
10-11 10 -10 10-9 10 -8 10-7 10-6 10 -5 10 -4 10-3
10
20
30
40
Quantity
Ct
 
 
 
 
 
 
 
 
 
R2 = 0.9879  Efficiency = 92.1% 
 
Dynamic Range = 15-34 Ct 
 
 
 
R2 = 0.9851  Efficiency = 103.4% 
 
Dynamic Range = 14-29 Ct 
 
 
 
R2 = 0.9958  Efficiency = 95.7% 
 
Dynamic Range = 15-31 Ct 
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STX11
10-11 10-10 10-9 10-8 10 -7 10 -6 10-5 10 -4 10-3
10
20
30
40
Quantity
Ct
 
RORγt
10 -11 10 -10 10 -9 10 -8 10 -7 10 -6 10-5 10 -4 10-3
10
20
30
40
Quantity
Ct
T-bet
10-11 10-10 10-9 10-8 10 -7 10 -6 10-5 10 -4 10-3
10
20
30
40
Quantity
Ct
 
 
 
 
 
 
R2 = 0.9978  Efficiency = 91.5% 
 
Dynamic Range = 22-33 Ct 
 
 
 
R2 = 0.9997  Efficiency = 98.8% 
 
Dynamic Range = 15-32 Ct 
 
 
 
R2 = 1.000  Efficiency = 99.9% 
 
Dynamic Range = 13-30 Ct 
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IL-21
10-11 10 -10 10-9 10 -8 10-7 10-6 10 -5 10 -4 10 -3
10
20
30
40
Quantity
Ct
 
IFN-γ
10 -11 10-10 10 -9 10 -8 10 -7 10 -6 10 -5 10 -4 10-3
10
20
30
40
Quantity
Ct
IL-10
10-11 10-10 10-9 10-8 10 -7 10 -6 10-5 10 -4 10-3
10
20
30
40
Quantity
Ct
 
 
R2 = 0.9978  Efficiency = 91.5% 
 
Dynamic Range = 22-33 Ct 
 
9 9 8
14 1
 
 
R2 = 0.9993  Efficiency = 101.78% 
 
Dynamic Range = 14-30 Ct 
 
 
 
R2 = 0.9982  Efficiency = 99.7% 
 
Dynamic Range = 13-33 Ct 
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APPENDIX C – PRIMER SEQUENCES 
 
IDT PRIMER SEQUENCES 
 
Gusb 
 
Primer 1  5'-GAG AACTGGTAT AAG ACG CAT CA-3' 
Primer 2  5'-GAA CAG CCT TCT GGT ACT CC-3' 
  
Tbp 
 
Primer 1 5'-TTC ACC AAT GACTCC TAT GAC C-3' 
Primer 2 5'-CAA GTT TAC AGC CAA GAT TCA CG-3' 
  
Stx11 
 
Primer 1  5'-GAA GCA GTA GAG AGC GTA GAA C-3' 
Primer 2  5'-TCCTGG ACA ATT CTT GAA GCT C-3' 
  
Il17a 
 
Primer 1 5'-AGA CTA CCT CAA CCGTTC CA-3' 
Primer 2 5'-GAG CTT CCC AGATCA CAG AG-3' 
  
Il23r 
 
Primer 1 5'-CAT CCC ACG AAC CTC AGA AG-3' 
Primer 2 5'-CAA GAA GAC CAT TCC CGA CAA-3' 
  
Tbx21 
 
Primer 1 5'-TTC AAC CAG CAC CAG ACA G-3' 
Primer 2 5'-CAA GAC CAC ATC CAC AAA CAT C-3' 
  
Il2r 
 
Primer 1 5'-CTG CCT CTT CCT GCT CAT C-3' 
Primer 2 5'-GCT CTG ACT TTT CTA GCT TGC T-3' 
  
Il21 
 
Primer 1 5'-TGA CTT GGATCC TGA ACT TCT ATC-3' 
Primer 2 5'-GGT TTG ATG GCT TGA GTT TGG-3' 
  
Il2 
 
Primer 1 5'-GCA GGATGG AGA ATT ACA GGA A-3' 
Primer 2 5'-GCA GAG GTC CAA GTT CAT CTT C-3' 
  
Ifngr1 
 
Primer 1 5'-TTG AAC CCT GTC GTATGC TG-3' 
Primer 2 5'-ATG ATC AGA AAT GTT GGT GCA G-3' 
  
Rorc 
 
Primer 1 5'-TCT GCA AGA CTC ATC GAC AAG-3' 
Primer 2 5'-GAG GTG CTG GAA GAT CTG C-3' 
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SIGMA PRIMER SEQUENCES 
Ifng 
 
Primer 1 5'-ATG AAC GCT ACA CAC TGC ATC-3' 
Primer 2 5'-CCA TCC TTT TGC CAG TTC CTC-3'  
  
Sec22 
 
Primer 1 5’-GCT AAC AAT TTG TCC AGT CTA TC-3’ 
Primer 2 5’-AAC CGC ACA TAC ACT ATC AG-3’ 
  
Snap23 
 
Primer 1 5’-GTT CTT GCT CAG GCT TCC-3’ 
Primer 2 5’-CCA ACC AAC CAA TAC CAA TAA TG-3 
  
Stx1 
 
Primer 1 5’-CAC CCA CTG CTC CAT TCT-3’ 
Primer 2 5’-CAC ACA CTG TCA CAA GAT CAT-5’ 
  
Stx2 
 
Primer 1 5’-GGT GGC AAA GGT GAT GTT-3’ 
Primer 2 5’-CAG GTA TGG TCG GAG TCA-3’ 
  
StX3 
 
Primer 1 5’-CCA CAA CCA CTA GCA TCA TAA-3’ 
Primer 2 5’-CTC AAG AGA TAT TCC GCC TTA A-3’ 
  
Stx4 
 
Primer 1 5’-GGT GTC AAG TGT GAG AGA G-3’ 
Primer 2 5’-AAC CTC ATC TTC ATC GTC TG-3’ 
  
Vamp1 
 
Primer 1 5’-CCC TCT GTT TGC TTT CTC A-3’ 
Primer 2 5’-CGT TGT CTT CGG GTA GTG-3’ 
  
Vamp2 
 
Primer 1 5’-CTC CTT CCC TTG GAT TTA ACC-3’ 
Primer 2 5’-TGA AAC AGA CAG CGT ATG C-3’ 
  
Vamp7 
 
Primer 1 5’-GAT GGA GAC TCA AGC ACA AG-3’ 
Primer 2 5’-GAC ACA ATG ATA TAG ATG AAC ACA AT-3’ 
  
Vamp8 
 
Primer 1 5’-GGC GAA GTT CTG CTT TGA-3’ 
Primer 2 5’-CTT GAC TCC CTC CAC CTC-3’ 
  
Vti1b 
 
Primer 1 5’-TAC CTT GGA GAA CGA GCA T-3’ 
Primer 2 5’-TGG ACA TTG AGC GAA GAA TC-3’ 
 
